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Addiction is a chronic, progressive disorder caused by repetitive drug use, which leads to 
long-lasting synaptic alterations in the brain. Drugs of abuse are powerful reinforcers that 
‘hijack’ specific brain circuits that control reward-motivated behaviors, creating a maladaptive 
state that can trigger craving and relapse, even after prolonged periods of abstinence. 
Environmental contexts and cues that are present during drug use can later evoke drug-related 
memories that promote drug-seeking conditioned responses. Despite recent attempts to treat 
addiction with a combination of behavioral and pharmacological tools, success has been limited, 
mainly because the underlying mechanisms that govern drug-associated memories have not been 
fully elucidated. Studying the neural circuits and the synaptic and molecular underpinnings of 
drug-associated memories may uncover a means to reduce their salience, thereby reducing the 
likelihood of relapse.  
The amygdala is important for integrating sensory information during cue-dependent 
learning and is activated by both fear- and drug-related stimuli. Preclinical models have shown 
that the amygdala activates behavioral responses to fear- or drug-conditioned cues. 
Neuroadaptations within amygdala-based circuits have been examined in models of aversive 
learning but have not been well studied during reward-based learning, especially in the context 
of drugs of abuse. The work presented in this dissertation focuses on understanding the circuit-
specific synaptic and molecular changes that occur within the amygdala both during the 
formation of a drug-cue memory and upon subsequent re-exposure to drug-related cues. Through 
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a combination of electrophysiological, molecular, optogenetic, and behavioral techniques we 
find that repeated self-administration of cocaine, paired with an audiovisual cue, involves 
strengthening of auditory thalamic, but not cortical, synapses in the lateral amygdala. We also 
find that reversing drug-cue induced plasticity in this pathway, either through extensive cue re-
exposure or by optical induction of postsynaptic LTD, inhibits cue-elicited relapse-like behavior. 
Finally, we show that specific pharmacological manipulations of an intracellular signaling 
pathway involved in bidirectional regulation of synaptic activity can interfere with 
reconsolidation and promote extinction of a drug-cue memory. Together, these studies suggest a 
projection-specific mechanistic approach for the inhibition of drug-cue memory, which may be 
informative for future pharmacobehavioral relapse prevention strategies. 
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1.0  INTRODUCTION: ADDICTION AS A DISORDER OF LEARNING AND 
MEMORY SYSTEMS 
Within the brain, there exists a set of evolutionarily conserved neural systems responsible for 
controlling primitive biological functions that are vital for survival. One of these systems is 
known as the mesocorticolimbic system, a series of interconnected brain regions that govern 
reward, learning and memory, emotion, and executive function. Activity within the 
mesocorticolimbic system is necessary for the procurement of naturally-occurring positive 
reinforcers, such as food and sex, and is accompanied by a pleasurable sensation that motivates 
future reward-driven behaviors (Berridge and Kringelbach, 2015). Drugs of abuse, including 
psychomotor stimulants (like cocaine and methamphetamine) also activate the 
mesocorticolimbic system, which enhances locomotor activity aimed towards obtaining the drug 
(Kalivas et al., 2005; Yeh and Haertzen, 1991). Repeated drug exposure can result in behavioral 
sensitization as well as tolerance, which necessitates an escalation in drug use in order to achieve 
the original psychophysiological response (Morgan et al., 2006; Robinson and Berridge). 
Additionally, by engaging brain areas involved in learning and memory, individuals remember 
the circumstances surrounding the rewarding experience. In this manner, drug use is reinforced, 
thus promoting a chronic, progressive increase in substance use that induces long-lasting 
neuroadaptations within the mesocorticolimbic system. Over time, these changes to the neural 
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circuitry can result in a shift from reward-driven behavior to the more compulsive behaviors that 
are characteristic of addiction, or substance use disorders (SUDs) (Hyman et al., 2006; Piazza 
and Deroche-Gamonet, 2013).  
Addiction is a highly prevalent disorder. Approximately 1 in 12 adults (8% of the 
population) struggles with substance abuse (National Household Survey on Drug Abuse, 2016). 
Drug use also represents a huge economic burden, whereby 600 billion dollars per year is lost 
due to substance abuse (National Household Survey on Drug Abuse, 2016). Addiction is 
characterized by repetitive cycles of drug use, withdrawal, abstinence, and relapse; throughout 
these periods, drug use continues despite the occurrence of sometimes severe, negative 
consequences (i.e. withdrawal, negative social relationships, economic hardship). A major 
problem facing individuals with a SUD is the dilemma of either engaging in drug-seeking 
behavior, which has immediate short-term rewarding effects, or maintaining abstinence, which 
has more long-term benefits. However, because drugs of abuse interact with and strengthen the 
connections within a system that is already evolutionarily hardwired for survival, SUDs are 
extremely difficult to overcome. Indeed, drug-induced alterations within the mesocorticolimbic 
system have been directly linked to craving and relapse-like behavior (Engblom et al., 2008; 
Mameli et al., 2011; Nugent et al., 2007). During early abstinence there is a progressive increase 
in craving during which time affected individuals are extremely vulnerable to relapse. Craving 
also remains elevated during prolonged abstinence (Gawin and Kleber, 1986; Kassani et al., 
2015; Miller et al., 2012), so as the duration of abstinence increases, the risk of relapse remains. 
Recent surveys by the National Institute of Health estimate relapse rates to be between 40-60%, 
and even as high as 90% for alcohol (National Household Survey on Drug Abuse, 2016). This 
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high tendency for relapse is perhaps the biggest challenge for the successful treatment of 
addiction (Sinha et al., 2011). 
Treatment of SUDs is therefore aimed at reducing the risk of relapse and sustaining 
abstinence. Over time, the weakening and strengthening of specific synapses by drugs of abuse 
generates abnormally strong, long-lasting memories of drug use. One strategy for preventing 
relapse has been to interfere with these “drug-associated memories.” Oftentimes, neutral 
environmental stimuli, or cues, that are present during drug use can become predictors of drug 
availability, thus acting as conditioned reinforcers (Di Ciano and Everitt, 2003; Stewart, 1992). 
Specific drug-associated cues can vary widely across individuals but can include friends and 
family members with whom the individual engaged in drug-related behaviors, a specific context 
or location in which drugs were formerly used, and drug paraphernalia. Generally, these stimuli 
are grouped into either contextual or discrete cues (Back et al., 2014; Marchant et al., 2015; 
O’Brien et al., 1992). Evidence from clinical and preclinical research suggests that re-exposure 
to these drug-paired cues triggers drug-related memories that remind the individual of past drug 
use and activate the drug-adapted reward pathways, ultimately leading to craving and relapse.  
Attempts to study the neural mechanisms that promote the activation of drug-associated 
memories have been undertaken with the hopes of developing an effective treatment medication; 
however, few pharmacological options have been found that can successfully prevent relapse 
across an extended period of time (Bossert et al., 2013; Tiffany and Conklin, 2002). Likewise, 
recent clinical efforts have utilized behavioral strategies aimed at suppressing drug-related 
memories, but behavioral approaches alone have also proven to be widely insufficient for 
maintaining abstinence. Interestingly, these strategies are highly effective at disrupting the 
emotionally-salient memories that form the basis of anxiety disorders, such as post-traumatic 
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stress disorder (PTSD). For example, cue exposure therapy (CET) can reduce the likelihood of 
fearful stimuli to evoke a detrimental stress response (Marin et al., 2015), and the effects of cue 
exposure can be enhanced by combining it with specific pharmacological compounds (Hofmann 
et al., 2006; Norrholm et al., 2016; Ressler et al., 2004). These same ideas have been utilized for 
the treatment of drug dependence; however, despite observed success of CET in the clinical 
setting, drug-seeking behavior is often renewed when the patient returns to the original drug-
paired environment and is re-exposed to drug-associated stimuli (Crombag et al., 2008; 
Thewissen et al., 2006). Clinical efforts that use both behavioral therapies and treatment 
medication have yielded the highest success rates at reducing the strength of drug-associated 
memories (Cleva et al., 2010; Torregrossa and Taylor, 2016). Many of the neural processes that 
regulate fear-associated memories have proven to play a role in drug-related memories as well, 
which has been useful for proposing candidates for pharmacological intervention (Milton and 
Everitt, 2010; Monfils et al., 2009). Still, compounds that enhance CET in patients with PTSD, 
have had mixed results in individuals with a SUD (Price et al., 2013; Santa Ana et al., 2009), 
suggesting that there may be important differences in the neural mechanisms that regulate fear- 
vs. drug-associated memories. Continuing to study the specific circuits and cellular mechanisms 
involved in the formation, storage, and maintenance of drug-induced maladaptive memories may 
prove useful for the development of a successful intervention for drug addiction that has long-
lasting inhibitory effects on relapse. 
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1.1 NEURAL MECHANISMS OF LEARNING AND MEMORY 
In order to learn about their environment and survive, most organisms need acquired information 
to be stored as a memory that can later be accessed, updated, and modified as new information 
about the given environment is learned. The organism then utilizes this information to make 
decisions and direct their behavioral response. This type of learning, in which behavioral 
responses are guided by an environmental stimulus is known as associative learning. Two types 
of associative learning exist: classical (Pavlovian) conditioning and operant (instrumental) 
conditioning (Jones and Skinner, 1939; Pavlov, 1927; Robinson and Berridge). In classical 
conditioning, a neutral environmental stimulus is repeatedly paired with a biologically relevant 
unconditioned stimulus (US), so that an association between the two stimuli forms. The 
previously neutral stimulus then becomes a conditioned stimulus (CS) that, when presented 
alone, can trigger a conditioned response (CR) that is similar to the unconditioned response. The 
classic example is the pairing of a bell (CS) every time a dog is given food, which triggers 
reflexive salivation (US); eventually ringing of the bell alone can induce salivation (Pavlov, 
1927). On the other hand, operant conditioning involves the modification of a behavioral 
response based on the outcome of a given action. The behavior can be increased if the response 
is reinforced (by reward) or decreased if the response is punished (Jones and Skinner, 1939). An 
example of this is when an individual learns that touching a hot stove burns his/her hand. As will 
be discussed in subsequent sections, both classical and operant conditioning are important 
principles that underlie drug-related memories and relapse-like behavior. However, it is 
important to first consider the cellular and molecular mechanisms that occur within neurons that 
enable these learning processes to occur. These mechanisms regulate the various stages of 
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learning and can serve as potential targets for manipulating the stability of maladaptive drug-
related memories. 
1.1.1 Synaptic and molecular mechanisms of learning and memory 
Hebbian learning suggests that memories form through the simultaneous activation of a set of 
neurons, which increases the synaptic strength between those neurons (Hebb, 1949). Hebb’s 
theory forms the basis of spike-timing dependent plasticity (STDP), whereby connections 
between two neurons are strengthened or weakened in a temporally-specific manner. This input-
specificity ensures that only synapses experiencing correlated activity will be modified. 
Typically, a synapse tends to be strengthened if, over time, a postsynaptic neuron depolarizes 
and fires an action potential immediately (10-20 ms) after receiving synaptic input from a given 
presynaptic neuron (Levy and Steward, 1983; Magee and Johnston, 1997; Markram et al., 1997). 
Conversely, synapses can be weakened if the order of firing reverses so that the postsynaptic 
neuron tends to fire prior to receiving the synaptic input (Bi and Poo, 2001). The refinement of 
synapses via STDP is an important hallmark of development and occurs universally throughout 
the nervous system (Katz and Shatz, 1996). A diverse set of cellular machinery is required at 
both the synaptic and molecular level for synaptic modifications to occur. Organisms have also 
developed specific neuroanatomical systems that specifically utilize these mechanisms for the 
formation, storage, and updating of memories. Importantly, drugs of abuse have actions at the 
neuroanatomical systems involved in memory (e.g. cocaine and amphetamine acting at the 
dopamine transporter; See Section 1.2) and exert their effects through many of the same cellular 
and molecular substrates, which accounts for drug-dependent learning. 
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The strengthening and weakening of synapses occurs through mechanisms known 
respectively as long-term potentiation (LTP) and long-term depression (LTD) (Bi and Poo, 1999; 
Malenka and Bear, 2004). Activity-dependent synaptic plasticity takes place universally 
throughout the nervous system at both glutamatergic and GABAergic synapses, and at both the 
pre- and postsynaptic membrane. A discussion of GABAergic synaptic plasticity is beyond the 
scope of this dissertation; however, it should be noted that activity at local inhibitory synapses is 
likely an important factor in the regulation of memory (Vogels et al., 2011). Excitatory synapses 
are referred to as asymmetric synapses because of the enriched postsynaptic density (PSD) 
(Carlin et al., 1980; Walikonis et al., 2001) that is host to an array of structural proteins (F-actin, 
integrins, AKAP5), intracellular signaling proteins (protein kinase A (PKA), protein kinase C 
(PKC), Ca2+/calmodulin-dependent kinase II (CaMKII), calcineurin (CaN), and protein 
phosphatase 1 (PP1)), and receptors (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptors (AMPAR) and N-methyl-ᴅ-aspartate receptors (NMDAR)) (Bosch et al., 2014; Gipson 
et al., 2014; Malenka et al., 1989; Moczulska et al., 2013). Glutamatergic postsynaptic sites are 
typically contained within transient, specialized structures known as dendritic spines. The shape, 
size, and number of dendritic spines are all indicators of synaptic strength (Meyer et al., 2014; 
Oh et al., 2013). Large, mushroom-shaped spines are thought to be more stable, and an increase 
in spine density is characteristic of a potentiated-state. 
The most commonly observed forms of long-term plasticity at glutamatergic synapses are 
NMDAR-dependent LTP and LTD (Kauer and Malenka, 2007; See Figure 1). NMDA-dependent 
LTP and LTD both require presynaptic glutamate release, concurrent with time-dependent 
AMPAR-mediated depolarization of a postsynaptic neuron. Postsynaptic depolarization 
displaces Mg2+ ions from the channel pore of NMDAR, allowing Ca2+ and other ions to enter the 
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postsynaptic neuron and subsequently activate protein kinases and phosphatases, which have 
downstream phosphorylation or dephosphorylation activity, respectively (Klann et al., 1991; 
Levy and Steward, 1983; Malenka et al., 1989). Depending on the concentration of Ca2+ and the 
balance between protein kinase and phosphatase activity, either LTP or LTD can occur. 
Synapses that receive the most consistent input undergo structural alterations that result in their 
stability (LTP), while those that are activated less frequently may be weakened or destabilized 
(LTD) (Hasegawa et al., 2015; Lüscher et al., 2000). Typically, LTP is triggered through high-
frequency presynaptic burst activity that results in transiently-elevated Ca2+ levels, although there 
are instances of LTP also being induced from low-frequency stimulation (Malenka et al., 1999). 
High levels of Ca2+ preferentially activates kinases (PKA, PKC, and CaMKII) that result in 
upregulated gene expression, increased protein synthesis, and/or the phosphorylation of several 
synaptic proteins, including AMPAR (Abel et al., 1997; Boehm et al., 2006; Sanhueza and 
Lisman, 2013). The phosphorylation of specific amino acids on AMPAR initiate its transport, 
insertion, and stability at the postsynaptic membrane (Lee et al., 2000; Malinow and Malenka, 
2002; Whitehead et al., 2013). Experimentally, measurements of LTP include increases in spine 
size and density as well as increased AMPA:NMDA ratios (Chen and Roche, 2007; Collin et al., 
1997; Hayashi, 2000).  
NMDA-dependent LTP involves activity of CaMKIIα (Figure 1), a protein that is 
necessary for various learning tasks (Coultrap et al., 2014; Lisman et al., 2012; Sanhueza et al., 
2011). For example, CaMKIIα knockout mice have deficits in LTP that correlate with 
impairments in hippocampal-dependent spatial learning (Silva et al., 1992a, 1992b). CaMKIIα is 
a dodecameric protein (consisting of 12 subunits) that is activated following Ca2+ influx through 
NMDAR. Ca2+ forms a complex with calmodulin (CaM) that binds CaMKIIα, initiating auto- 
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Figure 1. Mechanisms of excitatory synaptic plasticity. 
Simplified schematic of cellular mechanisms that regulate NMDAR-dependent forms of synaptic plasticity. 
Glutamatergic afferents form synapses primarily at dendritic spines. Under baseline conditions, the hyperpolarized 
postsynaptic neuron is minimally activated due to the block of NMDAR by Mg2+ ions, which prevents the influx of 
Ca2+ and other ions. However, under conditions of increased activity (brief, high frequency stimulation) postsynaptic 
depolarization removes Mg2+ ions from the NMDAR pore. When glutamate binds the NMDAR, Ca2+ ions enter the 
postsynaptic neuron. The relatively high level of Ca2+ activates kinases, including CaMKIIα, which is also 
dependent on CaM. CaMKIIα autophosphorylates and then phosphorylates several downstream proteins, including 
AMPAR GluA1 subunits. The phosphorylation of AMPAR results in its translocation and insertion in the synaptic 
membrane, leading to an increase in AMPA:NMDA and potentiation. Similar mechanisms underlie the 
reconsolidation of associative memories. Under conditions of sustained, subthreshold activity (long durations of low 
frequency stimulation) the postsynaptic is not as strongly depolarized, leading to a smaller influx of Ca2+ ions, for 
example through L-type voltage-gated Ca2+ channels (not pictured). The relatively low level of Ca2+ preferentially 
activates phosphatases, including CaN, which is also dependent on CaM activity. CaN activation causes the 
dephosphorylation of other phosphatases and results in the dephosphorylation of AMPAR GluA1 subunits, followed 
by the internalization of AMPAR and decrease in AMPA:NMDA. This mechanism of depotentiation is likely 
responsible for the extinction of associative memories. CaMKII: calcium/calmodulin-dependent protein kinase II; 
CaN: calcineurin; CaM: calmodulin. 
10 
 
phosphorylation at Thr286 (Baucum et al., 2015; Rodrigues, 2004), and leads to the translocation 
of CaMKIIα to the synapse, where it directly phosphorylates the AMPAR subunit GluA1 at 
Ser831 which primes AMPAR for synaptic insertion, thereby increasing channel conductance (El 
Gaamouch et al., 2012; Kristensen et al., 2011; Lemieux et al., 2012; Lu et al., 2010). The 
complex structure of CaMKIIα and its capacity for auto-phosphorylation makes it suitable for the 
regulation of synaptic activity. Once a single subunit is phosphorylated at Thr286, neighboring 
subunits can subsequently be phosphorylated, giving rise to the autonomous activity of the 
protein (Coultrap and Bayer, 2012). CaMKIIα can function autonomously even after its substrate 
for activation, Ca2+, falls below baseline levels. As a result, the protein can retain long-term 
modification and cause a cascade of molecular events over a longer course of time following a 
brief activation period, consistent with the theory for how LTP shapes learning and memory 
formation. CaMKIIα acts to mediate dendritic spines through its actions at synaptic proteins 
including the actin-binding protein, α-actinin, the guanine nucleotide exchange factor, kalirin-7, 
and cyclin-dependent kinase 5 (Hosokawa et al., 2006; Ma et al., 2008; Walikonis et al., 2001). 
CaMKIIα also forms a complex with NMDAR, by binding to the GluN2B subunit, that is 
thought to provide synaptic stability and contribute to long-term information storage (Coultrap 
and Bayer, 2012). CaMKIIα activity influences other signaling pathways that are involved in 
memory processes, including the PI3K/mTOR pathway (Joyal et al., 1997). 
NMDAR-dependent LTD arises from low-frequency presynaptic activity combined with 
a smaller-magnitude postsynaptic depolarization that results in a sustained, but lower Ca2+ 
concentration (Figure 1). This form of LTD is also dependent on activation of L-type voltage-
gated Ca2+ channels (LTCC), which are activated subsequent to NMDAR and because of their 
long activation duration, allow a more sustained increase in intracellular Ca2+ that preferentially 
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activates phosphatases (Bi and Poo, 1998; Ghosh et al., 2017). One phosphatase that is 
particularly important for this form of plasticity is CaN, a Ca2+/CaM-dependent phosphatase that, 
when activated initiates a sequence that leads to dephosphorylation of AMPAR, initiating their 
internalization. (Baumgartel and Mansuy, 2012; Mulkey et al., 1994). CaN is often described as 
a negative regulator of CaMKIIα activity (Wen et al., 2004) because the frequency and duration 
of Ca2+ input controls the relative activation of the two proteins and is an important predictor of 
the direction of synaptic activity (LTP vs LTD) (Lüscher and Malenka, 2012). CaN is a 
heterodimer composed of a catalytic A subunit and a regulatory B subunit (Mumby and Walter, 
1993). Sequential conformational changes following binding of Ca2+ and calmodulin to CaNB 
activates the phosphatase by allowing displacement of a CaNA autoinhibitory domain (Shen et 
al., 2008). CaN has both direct and indirect actions at postsynaptic proteins that promote 
depotentiation. CaN directly dephosphorylates GluA1 at Ser845 (the PKA phosphorylation site). 
Phosphorylation of Ser845 drives AMPAR membrane insertion and is associated with enhanced 
AMPAR current (Beattie et al., 2000; Man et al., 2007; Roche et al., 1996). CaN also directly 
dephosphorylates the A-type K+ channel, Kv4.2, which is itself a negative regulator of plasticity 
(Jung et al., 2008). Dephosphorylation of Kv4.2 by CaN leads to its stabilization in the 
membrane, thereby promoting LTD. Finally, CaN dephosphorylates a peptide known as 
inhibitor-1, which subsequently activates PP1 and protein phosphatase 2A, which function to 
inactivate LTP-promoting kinases (Mulkey et al., 1994). The internalization of AMPAR is linked 
to changes in spine morphology, decreased spine density and decreased AMPA:NMDA ratios, 
which are features of LTD (Beattie et al., 2000; Lu et al., 2000; Sanderson et al., 2016).  
In addition to CaMKII and CaN, several other intracellular signaling molecules can 
contribute to LTP and LTD.  The activation of G-protein coupled metabotropic receptors (e.g., 
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metabotropic glutamate receptors; mGluRs, dopamine receptors) can activate or inhibit PKA via 
effects on adenylyl cyclase and cyclic adenosine monophosphate (cAMP). PKA phosphorylates 
GluA1 at Ser845, which promotes insertion into the postsynaptic membrane (Zhang et al., 2016). 
Other metabotropic receptors (e.g., serotonin receptors, mGluR1) can activate phospholipase C 
(PLC), an important enzyme in the production of inositol 1,4,5-triphosphate (IP3), which induces 
release of Ca2+ from internal stores (Fukami et al., 2010). Diacyl glycerol (DAG), a byproduct of 
this reaction, induces PKC activation, which also has LTP-like effects (Malinow et al., 1989). 
Additionally, PLC initiates synthesis of endocannabinoids that retrogradely activate presynaptic 
CB1 receptors and leads to a presynaptic form of LTD characterized by decreased glutamate 
release (Andrade-Talavera et al., 2016). Finally, LTP can also be induced presynaptically, when 
repetitive synaptic activity increases presynaptic Ca2+ activation of PKA, leading to 
phosphorylation of proteins (Rab3a, RIM1α) that increase presynaptic glutamate release (Wong 
and Stanley, 2010). Increases and decreases in glutamate release probability are associated with 
presynaptic potentiation and depression, respectively. Experimental measures of presynaptic 
plasticity include paired pulse ratio (PPR) and frequency of spontaneous excitatory postsynaptic 
currents (EPSC). PPR is inversely correlated with presynaptic strength, such that decreases in 
PPR are associated with increased neurotransmitter release probability, and vice versa 
(Kleschevnikov et al., 1997). Conversely, measurements of postsynaptic plasticity include 
AMPA:NMDA ratio and EPSC amplitude. As will be described throughout this dissertation, 
these measurements are important for helping deduce the underlying mechanisms responsible for 
changes in synaptic plasticity. 
Finally, other neurotransmitters, especially neuromodulators such as dopamine (DA) 
have a prominent role in the regulation of synaptic plasticity at glutamatergic synapses (Ciranna, 
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2006; Hamilton et al., 2010; Otani et al., 2015; Sun et al., 2005). There are two primary classes 
of DA receptors: D1- and D2-like. D1-like receptors (D1R) are Gs/Gq-coupled and stimulate the 
production of adenylyl cyclase, which increases cAMP and enhances neural activity. Conversely, 
D2-like receptors (D2R) are Gi/o-coupled proteins that when activated, have opposing effects to 
D1R, and are therefore associated with decreased neural activity (Beaulieu and Gainetdinov, 
2011; Li and Rainnie, 2014). Both D1R and D2R mediate several downstream effectors, which 
facilitates synaptic changes that can ultimately result in LTP or LTD (Otani et al., 1998; 
Roggenhofer et al., 2010). D1R increase the activity of protein kinases (Chergui and Lacey, 
1999; Gutierrez-Arenas et al., 2014; Matsuyama et al., 2002), enhancing downstream 
phosphorylation; for example, phosphorylation of DARPP-32 (DA and cAMP-regulated 
phosphoprotein, 32kDA) by PKA regulates excitatory transmission through effects at LTCC, as 
well as AMPAR and NMDAR (Bibb et al., 1999; Flores-Hernandez, 2002; Nishi et al., 1997).  
D2R activation inhibits phosphorylation of PKA targets (DARPP-32). Additionally, 
presynaptically-located D2R activate G-protein-coupled inwardly rectifying potassium (GIRK) 
channels, which inhibit subsequent DA release (Martel et al., 2011; Michaeli and Yaka, 2010). 
As will be discussed below, drugs of abuse increase dopaminergic transmission particularly in 
areas involved in the expression and maintenance of reward sensitivity and memory, such as the 
medial prefrontal cortex (mPFC), nucleus accumbens (NAc), and lateral amygdala (LA). 
Together this leads to alterations in normal memory processes and promotes addictive-like 
behaviors. 
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1.1.2 Consolidation, reconsolidation, and extinction of memories 
The formation, maintenance, and modification of drug-cue associations depend on a series of 
processes known as consolidation, reconsolidation, and extinction (Lee et al., 2005; Marchant et 
al., 2013; Tronson and Taylor, 2007). These processes have been extensively studied for various 
types of classical and instrumental learning (Dudai, 2012; Todd et al., 2014), and are prominent 
during emotionally-salient learning, for example, auditory or contextual fear conditioning 
(Debiec et al., 2002; Duvarci et al., 2008; Schafe and LeDoux, 2000) as well as drug-cue 
learning. Consolidation is a time- and protein synthesis-dependent process that occurs following 
initial learning and is necessary for stabilizing and storing new information after it has been 
acquired. Over time, consolidated memories can be reactivated, which retrieves and destabilizes 
the memory, causing it to enter a transiently labile state. After reactivation, the malleable 
memory must then undergo reconsolidation to be re-stabilized (Dudai, 2012; Rodriguez et al., 
1993). As with consolidation, blocking protein synthesis prior to re-stabilization impairs the 
memory (Nader et al., 2000). Reconsolidation exists as a mechanism to update or strengthen 
memories, for example, the detection and encoding of environmental changes. Induction of 
reconsolidation is therefore strongest when new information is presented at the time of memory 
retrieval (e.g., reactivation in a novel context) (Haubrich et al., 2015; Lee et al., 2009). However, 
the extent to which reconsolidation affects pre-established memories is currently unclear. Some 
studies support reconsolidation as necessary to strengthen and update memories, while others fail 
to show memory-enhancing effects (Bonin and De Koninck, 2015; Fukushima et al., 2014). At 
the very least, successful reconsolidation seems to preserve memories that have been destabilized 
after recall. To this end, pharmacological agents that affect reconsolidation have been used as a 
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means for altering the strength of memories (Besnard et al., 2012; Finnie and Nader, 2012). For 
example, Tronson and colleagues demonstrated that stimulating PKA in the amygdala 
immediately after retrieval of a conditioned fear memory increases the degree of freezing during 
subsequent exposures to the CS (Tronson et al., 2006). An opposing effect was observed after 
intra-amygdala infusion of PKA inhibitors following cue retrieval: CS-elicited freezing was 
reduced, suggesting that reconsolidation was disrupted. Importantly, PKA inhibitors given in the 
absence of CS reactivation are insufficient to block the fear memory, verifying that retrieval is 
required as a precursor to reconsolidation, which can then be interfered with by amnestic agents. 
Utilizing this approach clinically could indeed prove beneficial for treating maladaptive memory 
disorders (Agren et al., 2012; Lee et al., 2005).  
 Reconsolidation occurs following just brief interaction with the CS, as short exposure 
durations are sufficient to reactivate CS-associated memories. Repeated or long-term exposure to 
CS in the absence of the associated US instead promotes memory extinction (Monfils et al., 
2009; Rich et al., 2016; Tronson et al., 2012a). Extinction is a separate and opposing process that 
involves the formation of a competing association, where the CS no longer predicts the US (Lee 
et al., 2006; Morgan et al., 1993; Quirk et al., 2010). Like reconsolidation, extinction was first 
characterized in studies of aversive learning, in which it effectively attenuated fear-like 
behaviors (Fucich et al., 2016; Santini, 2004). Despite learning of a new association, extinction 
does not result in erasure of the original memory. In fact, re-exposure to the US can promote 
reinstatement of the extinguished response (Rescorla and Heth, 1975). Additionally, extinction is 
highly context-dependent, so if the extinction context and the training context are different, 
responding to the CS can be renewed upon return to the original training context (Effting and 
Kindt, 2007; Todd et al., 2014). Finally, extinguished responses will often spontaneously 
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recover, suggesting there is competition between the original memory and the extinction 
memory. These characteristics (reinstatement, renewal, and spontaneous recovery) are especially 
problematic for memory-based relapse prevention therapies, which highlights the importance of 
therapeutic strategies aimed at inhibiting reconsolidation and enhancing extinction. The use of 
preclinical animal models of addiction has shed light on several of the neural mechanisms 
responsible for these memory processes, which have a great deal of overlap with the cellular and 
synaptic mechanisms involved in promoting LTP and LTD. 
1.2 NEURAL SUBSTRATES UNDERLYING DRUG-CUE MEMORY 
The strength of drug-associated memories is indicative of their potential to cause relapse; 
therefore, interfering with reconsolidation or strengthening extinction have been proposed as 
therapeutic strategies to prevent relapse (Taylor et al., 2009; Torregrossa and Taylor, 2013). 
These processes can be evoked in an animal model of operant conditioning where rodents learn 
to self-administer (SA) drugs of abuse. In this model, an operant response (nose poke or lever 
press) results in delivery of the drug (US) in unison with a discrete cue (CS). Over the course of 
many trials, the drug-cue association is consolidated and stored in memory (Hernandez et al., 
2002; Schafe and LeDoux, 2000; Wilensky et al., 1999). Next, the operant response is 
extinguished (instrumental extinction) by allowing animals to make nonreinforced responses. 
Over time, the animals adapt their behavior to cease performing the operant response, as it no 
longer results in a rewarding drug infusion. During this phase, operant responses are not paired 
with CS presentation, so that, although the operant response is extinguished, the drug-cue 
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association remains intact. Finally, the now extinguished behavioral response is reinstated, either 
by re-exposure to the CS, the reinforcing substance (drug), or a stressful stimulus. Importantly, 
instrumental responses made during reinstatement occur in the absence of drug reinforcement, 
thereby serving as a measure of risk of drug-seeking behavior. Typically, the number of operant 
responses is much higher than the number of responses under extinction conditions.  
The reinstatement paradigm closely mirrors patterns of human drug use in which subjects 
take a drug under their own volition (as opposed to experimenter administered drugs), and drug-
seeking occurs after a period of abstinence (Koob, 2000). Cue-induced reinstatement enables 
measurement of the subject’s behavioral and neural response to drug-associated CS. Similar 
behavioral strategies are often used clinically in drug-dependent individuals to measure 
physiological responses and subjective craving in response to relapse-promoting cues, making 
the reinstatement paradigm a valid translational model (Epstein and Preston, 2003; Katz and 
Higgins, 2003; Shaham et al., 2003). Reinstatement has been utilized almost universally across 
drug classes, including stimulants, opioids, nicotine, alcohol, and cannabinoids (Bertholomey et 
al., 2016; Feltenstein et al., 2012; Kirschmann et al., 2017; Shalev et al., 2002). Recently, our lab 
and colleagues have developed a slight modification to the model that provides an opportunity to 
separate instrumental extinction from the more clinically-relevant Pavlovian cue extinction, as 
well as to examine the neural correlates and behavioral effect of drug-cue memory 
reconsolidation (Rich et al., 2016; Torregrossa et al., 2010). Following instrumental extinction, 
subsequent, brief exposures to CS (3 CS presentations) trigger memory retrieval, followed by 
reconsolidation. If reconsolidation is successful, the original drug-cue association should be 
strengthened or at least maintained, and subjects will display high levels of reinstatement 
(Figure 2). Alternatively, if the CS is presented in sufficient number or over a long enough  
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Figure 2. Schematic representing events that follow re-exposure to drug-associated cues. 
Brief re-exposure initiates LTP-like synaptic mechanisms. These changes lead to memory reconsolidation and the 
maintenance or strengthening of drug-associated memory, which increases relapse potential upon subsequent 
presentation of cues. Repeated, or a longer exposure to cues causes LTD-like synaptic changes that induce memory 
extinction. The drug-cue memory is destabilized and weakened, resulting in lower relapse potential when the cues 
are re-encountered (From Rich and Torregrossa, 2017). 
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period without drug reinforcement (60-120 CS presentations), extinction can occur (Pedreira and 
Maldonado, 2003). In this scenario, CS is no longer predictive of drug delivery, and expression 
of the original drug-cue memory is blocked (Bouton and Moody, 2004). Thus, after sufficient 
extinction, subsequent encounters with the stimuli are less likely to trigger the relapse-promoting 
CR, and levels of reinstatement will be decreased (See Figure 2). Recent studies have utilized 
the reinstatement model in combination with optogenetic techniques to determine if stimulation 
or inhibition of specific neural circuits can promote or attenuate relapse-like behavior (Arguello 
et al., 2017; Ma et al., 2014; Stefanik and Kalivas, 2013), which has shed light on the underlying 
anatomical circuitry and neural mechanisms that are activated following re-exposure to drug-
associated cues. Combining these novel approaches with manipulations of reconsolidation and 
extinction may reduce the efficacy of drug-cue memories to trigger relapse. 
 
1.2.1 Central circuitry governing reward-related behavior 
Behavioral responses to addictive substances require coordinated communication between 
several areas of the mesocorticolimbic system as well as various sensorimotor brain regions. By 
serving as a mediator of reward-motivated behaviors, the mesocorticolimbic system plays an 
important role in drug-seeking and relapse-like behavior. Midbrain dopamine (DA) neurons 
located in the ventral tegmental area (VTA) send projections to cortical and subcortical limbic 
structures, including the medial mPFC, NAc, hippocampus (HPC) and amygdala (Lüscher and 
Malenka, 2011; Pierce and Kumaresan, 2006; Wise, 2004). Collectively, the projections from the 
midbrain form part of the medial forebrain bundle (MFB). Stimulation of the MFB results in 
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increased locomotor activity, which drives reward seeking (Wise, 1987). Animals will also learn 
to complete tasks that result in self-stimulation of the MFB, suggesting a role for this pathway in 
motivated behavior (Gallistel, 1978; Sagara et al., 2010). The brain regions that receive VTA 
projections are also coupled by dense excitatory and inhibitory projections, forming a complex, 
interconnected network that functions to control adaptive behaviors, which can be modulated by 
DA (Geisler and Zahm, 2005; Sesack and Grace, 2010). Drugs of abuse, as with naturally-
occurring rewards, increase the firing rate of VTA DA neurons, resulting in locally-elevated DA 
levels (Tomasi et al., 2015; Volkow et al., 2009). Additionally, psychostimulants block or 
reverse the presynaptic DAT, allowing postsynaptic activation of DA receptors to be enhanced 
(Harris and Baldessarini, 1973). These rapid pharmacodynamic effects of drugs enhance goal-
directed behaviors that serve to promote reinforcement learning and increase motivation for 
drugs of abuse over natural reinforcers (Montague et al., 2004; Robbins and Everitt, 2002). 
Drugs and drug-related stimuli also induce expression of the immediate early gene Fos in 
glutamtergic neurons throughout the mesocorticolimbic system (Ciccocioppo et al., 2001; 
Neisewander et al., 2000; Pierce and Kumaresan, 2006). Fos is a marker of neural activity, which 
further implicates these brain regions in the control of drug-related behaviors.  
Human imaging studies have revealed that drug-induced increases in DA release are 
accompanied by a subjective feeling of euphoria (Drevets et al., 2001), which creates an 
expectation for future reward, increasing the likelihood of future drug use, causing DA neurons 
to fire when reward is predicted (Schultz et al., 2000). This mechanism of anticipatory firing 
enables environmental stimuli to acquire incentive motivational properties that trigger future 
drug use. Re-exposure to drug-paired stimuli augment excitatory transmission to the VTA, 
increasing DA neuron firing rate even if the drug itself is withheld (Phillips et al., 2003; Stuber et 
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al., 2008). Based on theories of reward prediction error, if anticipated rewards are withheld 
following cue presentation, firing of DA neurons is inhibited (Schultz et al., 2000), and if 
repeated frequently enough, may shape behavior toward an inhibition of drug-seeking, thus 
acting as a signal mediating the extinction of drug-related memories. In addition to changes in 
firing rate, drugs of abuse induce synaptic changes in VTA DA neurons. For example, a single 
experimenter-administered cocaine injection is sufficient to rapidly increase excitatory 
transmission, a change that can last for up to 5 days (Ungless et al., 2001). Similar synaptic 
changes have been observed following cocaine SA even after 3 months of withdrawal (Chen et 
al., 2008). Drug-induced enhancements of VTA synaptic strength appear to be driven by 
alterations in the subtype of synaptic glutamate receptors. Specifically, cocaine increases the 
expression of GluN3A/GluN2B NMDAR, which have decreased conductance and are less 
permeable to Ca2+, and also increases the expression of synaptic GluA2-lacking, Ca2+-permeable 
AMPAR (Creed et al., 2016). Overall, drug-induced synaptic changes in VTA excitatory 
transmission may lead to the increases in intrinsic excitability that enhances DA release in 
downstream limbic structures (mPFC, amygdala, NAc) and helps perpetuate drug-seeking 
behavior. 
Two of the most well-studied brain regions in terms of understanding addictive behaviors 
are the mPFC and the NAc. The mPFC functions in the control of working memory and is 
specialized for the representation of abstract information that guides behaviors related to 
executive function and cognition (Goldman-Rakic, 1987). The mPFC forms excitatory synapses 
with several GABAergic brain regions and is therefore an important source of “top-down” 
inhibitory control over unwanted or unnecessary behaviors (Kesner and Churchwell, 2011; Quirk 
and Mueller, 2008). Abnormal DA signaling within the PFC has been demonstrated in human 
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addicted individuals (Volkow et al., 2009). Furthermore, chronic cocaine SA modulates 
membrane excitability of PFC pyramidal neurons (Dong, 2005). Drug-induced adaptations in the 
PFC may account for the failure to inhibit drug-seeking even in the face of negative 
consequences, although pre-existing dysfunction in the PFC may also make individuals more 
susceptible to risky decisions that increase vulnerability to addiction (Blum et al., 2015; Cheng 
and Lee, 2016). The rodent PFC can be subdivided anatomically into a dorsal prelimbic cortex 
(PL) and a ventral infralimbic cortex (IL), which are analogs of human dorsomedial and 
ventromedial PFC, respectively. PL and IL are often viewed as functionally distinct brain regions 
that have opposing effects on behavior. Typically, the PL has been shown to promote drug-
seeking behavior, while IL activity causes inhibition of drug-seeking (Peters et al., 2009).  
The mPFC projects to the NAc, which is a major site of sensorimotor integration that 
functions in the assignment of motivational significance to rewarding substances (and reward-
related cues) to drive goal-directed motor activity (Kalivas and Volkow, 2005). The NAc 
receives afferent information from the VTA, hippocampus, mPFC, and amygdala, and projects to 
the dorsal striatum and ventral pallidum. The NAc also has reciprocal connections with the VTA, 
which functions as an important feedback mechanism to control dopaminergic activity (Gibson 
et al., 2018). The major output neurons of the NAc are GABAergic medium spiny neurons 
(MSN), which represent approximately 90-95% of all neurons in the NAc (Kauer and Malenka, 
2007). The NAc can be subdivided into two distinct subregions (core and shell), which may have 
different roles in the control of drug-related behavior. For example, lesions of the NAc shell 
attenuate unconditioned behavioral responses to psychostimulants, but do not prevent the 
acquisition of conditioned drug-seeking behavior. Conversely, lesions to the NAc core impair the 
ability of drug-associated reinforcers to maintain drug-seeking behavior (Ito et al., 2004). The 
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core and shell also exhibit distinct responses to drugs of abuse and drug-related stimuli that are 
underscored by different patterns of synaptic activity. Re-exposure to drugs or drug-paired cues 
result in a rapid potentiation of AMPAR-mediated glutamatergic signaling in the core, but a 
reduction in AMPAR expression in the shell (Gipson et al., 2014; Shen et al., 2011).  
One possible explanation for the functional differences of the core and shell may be that 
the two regions receive a separate set of afferent projections. A common belief is that the PL 
projects to the NAc core to promote drug-seeking, while the IL innervates the NAc shell and 
functioned to suppress drug-seeking (Peters et al., 2009). Instrumental extinction results in 
activation of the IL-NAc shell, and inhibition of the IL is sufficient to induce a robust increase in 
relapse-like behavior (Peters et al., 2008). However, anatomical studies have contradicted this 
behavioral dichotomy, as there are also strong connections from IL to NAc core and from PL to 
NAc shell (Brog et al., 1993; Ma et al., 2014; Sesack et al., 1989). New behavioral evidence 
suggests that both the PL and IL can promote relapse. Activation of glutamatergic projections 
from IL to NAc shell can induce context-induced reinstatement of heroin seeking (Bossert et al., 
2012). Likewise, clusters of neurons within the IL respond to cues predictive of reward 
availability to promote reward seeking (Suto et al., 2016). These conflicting reports may be due 
to a cell-type specific circuit in which behavioral output (enhancement or inhibition of drug-
seeking) depends on the subtype of MSN that is predominately activated (D1- vs. D2-containing 
MSNs). Recent technological developments (e.g., optogenetics, DREADDs) have begun to shed 
light upon these discrepancies, such as studies demonstrating that D1-MSN activity promotes, 
and D2-MSN activity suppresses drug-seeking behaviors (Bock et al., 2013; Heinsbroek et al., 
2017; Ortinski et al., 2015). For example, specific inhibition of D2-MSNs increases motivation 
for cocaine, while activation of these neurons suppresses cocaine SA. The antagonistic effects on 
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drug-seeking are mediated by the different projection targets of D1- and D2-MSNs, whereby D1-
MSNs project to the substantia nigra (direct pathway) and D2-MSNs primarily project to the 
ventral pallidum (indirect pathway) (Kravitz et al., 2012). It should be noted that most of the 
studies that have investigated the role of the mPFC-NAc circuit on the extinction of drug-related 
behavior have done so using a model of instrumental extinction. Therefore, relatively little is 
known about the circuitry that mediates Pavlovian cue extinction, and likewise reconsolidation, 
of drug-associated memories. However, based on other studies of cue-related learning, the 
amygdala, which might be acting as a mediator between the mPFC and NAc, has emerged as a 
likely candidate for the control of memories evoked by drug-associated cues. 
1.2.2 Control of cue-dependent memory by the amygdala 
The amygdala is a phylogenetically-primitive collection of cortical and subcortical nuclei located 
within the temporal lobe that has been heavily implicated in the control of emotionally-salient 
memories, acting to establish emotional and motivational associations between CS and US 
(Cador et al., 1989; Johansen et al., 2011; Maren and Quirk, 2004). Early lesion studies showed 
that the amygdala was important for establishing behavioral responses to reinforcing stimuli as 
animals with amygdala lesions failed to exhibit typical freezing behavior in response to 
footshock-predictive cues (Weiskrantz, 1956). Similarly, amygdala lesions prevent various 
reward-related behaviors. Lesioned animals fail to exhibit conditioned place preference for 
methamphetamine (Hiroi and White, 1991). Additionally, amygdala lesions have no effect on 
responding during cocaine SA, but they do alter responding during cue extinction and abolish 
cue-induced reinstatement (Meil and See, 1997; See, 2002), suggesting a specific role in 
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mediating cue-dependent behaviors. More recent imaging studies in humans have demonstrated 
activation of the amygdala by drug-related stimuli, as well as when subjects are told to think 
about drug use, which correlates with physiological and subjective measures of craving 
(Childress et al., 1999; Garavan et al., 2000; Jasinska et al., 2014). Electrophysiological 
recordings show that amygdala neurons fire in response to reward-predictive cues and are also 
activated during goal-directed seeking of both natural rewards and drugs of abuse (Schoenbaum 
et al., 1999; See, 2002). Finally, increased Fos expression is observed in the amygdala following 
acute exposure to cocaine and cocaine-associated stimuli as well as cocaine-cue extinction, 
suggesting that intracellular changes within the amygdala occur during drug-induced memory 
processes (Ciccocioppo et al., 2001; Neisewander et al., 2000; Nic Dhonnchadha et al., 2010).  
The amygdala can be broadly subdivided into the basolateral amygdala (BLA) and the 
central amygdala (CeA). The BLA can be further divided anatomically into lateral (LA), basal 
(BA), and basomedial (BM) nuclei, while the CeA is made up of both lateral (CeL) and medial 
(CeM) nuclei. The major projection neurons of the BLA are glutamatergic principal neurons 
while the CeA is more “striatal-like” in that it is made up of mostly GABAergic projection 
neurons (Janak and Tye, 2015). Additionally, interposed between the BLA and CeA are groups 
of GABAergic neurons known as intercalated cell masses, that project to the BLA and CeA and 
serve an important inhibitory function by suppressing amygdala output (Asede et al., 2015a; 
Pinard et al., 2012). The general construct of information flow through the amygdala is that the 
LA receives input and forwards this to the BA, BM, and CeL, which in turn project to the CeM. 
The CeM is considered the major output nucleus of the amygdala, although this is an 
oversimplification, as the BLA and CeL also have direct projections to other brain regions, 
including the NAc (Janak and Tye, 2015).  
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The amygdala is well positioned anatomically to integrate converging afferent input from 
multiple brain areas (PFC, sensory cortex, thalamus, and VTA; See Figure 3), all of which are 
also activated by cue/context exposure (Cho et al., 2017; Ciccocioppo et al., 2001; Do-Monte et 
al., 2015; Peter et al., 2012). The LA has reciprocal connections with the cortex, including IL, 
PL, and primary sensory areas. The PL and IL send glutamatergic projections to LA principal 
neurons, but also synapse with LA GABAergic interneurons and intercalated neurons, which 
then inhibit LA neuronal output (An et al., 2017; Quirk and Mueller, 2008). The role of the 
amygdala in cue-dependent memory arises from the diversity of its inputs, as it receives afferent 
sensory information about CS and also interoceptive information about US. Together, CS-US 
pairings enhance excitatory synaptic plasticity. Fear conditioning, in particular, has repeatedly 
been shown to induce LTP within the LA. The enhanced synaptic strength of CS inputs allows 
future presentations of the CS to activate the same LA neurons that are activated by the US 
(footshock) alone, thereby initiating conditioned freezing responses (Schafe et al., 2001). The 
specific inputs responsible for carrying CS-relevant information have also begun to be 
delineated. Brain regions responsible for auditory perception synapse directly with LA principal 
neurons (Figure 3). Auditory cortical projections are carried by the external capsule (EC), while 
subcortical/thalamic auditory information is carried by the internal capsule (IC; LeDoux et al., 
1984; Romanski and LeDoux, 1992). IC- and EC-BLA synapses have been identified as 
potential loci for cue-mediated behaviors, and plasticity at these synapses is involved in the 
formation and extinction of fear-associated memories. For example, following fear conditioning, 
increases in cue-elicited freezing are correlated with increased synaptic strength at both thalamo-
amygdala (T-LA) and cortico-amygdala (C-LA) synapses, and these changes are reversed by fear 
extinction (Kim et al., 2007; Hong et al., 2009). These bidirectional changes were also observed 
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Figure 3. Afferent and efferent projections of the amygdala. 
Simplified schematic representing the inputs and outputs of the amygdala. The amygdala receives sensory input 
from regions of thalamus and cortex from separate glutamatergic projections to lateral amygdala (LA) principal 
neurons. Auditory input is carried from the medial geniculate nucleus (MGN) by the internal capsule and from the 
auditory cortex (Te3) by the external capsule. The amygdala also has reciprocal connections with the mPFC; 
glutamatergic mPFC afferents synapse on LA principal neurons, but also on GABAergic interneurons and 
intercalated cell masses (not pictured). Bot the LA and BA received dopaminergic inputs from the ventral tegmental 
area (VTA) that can shape the response to glutamatergic inputs. The LA and BA integrate information and forward 
it to the central amygdala (CeA) and nucleus accumbens (NAc). The NAc functions as a sensorimotor gate which 
helps process incoming reward-related information and generate motor responses. The NAc also receives 
glutamatergic input from the mPFC and dopaminergic input from the VTA (Omitted for simplicity). 
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in a separate study that measured dendritic structural plasticity. Authors showed that fear 
conditioning increases BLA spine density while fear extinction reverses spine density back to 
control levels (Heinrichs et al., 2013). Optogenetic techniques have also been utilized to activate 
specific inputs to the LA during conditioned behaviors. In one such study, conditioned freezing 
responses and synaptic potentiation was evoked when a footshock US was paired with 
photoactivation of ChR2-expressing terminals from the medial geniculate nucleus (MGN; 
primary auditory thalamus) and/or primary auditory cortex (Te3). Subsequent induction of in 
vivo LTD in these pathways resulted in extinction of the fear-evoked response (Nabavi et al., 
2014). 
Interestingly, while aversive memories involve plasticity from both thalamic and cortical 
inputs, reward-associated learning appears to be a more complicated situation. As with fear-
associated CS, LA neurons also develop enhanced excitatory responses to sensory cues paired 
with rewarding substances, like palatable food (Schoenbaum et al., 1998; Tye and Janak, 2007). 
In a series of experiments, Tye and colleagues trained rats to associate an auditory cue with a 
sucrose reward. Under normal circumstances, increases in AMPA:NMDA ratio were observed at 
T-LA synapses (IC pathway) but not C-LA synapses (EC pathway) (Tye et al., 2008). However, 
enhancing DA activity during cue-reward training by blocking DAT in the LA acted to prime C-
LA synapses, resulting in enhanced synaptic activity at both T-LA and C-LA synapses (Tye et 
al., 2010). The implications of these results for understanding the acquisition of drug-cue 
learning remain unclear, although one might anticipate that since cocaine also blocks the DAT, 
pairing cocaine infusions with cues during cocaine SA might also enhance synaptic activity at 
both T-LA and C-LA synapses. The interplay between glutamatergic and dopaminergic activity 
is an important consideration, as activity of both neurotransmitters in the LA has been shown to 
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directly modulate aspects of synaptic activity during various types of Pavlovian conditioning 
(Feltenstein and See, 2007; Lee et al., 2005; Milton et al., 2008; Sanchez et al., 2010). For 
instance, application of the DA receptor antagonist, haloperidol, can block enhancements in 
neuronal excitability that are normally observed when a footshock is repeatedly paired with a 
particular odor (Rosenkranz and Grace, 2002). NMDAR antagonists also prevent the acquisition 
and extinction of several conditioned behaviors (Rodrigues et al., 2001; Sotres-Bayon et al., 
2007; Zimmerman and Maren, 2010).  
Finally, as was mentioned earlier, the initiation of drug-cue elicited behaviors is 
dependent on activity in the NAc. Recent studies have shown that the NAc receives direct cell-
specific input from the BLA that may promote reward seeking (Figure 3). Optical stimulation of 
BLA-NAc glutamatergic fibers has been shown to be in and of itself reinforcing (Britt et al., 
2012; Stuber et al., 2011). This positive reinforcement effect was blocked by intra-NAc 
injections of D1- but not D2-antagonists. Furthermore, optical inhibition of BLA-NAc 
projections blocked the ability of cocaine-paired cues to elicit reinstatement, and the same effect 
was observed when BLA-PL projections were inhibited (Stefanik et al., 2013). Together, the 
collective body of research gives rise to a potential circuit whereby the PL, IL, and LA function 
together to integrate subcortical information, and forward this processed information to the NAc 
core or shell, which either increases or limits drug-seeking, depending on the strength of the 
contextual association, the balance of afferent input, and the subtype of neurons that are 
activated. Although not directly tested, it is probable that drug-dependent learning would also 
involve LA-dependent synaptic changes that affect downstream communication to the NAc. 
Successful manipulation of the mechanisms that strengthen drug-associated memories may serve 
to disrupt the conditioned behaviors that promote relapse. Based on this premise, an emerging 
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line of research has been the use of pharmacological agents in the amygdala to target the 
molecules involved in the regulation of drug-associated memory reconsolidation and extinction. 
1.2.3 Synaptic and molecular mechanisms underlying drug-associated memories 
Early studies examining the role of DA transmission in reward-related behavior suggested that 
phasic DA release was responsible for encoding motivational significance. However, the diffuse 
projections of the VTA preclude DA, on its own, from encoding more detailed information, 
including specific details about an individual’s experiences within an environment. In order for 
an individual to make specific predictions about a given stimulus, DA requires interaction with 
other circuits that are involved in encoding detailed information (Hyman et al., 2006; Robbins 
and Everitt, 2002). Therefore, associative learning processes (e.g., consolidation, 
reconsolidation, and extinction) require similar mechanisms that govern forms of excitatory 
neural plasticity, providing a conceptual framework for understanding how these memory 
processes function. As was mentioned above, LTP and LTD both require a specific temporal 
pattern of presynaptic glutamate release and postsynaptic depolarization. Similarly, for a CS to 
develop emotional significance and elicit a CR, CS-US pairings must occur in a time-specific 
manner, where the CS precedes the US by a short interval (Davis et al., 1989). The cellular 
processes that occur following cue retrieval (and lead to reconsolidation and/or extinction) also 
closely mirror the processes that occur following induction of LTP/LTD. For example, protein 
degradation (via polyubiquitination and proteasomal degradation) followed by the synthesis of 
new proteins is required for both LTP and reconsolidation (Artinian et al., 2008; Fonseca et al., 
2006). Inhibiting protein degradation blocks destabilization and therefore prevents recall-induced 
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memory strengthening (Fukushima et al., 2014; Ren et al., 2013). The administration of protein 
synthesis inhibitors is also sufficient to block both the reconsolidation of fear after retrieval and 
the consolidation of extinction memories (Nader et al., 2000; Santini, 2004). The dependence on 
protein synthesis has been extended to drug-associated memories; inhibition of protein synthesis 
in the BLA prevents the reconsolidation of cocaine-associated cue and contextual memories 
(Fuchs et al., 2009; Lee et al., 2005). Similarly, inhibition of protein synthesis interferes with the 
induction and maintenance of both LTP and LTD (Barea-Rodríguez et al., 2000; Osten et al., 
1996; Sajikumar and Frey, 2003).  
Some of the most commonly investigated targets for the disruption of drug-associated 
memory are components of glutamatergic signaling (Figure 4). Activation of NMDAR are 
required for the reconsolidation of drug-cue memories, and therefore, NMDAR antagonists can 
interfere with reconsolidation. For example, intra-BLA infusion of the NMDAR antagonist ᴅ-
APV prior to reconsolidation reduces subsequent cue-dependent drug-seeking behavior, which 
correlates with decreased expression of the immediate early gene, zif268 (Lee et al., 2005). 
Furthermore, systemic injections of the NMDAR antagonist MK-801 prior to reactivation also 
reduce cue-reinforced drug-seeking (Milton et al., 2008). Together, these studies suggest that 
NMDAR-dependent increases in BLA neural activity are necessary for drug-cue reconsolidation 
and the maintenance of drug-associated conditioned behaviors. Studies aimed at enhancing 
extinction have also targeted the glutamatergic system (Figure 4). Extinguishing an operant 
response for cocaine is associated with a reversal in cocaine-induced decreases in GluA1 and 
GluA2/3 expression in the NAc shell. Moreover, extinction is enhanced by viral overexpression 
of GluA1 and GluA2 in the NAc, demonstrating that extinction involves enhanced glutamatergic 
activity in the NAc shell (Self and Choi, 2004; Sutton et al., 2003). Antagonism of NMDAR in 
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this region results in disrupted extinction (Feltenstein and See, 2007; Fuchs et al., 2008). The 
involvement of gluamatergic activity during extinction has led to attempts to pharmacologically 
facilitate extinction via glutamate receptor agonists. ᴅ-Serine, an agonist at the glycine site of the 
NMDAR was shown to facilitate extinction, resulting in a decrease in cocaine-primed 
reinstatement (Kelamangalath et al., 2009). Similarly, N-acetylcysteine, given in combination 
with instrumental extinction training, produces long-lasting reductions in cue- and heroin-primed 
drug seeking (Zhou and Kalivas, 2008). Finally, D-cycloserine (DCS), a partial agonist at the 
NMDAR, has also been shown to augment the extinction of drug-associated memories. For 
example, the extinction of responding for self-administered cocaine was enhanced by DCS in 
both rats and monkeys, thereby reducing cocaine reacquisition (Nic Dhonnchadha et al., 2010). 
Additionally, DCS treatment following cue extinction in a novel context inhibits cue-induced 
renewal of drug-seeking, but only when injected systemically or directly to the NAc core 
(Torregrossa et al., 2010). The effects of DCS on the extinction of drug memories are similar to 
results observed in studies of fear memory extinction in both animal models and human clinical 
studies (Ledgerwood et al., 2004; Ressler et al., 2004). However, in clinical studies of human 
drug using populations, the success of DCS has been limited. A randomized, placebo-controlled 
study showed that DCS was unable to facilitate extinction, and instead, enhanced craving in 
cocaine-dependent individuals (Price et al., 2013). Moreover, in preclinical studies, DCS 
treatment can increase reinstatement of drug seeking. Increased cue-induced drug seeking after 
DCS treatment appears to occur following a brief re-exposure to the CS, suggesting that DCS 
may be strengthening the reconsolidation process as opposed to promoting extinction (Lee et al., 
2009). Indeed, in this study, DCS was administered after re-exposure to 30 cue presentations, 
and studies from our lab indicate that 60 cue presentations only yield a mild reduction in  
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Figure 4. Pharmacological agents that weaken drug-associated memories. 
List of pharmacological compounds that have been demonstrated to weaken drug-associated memories, either by 
inhibiting reconsolidation, facilitating extinction, or both. These manipulations are most often examined in the 
context of either reconsolidation or extinction, not both. Inhibition of CaMKII is the first manipulation that has been 
shown to inhibit reconsolidation and facilitate extinction. From (Rich and Torregrossa, 2017). 
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reinstatement, indicating that 30 was unlikely to sufficient produce extinction (Rich et al., 2016). 
Together, these studies highlight the complicated nature of reconsolidation and extinction 
following cue reactivation, and demonstrate that a combined approach, in which a single 
pharmacological compound can simultaneously enhance extinction and inhibit reconsolidation, 
may have a better likelihood of weakening drug-associated memory to prevent relapse.  
Several intracellular signaling pathways that are important for the induction of LTP and 
LTD also mediate drug-memory reconsolidation. Chronic cocaine exposure persistently 
increases PKA activity (Lynch and Taylor, 2005; Nestler, 2004), and post-retrieval inhibition of 
PKA in the BLA reduces both cue-and context-induced, but not drug-primed reinstatement 
(Arguello et al., 2014; Sanchez et al., 2010). Inhibition of a constitutively active isoform of PKC, 
known as PKMζ blocks the development of cocaine sensitization, while reducing AMPAR 
membrane expression (Howell et al., 2014). Furthermore, direct inhibition of PKMζ in the NAc 
can disrupt the retrieval and reconsolidation of a drug-dependent conditioned approach behavior 
(Crespo et al., 2012). Additionally, the reconsolidation of cocaine-associated contextual 
memories depends on ERK (extracellular-regulated kinase) signaling. Intra-NAc core ERK 
inhibition decreases preference for a cocaine-conditioned context (Miller and Marshall, 2005), 
whereas intra-BLA ERK inhibition following reactivation results in less context-induced 
reinstatement (Wells et al., 2013). As with other kinases, ERK2 is involved in synaptic plasticity, 
including LTP in the BLA (Schafe et al., 2008), further demonstrating the importance for long-
term synaptic alterations in the reconsolidation of drug-cue memories. Finally, the mammalian 
target of the rapamycin signaling (mTOR) pathway, heavily characterized for its involvement in 
the cell cycle and regulation of protein translation, has also been linked to synaptic plasticity and 
reconsolidation. The mTOR pathway has been linked to the insertion of AMPAR during the 
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maintenance phase of LTP in the hippocampus and mPFC (Man et al., 2003; Stoica et al., 2011). 
Due to its LTP-promoting effects, preventing the activation of mTOR has been linked to the 
inhibition of fear- and cocaine-associated memories (Gafford et al., 2011; Jobim et al., 2012; Shi 
et al., 2014).  
Overall, because of the similarities between LTP/LTD and reconsolidation/extinction, 
many of the specific manipulations aimed at disrupting reconsolidation and/or facilitating 
extinction of drug-cue memories have targeted the same molecules that are involved in 
regulating mechanisms of LTP and LTD. The predominant process that occurs following 
memory retrieval (reconsolidation vs. extinction) appears to depend on the balance of 
intracellular signaling molecules and protein phosphorylation/dephosphorylation cascades.  It 
should be noted that much of the research to this point has dealt with reconsolidation and 
extinction separately; there are very few, if any, studies that examine the effects of a single 
manipulation on both reconsolidation and extinction. This is an important limitation because, as 
is often the case, a pharmacological manipulation that is effective at enhancing extinction of 
drug-cue memories may fail to inhibit reconsolidation, leading to unintentional memory 
strengthening effects. A better approach is to identify cellular signaling events that simultaneous 
inhibit reconsolidation and enhance extinction. 
1.2.4 Towards a bidirectional approach for targeting drug-cue memory 
To determine if there was any overlap in the specific cellular events regulating extinction and 
reconsolidation, our lab recently conducted a study aimed at identifying specific phosphoproteins 
that are oppositely regulated by extinction and reconsolidation of a memory associated with self-
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administered cocaine (Rich et al., 2016; Appendix A). Rats learned to associate self-administered 
cocaine infusions with an audiovisual cue and were later subjected to unreinforced presentations 
of the cue either 3 times to trigger reconsolidation or 120 times to trigger extinction. A 
phosphoproteomics analysis of the BLA identified a small number of signaling events that were 
oppositely regulated, including a novel phosphorylation event on calcium-calmodulin-dependent 
kinase II α (CaMKIIα) at Ser331. As described above, CaMKII is a well-characterized protein 
involved in various forms of memory and synaptic plasticity (Coultrap et al., 2014; Sanhueza & 
Lisman, 2013). Autophosphorylation of Thr286 has been implicated in numerous forms of 
learning, including those involved with drug-related memories (Easton et al., 2013, 2014). Not 
surprisingly, CaMKIIα dysfunction has been linked to neuropsychiatric disorders that involve 
changes to the number or size of dendritic spines, including schizophrenia, Angelman syndrome, 
and addiction (Müller et al., 2016a; Robison, 2014). Drugs of abuse may induce an upregulation 
of CaMKIIα, as evidenced by a reduction in amphetamine SA following NAc shell inhibition of 
CaMKIIα (Loweth et al., 2013). CaMKIIα has also been previously identified and studied as a 
potential key player in the regulation of synaptic memory associated with certain types of drug-
associated stimuli (Sanchez et al., 2010, but see Arguello et al., 2014). To further characterize 
the effects of CaMKII in drug-cue memory, we tested the effects of intra-BLA CaMKII 
inhibition on cocaine-cue memory reconsolidation and extinction, and discovered that in both 
conditions, this pharmacological manipulation resulted in a reduction in cue-induced 
reinstatement, relative to controls. Whereas CaMKII mediates LTP via phosphorylation of 
GluA1 at S831, LTD can also be evoked by CaMKII-mediated phosphorylation of GluA1 at 
S567 (Coultrap et al., 2014). Thus, the effect of CaMKII inhibitors on reconsolidation and 
extinction might be explained by differential effects on LTP vs. LTD, respectively, suggesting 
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the existence of molecular mechanisms capable of simultaneously augmenting extinction and 
disrupting reconsolidation (Rich et al., 2016; See Appendix A).  
Due to the involvement of CaMKIIα in the bidirectional control of drug-cue memories, it 
is possible that CaN (a ‘negative regulator of CaMKIIα’) may also be involved in extinction and 
reconsolidation. Whereas the inhibition of CaMKIIα may promote drug-memory amnestic 
effects, pharmacological agents that facilitate CaN activity would perhaps yield the same results. 
A series of studies by Gean and colleagues first identified a role for CaN in the regulation of 
fear-associated memories (Lin et al., 2003a; Lin et al., 2003b). Protein levels and enzymatic 
activity of CaN were increased by the extinction of a fear-associated memory. This was 
accompanied by the reversal of fear conditioning-induced phosphorylation of CaN substrates, 
including ERK. The administration of CaN inhibitors prevented this pattern of 
dephosphorylation and enhanced the resistance to fear extinction. A subsequent study showed 
that inhibitors of CaN blocked extinction-dependent decreases in CREB phosphorylation. These 
data suggest that CaN functions in a negative feedback loop and either directly or indirectly 
dephosphorylates specific substrates whose phosphorylation is required for memory 
consolidation. Several other studies have supported a role for CaN as a negative regulator of 
emotionally-salient memories (Baumgärtel et al., 2008; de la Fuente et al., 2014; Havekes et al., 
2008).  
As described above, the internal and external capsule are important signaling pathways 
that carry sensory information via thalamic and cortical routes, respectively, to the amygdala. 
Fear conditioning has been associated with potentiation of these synapses while fear extinction is 
associated with depotentiation. To model fear extinction, low-frequency stimulation (LFS) of the 
external capsule was used to elicit depotentiation in the LA following fear conditioning (Lin et 
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al., 2003a). LFS-induced depotentation was associated with an increase in CaN activity, and 
required NMDAR, LTCC, as well as CaN activation. Inhibitors of CaN prevented LFS-induced 
depotentiation in vitro and blocked LFS-induced fear extinction in vivo. Furthermore, an elegant 
study by Everitt and colleagues, investigated the molecular changes that occur during the shift 
from fear-memory reconsolidation to extinction by correlating results from biochemical assays 
with behavioral output after a various number of cue re-exposures (Merlo et al., 2014). Protein 
levels of calcineurin were shown to increase after 10 (but not fewer) presentations of a fear-
associated CS, suggesting that CaN is specifically activated during extinction memory 
consolidation, and may be important during the shift between maintenance and loss of the fear-
associated memory trace.  
Finally, CaN has recently been identified in the destabilization of a methamphetamine 
(METH)-associated contextual memory (Yu et al., 2016). In this study, authors performed 
METH-CPP followed by treatment with the protein synthesis inhibitor, anisomycin, to disrupt 
reconsolidation. Memory destabilization was associated with a decrease in phosphorylation of 
GluA1 at Ser845, a decrease in spine density, and a decrease in AMPA:NMDA ratio. Blockade 
of NMDAR with MK801 or GluN2B-specific antagonists prevented destabilization-induced 
synaptic alterations. This is likely due to a block of the downstream phosphatase effects, as both 
PP1 and CaN inhibitors prevented the effects of anisomycin (Yu et al., 2016). This study 
indicates that destabilization of a METH-associated contextual memory occurs through a cascade 
of events that are CaN-dependent. Specifically, dephosphorylation of the peptide, Inhibitor-1, by 
CaN results in the activation of PP1, which dephosphorylates GluA1 at Ser845, resulting in the 
internalization of AMPAR and LTD (Mulkey et al., 1994). Together, there is strong evidence 
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that upregulating CaN activity may be an effective strategy for reducing the strength of drug-
related memories, either via the blockade of reconsolidation or by the enhancement of extinction. 
1.3 DISSERTATION AIMS 
It has become clear that memory recall activates multiple processes that may have opposite 
effects on memory strength. That reconsolidation and extinction might be occurring 
simultaneously following memory recall makes it difficult to specifically target either 
reconsolidation or extinction via pharmacological manipulations. As described above, one 
strategy to overcome this difficulty is to develop a pharmacological agent that simultaneously 
disrupts reconsolidation and enhances extinction. A second strategy is to develop a 
methodological approach that directly and specifically manipulates neural circuits involved in 
the regulation of drug-cue memory. Studies within this dissertation examine afferent-specific 
synapses in the LA as potentially important for the bidirectional regulation of drug-cue memories 
and in mediating drug-seeking behaviors. Furthermore, these studies seek to uncover 
mechanisms by which drug-cue memories may be weakened to interfere with cue-evoked 
reinstatement. To this end, we use a combination of behavioral, physiological, optogenetics, and 
pharmacological approaches to (a) determine if drug-cue memory reconsolidation and extinction 
are encoded by LA synapses and (b) test whether circuit-specific induction of LTD in the LA 
and/or the activation of CaN is sufficient to interfere with drug-cue memories and prevent 
relapse-like behavior. The central hypothesis of this dissertation is that thalamo-amygdala 
synapses are specifically involved in the consolidation, reconsolidation, and extinction of 
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cocaine-cue memories, and that optical or pharmacological induction of depotentiation of these 
synapses is sufficient to attenuate cue-activated cocaine-seeking behavior. We test these 
hypotheses through the following experimental aims: 
 
Aim 1: To determine whether thalamic and/or cortical LA synapses are potentiated by 
cocaine-cue pairings, strengthened by reconsolidation, and depotentiated by extinction.  
Aim 2: To determine if MGN-LA synapses are specifically involved in regulating 
cocaine-cue memories, and whether optically-inducing LTD at this pathway is sufficient to 
reduce cocaine-seeking behavior.  
Aim 3: To determine if cocaine-seeking behavior can be attenuated by pharmacological 
induction of LTD at thalamo-amygdala synapses during cocaine-cue memory processes. 
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2.0  PLASTICITY AT THALAMO-AMYGDALA SYANPSES REGULATES 
COCAINE-CUE MEMORY FORMATION AND EXTINCTION 
Matthew T. Rich, Yanhua H. Huang, Mary M. Torregrossa; adapted from a version that is 
currently in submission at Cell Reports. 
 
Repeated drug use has long-lasting effects on plasticity throughout the brain’s reward and 
memory systems that promote future drug use. Environmental cues that are associated with drugs 
of abuse can elicit craving and relapse, but the neural circuits responsible have not been well 
delineated, thereby creating a major hurdle for the development of effective relapse-prevention 
therapies. In this study, we used a cocaine+cue self-administration paradigm followed by cue re-
exposure to establish that the strength of the drug-cue association corresponds to the strength of 
synapses between the medial geniculate nucleus (MGN) of the thalamus and the lateral amygdala 
(LA). Furthermore, we demonstrate, via optogenetically-induced LTD of MGN-LA synapses, 
that reversing cocaine-induced potentiation of this pathway is sufficient to inhibit cue-induced 
relapse-like behavior. 
42 
 
2.1 INTRODUCTION 
Chronic use of drugs like cocaine leads to the formation of long-term memories of the drug using 
experience and the environmental stimuli associated with that experience. Over time, exposure to 
just the drug-paired stimuli, or cues, is sufficient to induce physiological and psychological 
responses, such as craving, that drive continued use and relapse (Fuchs et al., 2008; Sinha and Li, 
2007). Thus, one potential treatment strategy is to reduce the strength of drug-cue associations, 
so that the cycle of abstinence, craving, and relapse is blocked (Childress et al., 1986; Price et al., 
2010). This may be possible by inducing extinction of the drug-cue association, a process 
whereby repeated cue exposure in the absence of the drug leads to a reduced expectation that the 
cue is predictive of drug use  (Pedreira and Maldonado, 2003; Torregrossa and Taylor, 2013). 
However, a major limitation to enacting a memory-based treatment approach is that the precise 
neural correlates underlying drug-cue memories have not been well established.  
In classical animal drug self-administration (SA) models, drug-cue associative memories 
form when an instrumental response (e.g., lever press) results in delivery of the drug 
(unconditioned stimulus; US)) together with a conditioned stimulus (CS; audiovisual cue). After 
repeated CS-US pairings, subsequent CS presentations by themselves can increase drug-seeking 
actions (lever presses). Cue-driven drug-seeking behaviors likely develop through cellular 
processes such as long-term potentiation (LTP) within neurons that are activated by the drug-cue 
experience (Cruz et al., 2014a; Shaham and Hope, 2005). On the other hand, extinction of drug-
cue memories may reverse this plasticity and/or result in new LTP that inhibits the original 
memory, yet these possibilities have not been directly tested. Rather, prior studies have focused 
on neuroadaptations associated with the drug-seeking action, as opposed to the drug-associated 
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cue memories that drive craving and relapse. Moreover, pre-clinical studies of memory-based 
interventions, such as extinction learning, have largely focused on extinction of the lever press 
response, not of the drug-cue memory (Kalivas et al., 2005; Peters et al., 2008). In contrast, most 
clinical efforts aimed at extinguishing drug memories have focused on the cues that initiate the 
craving and relapse cycle. Thus, there is a large gap in the pre-clinical literature in identifying the 
locus of drug-cue memories, and the molecular mechanisms that regulate their formation and 
extinction remains unknown.  
In contrast, numerous studies have investigated mechanisms regulating fear-conditioned 
memories, where manipulation of the cue, rather than the action, is the norm. These studies have 
shown that synaptic changes within thalamic and cortical inputs to the lateral amygdala (LA) 
underlie the formation and extinction of a conditioned fear memory (Hong et al., 2009; Kim et 
al., 2007a). Furthermore, Nabavi et al., (2014) used optogenetically induced long-term 
potentiation and depression (LTP or LTD) to demonstrate a causal link between synaptic 
modifications in the LA and the expression of a fear-associated memory. Given that, in addition 
to negatively valenced memories, the amygdala is also critical for the expression of memories 
related to positive affective value (Beyeler et al., 2016; Shabel and Janak, 2009),  it may be that 
drug-cue associative memories are encoded in the amygdala, and can be targeted for treatment.  
Here, we present the first evidence that cocaine cue-associated memory formation 
induces synaptic potentiation at medial geniculate nucleus (MGN) thalamo-amygdala, but not 
cortico-amygdala synapses, and that extinction of the cue memory, but not the lever pressing 
action, reverses this plasticity to reduce cue-induced relapse-like behavior. Furthermore, 
optogenetic LTD of MGN-LA synapses results in physiological and behavioral changes 
indicative of cue extinction. Together, these results identify a specific neural correlate and 
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cellular mechanism responsible for the acquisition and extinction of drug-cue memory, and 
present potential therapeutic approaches to prevent relapse. 
2.2 METHODS 
2.2.1 Animals 
Naïve, adult male Sprague-Dawley rats (Envigo/Harlan), weighing 275-325 g on arrival, were 
used in all studies. All rats were housed in a temperature- and humidity-controlled room, in auto-
ventilated racks with an automated watering system. Animals were housed in pairs, given ad 
libitum access to food and water, and maintained on a 12 h light-dark cycle. Prior to surgical 
procedures, rats were given at least 5 d to acclimate to the facility. Rats were food-deprived 24 h 
prior to the start of behavioral experiments and maintained at ~90% of their free-feeding body 
weight (~20 g of chow per day) for the duration of testing. All behavioral experiments were run 
during the light-cycle. Animals were allocated to groups following cocaine self-administration 
(SA) and, when applicable, instrumental extinction (IE), based on a matching procedure that 
ensured no significant differences between acquisition and IE behavior (See Figures 8 and 11).  
All procedures were conducted in accordance with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals and were approved by the University of Pittsburgh’s 
Institutional Animal Care and Use Committee. 
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2.2.2 Viral vector construct 
Adeno-associated virus serotype 5 (AAV5) vectors were constructed to deliver oChIEF, a variant 
of the blue-light sensitive opsin channelrhodopsin (ChR2). oCHIEF is a mammalian codon 
version of ChIEF, with stronger expression in mammalian cells and an additional N-terminal 
amino acid residue that can respond to both low and high frequency stimulations (Nabavi et al., 
2014; Lin et al., 2013). oChIEF was flanked downstream by the fluorescent marker tdTomato 
and expression of oChIEF was driven by the neuron-specific synapsin (hSyn) promoter (Lin et 
al., 2013). The construct was donated by Dr. Roger Tsien and processed for packaging and 
purification by the Duke Viral Vector Core.  
2.2.3 Drugs 
Cocaine hydrochloride (generously provided by the Drug Supply Program of the National 
Institute on Drug Abuse, Research Triangle Park, NC) was dissolved in sterile 0.9% saline (2 
mg/ml) and filter-sterilized for SA. 
2.2.4 Rodent intravenous catheterization 
Rats were fully anesthetized with ketamine hydrochloride (87.5-100 mg/kg, i.m.) and xylazine 
hydrochloride (5 mg/kg, i.m.) and then received an analgesic (Carprofen, 5 mg/kg, s.c.) and 5 ml 
of Lactated Ringer’s (s.c.) prior to surgery. Betadine and 70% ethanol were applied to all 
incision sites. All rats received a chronic indwelling intravenous (i.v.) catheter as described 
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previously (Rich et al., 2016). Catheters were implanted into the right jugular vein, then fed 
subcutaneously to the midscapular region, where they exited through a round incision. After 
surgery, rats recovered on a heating pad. Rats were then individually housed and given at least 7 
d to recover before behavioral training. Rimadyl (5 mg/kg; s.c.) was administered for the first 
two days after surgery and catheters were kept patent by daily infusions of sterile saline 
containing gentamicin (5 mg/ml) and heparin (30 USP/ml). 
2.2.5 Virus delivery and optic fiber implantation 
For experiments involving viral infection of MGN neurons, rats were placed in a stereotaxic 
frame immediately following catheter surgery. They were given a small injection (~0.2-0.3 ml) 
of lidocaine (Henry Schein) to the scalp as a local anesthetic. A 26-gauge stainless steel injection 
cannula connected to a Hamilton syringe was used to bilaterally inject 1 μL of concentrated 
AAV solution into the medial portion of MGN (in mm from bregma, anterior and posterior (AP): 
–5.4; medial and lateral (ML): ±3.0; dorsal and ventral (DV): –6.6) through a pump (Harvard 
Apparatus) at a flow rate of 0.1 μL/min. Cannula were left in place for 5 min after infusions were 
complete before being slowly withdrawn. For experiments involving in vivo optogenetic control 
of MGN-LA terminals, two 200-μm optic fibers  (0.5 NA, Thor Labs) were implanted (See 
Sparta et al., 2012) at the dorsal portion of the lateral amygdala (in mm from bregma, AP: -3.0; 
ML: ±5.1; DV: -7.9 mm). Fibers were lowered at a rate of 2 mm/min, then secured to the skull 
with screws, Loctite instant adhesive (Henkel Corp) and OrthoJet dental cement (Lang Dental). 
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2.2.6 Rodent cocaine or saline self-administration 
Rats were trained to SA cocaine in standard operant conditioning chambers (MedAssociates), as 
described previously (Rich et al., 2016). Rats administered saline (0.9%) or cocaine (2 mg/ml) 
during daily sessions for 1 h, on a fixed ratio 1 (FR1) schedule of reinforcement with a 10 s 
timeout. The designated active lever (counterbalanced across left and right levers) produced a 
cocaine or saline infusion paired with a 10 s compound light and tone cue. Pump durations were 
adjusted daily according to body weight in order to deliver the correct dose of drug (1.0 mg/kg of 
body weight per infusion). Responses on the other, inactive, lever were recorded, but had no 
programmed consequences. Rats underwent training for at least 10 d and until they administered 
at least 8 infusions per day over 3 consecutive days. Cocaine self-administering rats that did not 
meet acquisition criteria by 20 d were excluded from the study; saline self-administering rats 
were advanced regardless, as most do not reach acquisition criteria. The program was controlled 
by and data were collected using MedPC IV (MedAssociates). 
2.2.7 Instrumental lever extinction 
After successful acquisition of SA, rats underwent IE for at least 7 d. During these daily 1 h 
sessions, responses on both the active and inactive levers were recorded but had no programmed 
consequences. IE continued until extinction criteria had been met (an average of < 25 lever 
presses on the last two days of extinction). Throughout IE, rats received no cocaine or cocaine-
associated cue reinforcement, thus reducing responses to a stable, low rate. This reduces the 
motivational value of other cues in the SA context, so that subsequent reinstatement testing or 
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physiological assessment specifically isolates the memory for the discrete cue associated with 
cocaine infusion. 
2.2.8 Pavlovian cue re-exposure 
Cue re-exposure occurred as described previously (Rich et al., 2016). Briefly, rats were returned 
to the SA context 24 h after the final day of SA (or IE) and lasted for 1 hr. During this session, 
rats that had undergone cocaine SA received noncontingent presentations of the previously drug-
paired cues: either 0, 3, 60, or 120. A separate group of cocaine-trained rats were left in their 
home cages undisturbed as a control for re-exposure to the training context. Saline-trained 
animals were returned to the training context and did not undergo cue re-exposure (0 cue 
presentations).  During re-exposure sessions, the cocaine-associated cue was presented for 10 s, 
with each presentation separated by 30 s.  
2.2.9 Cue-induced reinstatement 
24 h after cue re-exposure, cue-induced reinstatement was assessed during a 1 h session that took 
place in the original SA context. A lever press on the active lever produced a 10-s presentation of 
the cocaine-associated cue on an FR1 schedule, but no drug reinforcement. Lever presses on the 
inactive lever were recorded but had no programmed consequences. In the optical LTD 
experiment, to measure spontaneous recovery of drug-seeking, rats underwent a second cue-
induced reinstatement test 7 d later. 
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2.2.10 Ex vivo slice preparation 
Slices were prepared as described previously (Dong et al., 2006; Huang et al., 2008b), with slight 
modifications, and using methods designed to improve neuronal health in adult rodents (Ting et 
al., 2014). Briefly, 24 h after cue re-exposure sessions, rats were deeply anesthetized with 
isoflurane. Rats were then briefly perfused with ice-cold cutting solution containing (in mM): 92 
N-methyl-d-glucamine (NMDG), 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 
sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO4, and 0.5 CaCl2, saturated with 
carbogen (95% O2/5% CO2), pH adjusted to 7.4 with HCl. Rats were then decapitated and 
brains removed. Acute coronal slices of the amygdala (250 μm thick) were obtained (normally 
4–6 slices were obtained from each rat) using a VT1200S vibratome (Leica, Weltzar, Germany) 
in 4 °C cutting solution. Slices were placed in a holding chamber filled with the same cutting 
solution, and incubated at 37°C for 10-15 min before being transferred to a beaker of HEPES-
based holding solution containing (in mM): 86 NaCl, 2.5 KCl, 1.2 NaH2PO4, 35 NaHCO3, 20 
HEPES, 25 glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 1 MgCl2, and 2 CaCl2, 
saturated with carbogen. Slices were allowed to recover for >30 min at room temperature before 
experimentation. 
2.2.11 Ex vivo electrophysiological recordings 
Slices were transferred to an Olympus BX51WI upright microscope equipped with gradient 
contrast infrared optics. The LA was identified using a 4X objective and this region was then 
magnified for identification of neurons with a 40X water immersion lens. Whole-cell recordings 
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were obtained from individual principal neurons in the dorsal LA using glass pipettes (3–5 MΩ). 
Principal neurons are identified by morphology, and in voltage clamp, typically show low levels 
of spontaneous activity. For a subset of cells, principal neurons could be confirmed in current 
clamp by injecting current pulses to elicit action potentials, as described elsewhere (Kim et al., 
2007a; See Figure 5A). Voltage-clamp experiments used pipettes filled with a cesium-based 
internal solution [in mM, cesium methanesulfonate 108, CsCl 15, CsEGTA 0.4, TEA-Cl 5, 
HEPES 20, Mg-ATP 2.5, Na-GTP 0.25, QX-314-Cl 1, sodium phosphocreatine 7.5, and L-
glutathione 1, and pH to 7.3 with CsOH] and current-clamp experiments used pipettes filled with 
a potassium-based internal solution [in mM, potassium methanesulfonate 108, KCl 20, K-EGTA 
0.4, HEPES 10, Mg-ATP 2.5, Na-GTP 0.25, sodium phosphocreatine 7.5, L-glutathione 1, 
MgCl2 2, and pH to 7.3 with KOH]. During recordings, slices were superfused with aCSF that 
was heated to 31–33 °C by passing the solution through a feedback-controlled in-line heater 
(Warner, CT) before entering the chamber. External perfusion consisted of a modified artificial 
cerebrospinal fluid (ACSF), containing, in mM NaCl 119, KCl 2.5, NaHCO3 26, NaH2PO4 1.2, 
glucose 12.5, HEPES 5, MgSO4 1, CaCl2 2, saturated with 95% O2/5% CO2. Neurons were 
voltage-clamped at -70 mV. For experiments involving electrical stimulation, a concentric 
bipolar stimulating electrode (FHC, Bowdoin, ME) was placed over axon fibers emerging from 
the internal capsule (putative thalamic afferents) or external capsule (putative sensory cortical 
afferents). Projections to the LA were stimulated using 0.1 ms pulses at predetermined series of 
intensities (10-35 μA) using an isolated current stimulator (A-M instruments; Digitimer Ltd, 
Hertfordshire, England), and the evoked excitatory postsynaptic currents (EPSCs) were recorded. 
For paired pulse delivery, each pulse was separated by a 50 ms interpulse interval. AMPAR 
currents were elicited at ERev-70 mV holding potential and NMDAR currents were elicited at a 
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ERev+40 mV holding potential. NMDAR amplitude was operationally defined as the amplitude of 
the current 35 ms after the peak of the AMPAR current; at this time point, AMPAR-mediated 
currents have subsided (Huang et al., 2008). To elicit action potential firing, in current clamp 
mode, depolarizing current pulses of -100 to +200 pA (20 pA steps, 1 s duration) were delivered. 
For experiments involving optical stimulation, AAV-infected MGN projections were identified 
using fluorescence and then stimulated using a blue light (473 nm) DPSS laser (IkeCool), that 
was generated using the Clampex software (Molecular Devices) and a pulse generator (A-M 
Systems). Collimated laser light was coupled to a fluorescent port of the Olympus BX51WI 
microscope, allowing the blue laser light to illuminate the slice through the objective, placed 
immediately above the cell. Optical stimulations of 1 ms duration were used for paired-pulse or 
AMPA:NMDA ratio measurements. Neurons receiving input from AAV-infected MGN neurons 
exhibited reliable EPSCs in response to stimulation (See Figure 5B). Likewise, under current-
clamp conditions, AAV-infected MGN neurons generated action potentials in response to 
various frequencies of blue-light stimulations (See Figure 5C). Ex vivo LTD experiments were 
performed in current-clamp mode, with the bridge balanced routinely. Optically-evoked EPSPs 
were recorded at 0.1 Hz for 10 minutes prior to LTD induction [900 2-ms pulses of blue light, at 
1 Hz (15 min induction protocol)]. Following LTD induction, EPSPs were continuously recorded 
at 0.1 Hz for the next 60 minutes. For all experiments, series resistance was 10–25 MΩ, 
uncompensated, and monitored continuously during recording. Cells with a change in series 
resistance beyond 20% were not accepted for data analysis. Synaptic currents were recorded with 
a MultiClamp 700B amplifier (Molecular Devices), filtered at 3 kHz, amplified 5 times, and then 
digitized at 20 kHz. Picrotoxin (100 μM; dissolved in DMSO) was included in the bath solution 
to inhibit GABAA receptor-mediated currents in all experiments.  
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Figure 5. Sample electrophysiological recordings from LA and MGN neurons. 
(A) Sample current clamp recording from LA neuron. Injection of a prolonged depolarizing current (0.2 nA, 1 s) 
demonstrating action potential firing that shows spike frequency adaptation typical of principal neurons (See Kim et 
al., 2007a). Scale bars: 100 ms, 40 mV. (B) Sample voltage clamp recording from LA neuron receiving projections 
from AAV-oChIEF-infected MGN neurons. EPSCs were elicited by two brief (1 ms) pulses of blue light (473-nm) 
separated by 50 ms. Scale bars: 25 ms, 50 pA. (C) Sample current clamp recordings from AAV-oChIEF-infected 
MGN neurons. Action potentials were elicited by blue light stimulation (5-100 Hz), demonstrating the capacity for 
MGN-infected neurons to respond to both low and high frequency stimulation. Scale bars: 100 ms, 40 mV. 
 
 
 
53 
 
2.2.12 In vivo optogenetic procedures 
Rats were transferred to a clean standard housing cage. Bilateral optic fiber implants were 
connected to an optic fiber patch cord, which was connected to a 473-nm blue laser diode 
(IkeCool) via a rotary joint (Prismatix). The light intensity through the optical fiber, which was 
measured by a light sensor (S130A; Thor Labs), was adjusted to ~5-10mW. Rats were allowed to 
explore the environment for 3 min prior to LTD induction. LTD was induced using the paradigm 
described above (900 2-ms pulses of light delivered at 1 Hz). After induction rats remained in the 
cage for 3 min, before being placed back in their home cage. Control rats had a sham optic fiber 
patch cord attached to the head-mounted optic fiber for the same duration as the LTD induction. 
24 hours after in vivo optogenetic stimulation, rats were assessed for drug-seeking in a standard 
cue-induced reinstatement session (See above). 
2.2.13 Staining, fluorescence, and imaging 
Animals were deeply anesthetized with sodium pentobarbital (100 mg/kg, i.p.). Rats were 
perfused through the aorta with 1X PBS for 5 min followed by 4% paraformaldehyde in 1X PBS, 
pH 7.4 for 10 min. The brains were extracted, postfixed in 4% paraformaldehyde for 24 h, and 
transferred to 30% sucrose solution. Brains were sectioned at 50 μm using a cryostat (Leica). 
Slices containing the LA or MGN were mounted onto glass slides, and cover-slipped with 
Fluoroshield with DAPI (for nuclear identification) mounting media (Sigma-Aldrich). Slices 
were imaged using an Olympus BX61VS epifluorescent slide-scanning microscope to verify 
AAV-oChIEF-tdTomato expression in the MGN and its projections to the LA (See Figure 6). 
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Additionally, position of the optic fiber over the LA was verified. Rats lacking expression of 
AAV in MGN or LA and those in which the optic fiber was not correctly positioned were 
removed from the study. 
2.2.14 Data Acquisition and Statistical Analysis 
All statistical analyses were performed using GraphPadPrism for Windows and results are 
expressed as mean ± SEM. Rats were distributed into groups based on a matching procedure that 
ensured that each group had no statistical differences in their cocaine infusions acquired over 
days, or differences in instrumental extinction behavior. For behavioral experiments, 
reinstatement tests were analyzed by two-way ANOVA with repeated measures, with the within-
subjects factor being responding on the last day of instrumental extinction versus reinstatement 
responding and the between-subjects factor being cue re-exposure condition. For 
electrophysiological experiments, data were coded such that experimenters were not aware of 
treatment groups when performing data analysis, and then decoded for final results. Data were 
analyzed offline using ClampFit 10.3. For experiments in which the end points were from 
individual cells, such as EPSCs, we used the averaged value of a parameter from all cells 
recorded from an animal to represent the parameter of this animal. For electrical stimulation 
experiments, EPSC amplitude was calculated at each stimulation intensity and compared 
between groups using two-way ANOVA with repeated measures, with the within-subjects factor 
being stimulation intensity and the between-subjects factor being cue re-exposure condition. For 
correlation analyses, Pearson’s correlation coefficients were calculated, with number of infusions 
as the independent variable and EPSC amplitude as the dependent variable. Paired pulse ratio 
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(PPR) was calculated as the ratio of the peak current of the second EPSC to the first EPSC. 
AMPAR current was calculated as the peak current at Erev -70mV and NMDAR current was 
calculated as the peak current at Erev+40 mV, 35 ms after peak AMPAR current. For AMPA, 
NMDA, and PPR, comparisons were made using one-way ANOVA. All data points were an 
average of 10 trials. For optical stimulation experiments, EPSC amplitude, PPR, and 
AMPA:NMDA ratios were calculated as described above and compared using one-way ANOVA 
or unpaired t-test. For LTD experiments, peak EPSP amplitude and EPSP rise slope were 
calculated for every trial and six consecutive trials were averaged together for each data point. 
For comparisons of pre- and post-LTD comparisons, data points across the last 7 minutes of 
baseline were compared to the last 7 minutes of post-LTD recordings with a paired t-test. Each 
experiment was replicated in at least 5-6 rats (1-5 cells were recorded from each rat) for 
electrophysiological analysis and at least 6 rats for behavioral tests. For all analyses, significant 
effects were further analyzed by Tukey’s or Bonferroni’s post hoc tests, with significance set at P 
< 0.05. All data were determined to be normally distributed using the Shapiro-Wilk test, and 
Bartlett’s test was used to determine that there were no significant differences in the estimated 
variance between groups. Statistical parameters for each analysis can be found in the 
corresponding figure legends. 
56 
 
 
 
Figure 6. Histological verification of AAV injection and optic fiber placements. 
(A) Schematic showing injection of AAV-oChIEF-tdTomato throughout the anterior-posterior extent of the MGN 
(For Figures 13; n = 33 rats and 14; n = 13 rats). Dark red shading shows representation of smallest acceptable virus 
spread, and light pink shading shows representation of largest acceptable spread. Inclusion required dual hemisphere 
viral expression. (B) Schematic showing spread of AAV-oChIEF-tdTomato (corresponding to Figures 13 and 14) 
and optic fiber placements (corresponding to Figure 14) throughout the anterior-posterior extent of the LA. Light 
pink shading shows representation of AAV-infected MGN-projecting axons. There is robust expression through the 
internal capsule targeting the LA. Notably, there is also expression in auditory temporal cortex, which receives 
dense projections from the MGN. Blue circles correspond to successful optic fiber placement in both hemispheres. 
Black circles correspond to successful optic fiber placement in only one hemisphere. Black “X” corresponds to 
unsuccessful fiber placement. To be included in final analysis, rats required viral expression in the LA as well as 
successful placement of fibers in both hemispheres. Coordinates are in mm, posterior from bregma. 
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2.3 RESULTS 
2.3.1 Thalamo-amygdala synaptic modifications regulate cocaine-cue memories 
To determine how the strength of drug-cue associations impacts drug-seeking behavior, rats were 
trained on a fixed ratio 1 (FR1) schedule of reinforcement, during which a single active lever 
press was required to receive an infusion of cocaine or saline (Sal), paired with an audiovisual 
CS (Figure 7A). Cocaine- but not saline-trained animals demonstrate reliable acquisition of SA 
(Figure 7B). After the completion of at least 10 daily training sessions, and once acquisition 
criteria were met, rats underwent instrumental extinction (IE) for ~7 days, where lever pressing 
produced no consequences, and was thus reduced. 24 h following the last IE session, rats 
underwent ‘cue re-exposure sessions’ during which they received passive presentations of the CS 
(0, 3, 60, or 120 times) in the absence of cocaine reinforcement. 24 h later, the capacity of the CS 
to promote cocaine-seeking behavior was determined during a cue-induced reinstatement 
session. Increasing the number of CS presentations during cue re-exposure resulted in a 
progressive reduction in cue-elicited drug seeking (Figure 7C). Compared to non-re-exposed 
controls (0 CS presentations), 120 CS presentations significantly attenuated reinstatement, 
confirming previous studies demonstrating that relapse-promoting, drug-cue associations that 
form during cocaine SA can be extinguished by sufficient cue re-exposure in the absence of drug 
reinforcement (Torregrossa et al., 2013).  
In separate groups of animals, we next tested if drug-cue associations were regulated by 
specific synaptic modifications in the LA by performing ex vivo electrophysiological recordings 
in rats trained to SA cocaine or saline, followed by cue exposure either 24 h after the last SA  
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Figure 7. Drug-cue memory manipulations alter cue-induced reinstatement. 
(A) Experimental timeline and schematic demonstrating timepoints of each experimental phase and color-coded 
treatment groups. SA, self-administration; IE, instrumental extinction; CS, conditioned stimuli; LA, lateral 
amygdala. (B) Cocaine SA (Left, n = 50), but not saline SA (Right, n = 15) animals exhibit an increasing number of 
cocaine infusions throughout acquisition. (C) Effect of cue re-exposure on cue-induced reinstatement. All groups 
made significantly more active lever presses during reinstatement compared to the last day of IE; however, 
reinstatement is reduced by extended cue extinction (120 CS). Two-way ANOVA, main effect of group (F(3,112) = 
12.56, P < .001) and a day x group interaction (F(3, 112) = 14.69, P < .001); post hoc analysis: *p < .05, **p < .01, 
***p < .001. Error bars equal mean ±SEM, n in italics, number of rats (number of neurons). 
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Figure 8. No group differences in acquisition of cocaine self-administration. 
Acquisition data for rats from electrophysiological experiments. There were no differences in infusions earned (Left: 
F(4,49) = 1.92, P > .05), active lever presses (Middle: F(4,49) = 1.46, P > .05), or inactive lever presses (Right: F(4,49) = 
2.19, P > .05) between any cocaine SA animals (all two-way ANOVA; n in italics, number of rats), but there are 
differences between cocaine and saline SA animals. 
 
 
session or after IE sessions (described below). Importantly, the timing of recordings 
corresponded to the time when cue-induced reinstatement behavioral tests were conducted 
(Figure 7A). Additionally, rats were assigned to groups based on a random matching procedure 
to ensure no significant differences between groups for the number of infusions earned, active 
lever presses, or inactive lever presses during acquisition (Figure 8). Previous studies involving 
auditory fear conditioning revealed that the strength of thalamic and cortical synapses in the LA 
correspond to the strength of the fear memory (Hong et al., 2009; Kim et al., 2007a), suggesting 
that similar synaptic modifications may underlie drug-cue associations. To test this, electrically-
evoked EPSCs were recorded from LA principal neurons by stimulating either internal capsule 
(IC: putative thalamic afferents or external capsule (EC: putative cortical afferents (Doron and 
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Ledoux, 2000; Hong et al., 2009; Kim et al., 2007a) (Figures 9A and 12A). We tested a series of 
stimulation intensities to generate an input-output relationship, whereby EPSC amplitude is 
increased with larger stimulation intensity. These relationships have commonly been used to 
assess synaptic changes following extinction of conditioned fear memories (Hong et al., 2009; 
Kim et al., 2007a). Relative to saline-trained controls, cocaine-trained non-CS re-exposed 
animals showed significantly increased EPSC amplitudes at thalamo-amygdala (T-LA) synapses 
at given current injections, suggesting that the formation of drug-cue associations potentiates this 
synapse (Figure 9B). To determine if context re-exposure alone could account for changes in T-
LA synaptic strength, a control group of animals remained in their home cage instead of 
undergoing cue re-exposure. Although context re-exposed animals show slightly higher EPSC 
amplitudes than the home-cage controls, these differences were not significant (Figure 10). This 
reveals that synaptic strengthening is likely due to the repeated pairing of discrete and contextual 
cues in combination with cocaine SA and is not dependent on re-exposure to the drug-related 
context alone. 
We next assessed how the number of CS presentations during cue re-exposure impacted 
T-LA synaptic strength and again discovered a progressive effect of CS re-exposure (Figure 
9B). Compared to 0 CS animals, EPSC amplitude was slightly, although non-significantly 
increased in animals that underwent brief CS re-exposure (3 CS), suggesting that brief cue 
memory reactivation in the absence of cocaine does not disrupt the original drug-cue association, 
and may tend to strengthen the association through reconsolidation processes. However, EPSC 
amplitude was attenuated by increasing the number of cue presentations (60 and 120 CS). 
Animals that underwent 120 CS re-exposure exhibited average EPSC amplitudes similar to that 
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of saline-controls. This shows that long-term cue re-exposure depotentiates T-LA synapses, 
thereby reversing the synaptic changes that occur after Coc+cue SA.  
We next asked whether T-LA synaptic strength was directly affected by the strength of 
the cocaine-cue association (Figure 9C). We discovered a positive correlation between the total 
number of US-CS pairings received during SA and the average EPSC amplitude for animals that 
received no cue re-exposure. Conversely, in animals that underwent either 60 or 120 CS re- 
exposure (cue memory extinction), there was no correlation between these two factors. These 
data suggest that increased cocaine-cue pairings is associated with more strongly potentiated T-
LA synapses. However, sufficient cue re-exposure in the absence of drug reinforcement weakens 
T-LA synapses independent of prior drug-cue experience.  
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Figure 9. Cocaine-cue manipulations drive thalamo-amygdala synaptic modifications. 
(A) Image of LA coronal section, demonstrating placement of stimulating electrode above IC fibers and position of 
patch pipette. EPSCs were evoked from LA principal neurons by stimulating the IC (putative T-LA synapses). IC, 
internal capsule; EC, external capsule. (B) Cocaine SA and drug-cue manipulations alter T-LA synaptic strength. 
Left, Average EPSC amplitude for each group at various stimulation intensities. Right, Average EPSC amplitude at 
the highest stimulation intensity (35 μA). Cocaine SA increases EPSC amplitude relative to Sal SA. Brief cue re-
exposure (3 CS) does not further alter EPSC amplitude, but moderate (60 CS) and extended (120 CS) cue extinction 
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reverses the cocaine-cue-induced potentiation. Two-way ANOVA, main effect of group (F(4,40) = 13.54, P < .001) 
and a stim. intensity x group interaction (F(20,200) = 8.96, P < .001); post hoc anlaysis: *p < .05, ***p < .001. Inset: 
Sample average EPSC traces evoked at -70 mV. (C) Left, EPSC amplitude (35 μA stimulation intensity) was 
strongly correlated with the number of CS-US pairings received during acquisition for cocaine- and saline SA 
animals that did not receive cue re-exposure; r(30) = 0.532, **p < .01, n = 32. Right, EPSC amplitude was not 
correlated with number of CS-US pairings for animals that received cue extinction (60 or 120 CS); r(21) = -0.109, p 
= .619, n = 23. (D) Instrumental extinction does not alter T-LA synaptic strength. EPSC amplitude was significantly 
higher for rats that received no cue re-exposure (0 CS) compared to rats that received extended extinction (120 CS), 
independent of IE. Two-way ANOVA, main effect of group (F(3,24) = 8.38, P < .001) and a stim intensity x group 
interaction (F(15,120) = 4.87, P < .001); post hoc analysis: **p < .01, ***p < .001. Inset: Sample average EPSC traces 
from each group evoked at -70 mV. (E) Changes in T-LA synapses are driven by postsynaptic changes in AMPAR. 
Cocaine-cue memory manipulations significantly affect AMPAR (Left: F(4,34) = 12.70, P < .001) and NMDAR 
current (Middle: F(4,34) = 5.77, P = .001) but do not alter PPR (Right: F(4,40) = 1.81, P > .05); all one-way ANOVA; 
post hoc analysis: *p < .05, **p < .01. Inset: Sample average EPSC traces evoked at Erev -70 mV (AMPA, PPR) and 
Erev +40 mV (NMDA). Error bars equal mean ±SEM, n in italics, number of rats (number of neurons). All scale 
bars: 50 ms, 200 pA 
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Figure 10. Potentiation of thalamo-amygdala synapses following drug-cue learning is not context-dependent. 
(A) Experimental timeline. Rats self-administered cocaine for 10-20 d. 24 h following the last day of acquisition, 
one group of rats was returned to the operant chamber, but received 0 CS presentations, while a second group of rats 
remained undisturbed in their home cage. The following day, rats were euthanized and slices were prepared for 
electrophysiological recordings. T-LA EPSCs were elicited by stimulating fibers from the internal capsule. (B) No 
difference in EPSC amplitude between the two groups. Average EPSC amplitude for the two groups at various 
stimulation intensities. Context re-exposed animals show slightly higher, yet nonsignificant EPSC amplitude than 
home cage controls (Two-way ANOVA, F(1,12) = 0.84, P > .05; n in italics, number of rats (number of neurons)). 
Scale bars: 50 ms, 200 pA. 
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As described above, previous studies have found that extinction of a drug-seeking action 
is associated with synaptic changes throughout the brain’s reward circuitry (Kalivas et al., 2005; 
Park et al., 2002). To determine whether T-LA synapses would be differentially regulated by 
whether or not the instrumental extinction (IE) phase of the experiment was included, a separate 
group of rats underwent cocaine SA followed by 1-7 days of IE. During IE, animals had the 
opportunity to make unreinforced responses (no cocaine infusion, no CS presentation) on both 
the active and inactive levers. During the first day of IE rats demonstrate a high tendency to press 
the active lever (Figure 11B), likely in anticipation of a cocaine infusion. However, rats quickly 
adapt to the new association, resulting in extinction of the lever pressing response. Interestingly, 
IE alone was insufficient to depotentiate T-LA synapses (Figure 9D). Cocaine-trained rats that 
underwent IE followed by 0 CS re-exposure had EPSC amplitudes similar to rats that did not 
undergo IE. Similarly, rats that underwent IE plus 120 CS re-exposure exhibited depotentiated T-
LA synapses, as did the group that underwent 120 CS re-exposure in the absence of IE. These 
differences are not due to pre-existing group differences, as rats were again grouped to ensure no 
differences in SA or IE behavior (Figure 11). Together, these data demonstrate that T-LA 
synapses are regulated explicitly by the strength of drug-cue associations and not by memories of 
the drug-taking action.  
We next tested whether changes in the T-LA synaptic strength may be due to 
postsynaptic changes in glutamatergic receptors, by examining whether AMPAR and NMDAR 
currents changed as a result of cocaine SA and subsequent cue re-exposure. We determined that 
the observed synaptic changes were driven by changes in AMPAR, not NMDAR (Figure 9E).  
AMPAR current was enhanced by cocaine SA, and maintained by brief cue re-exposure;  
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Figure 11. No group differences in acquisition of self-administration or instrumental extinction. 
(A) Comparison of acquisition data for rats that underwent instrumental extinction (IE) prior to drug-cue re-
exposure sessions. Following IE, rats received either no cue re-exposure (0 CS) or extended cue extinction (120 CS). 
During SA, there were no differences in infusions earned (Left: F(1,11) = 0.02, P > .05), active lever presses (Middle: 
F(1,11) = 0.10, P > .05), or inactive lever presses (Right: F(1,11) = 0.45, P > .05) between the two groups (all two-way 
ANOVA; n in italics, number of rats). (B) Comparison of IE data. There were no differences in active lever presses 
(Middle: F(1,11) = 0.07, P > .05), or inactive lever presses (Right: F(1,11) = 1.99, P > .05) between the two groups (all 
two-way ANOVA). 
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however, it was decreased by cue extinction. Interestingly, changes in NMDAR may be a 
contributing factor to the potential memory-strengthening effects of brief cue reactivation, as 3-
CS re-exposed animals had significantly higher AMPAR and NMDAR current relative to saline-
trained controls and 120-CS re-exposed animals (Figure 9E). To rule out a presynaptic 
mechanism, such as changes in neurotransmitter release probability, we also compared paired 
pulse ratio (PPR), and found no significant differences between groups (Figure 9E). Together, 
these data suggest that during cocaine-cue memory formation, T-LA synapses are potentiated 
due to increased AMPAR transmission, which may promote drug-seeking behavior. Sufficient 
cue re-exposure in the absence of drug reinforcement reverses these changes, leading to an 
extinction of the drug-cue memory, and a decreased ability of the CS to promote drug-seeking. 
Finally, we sought to determine if cortico-amygdala (C-LA) synapses also encode the 
strength of drug-cue associations. To test this, we performed similar electrophysiological 
recordings from LA principal neurons, while stimulating EC afferents (Figure 12A). In contrast 
to T-LA synapses, the EPSC amplitude input-output relationship was not affected at C-LA 
synapses by cocaine SA or CS re-exposure (Figure 12B). Also, unlike T-LA synapses, AMPAR 
EPSC amplitude at C-LA synapses did not correlate with the number of CS-US pairings received 
during training. (Figure 12C). These results suggest that cortical afferents to the amygdala are 
not correlated with cocaine-cue learning. Nevertheless, instrumental extinction depotentiated 
AMPAR EPSCs at C-LA synapses, independent of cue extinction (Figure 12D). EPSC 
amplitude at C-LA synapses was significantly decreased after IE both in rats that received no cue 
re-exposure (Coc + 0 CS) and those that received extended cue re-exposure (Coc + 120 CS). 
Therefore, cortical input to the amygdala appears to be regulated not by drug-cue associations, 
but by memories of the drug-taking action.
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Figure 12. Cortico-amygdala synapses are altered by instrumental extinction, but not by drug-cue memory 
manipulation. 
(A) Image of LA coronal section, demonstrating placement of stimulating electrode above EC fibers and position of 
patch pipette. EPSCs were evoked from LA principal neurons by stimulating the EC (putative C-LA synapses). IC, 
internal capsule; EC, external capsule. All scale bars: 50 ms, 200 pA. (B) Cocaine SA and cue-memory 
manipulations have no effect on C-LA synaptic strength. Left, Average EPSC amplitude for each group at various 
stimulation intensities. Right, Average EPSC amplitude at the highest stimulation intensity, 35 μA. Two-way 
ANOVA, (F(4,31) = 0.854, P > .05). Inset: Sample average EPSC traces evoked at -70 mV. (C) EPSC amplitude (35 
μA stim intensity) was not correlated with the number of CS-US pairings received during acquisition for cocaine- 
and saline-SA animals that did not receive cue re-exposure (Left; r(12) = 0.010, p = .972, n = 14) or for those that 
received cue extinction (Right; r(13) = 0.118, p = .677, n = 15). (D) C-LA synapses are depotentiated by IE. EPSC 
amplitude was significantly lower for all rats that received IE, independent of cue re-exposure. Two-way ANOVA, 
main effect of group (F(3,22) = 5.11, P = .008) and a stim intensity x group interaction (F(15,110) = 3.69, P < .001); post 
hoc analysis: **p < .01, ***p < .001. Inset: Sample average EPSC traces evoked at -70 mV. Error bars equal mean 
±SEM, n in italics, number of rats (number of neurons). All scale bars: 50 ms, 200 pA 
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2.3.2 MGN-LA synapses are altered by cocaine-cue associations 
Projections from multiple thalamic nuclei innervate the amygdala (LeDoux et al., 1990; Nabavi 
et al., 2014; Vertes et al., 2015), and studies involving auditory fear conditioning suggest that 
connections between the MGN and LA are particularly important for mediating auditory cue-
specific memories. To test whether projections from the MGN to the LA are strengthened by 
cocaine-cue associations, we expressed a variant of channelrhodopsin in MGN neurons 
(AAV5.hSyn.oChIEF.tdTomato) (Lin et al., 2013; Nabavi et al., 2014). Approximately 2 weeks 
after viral infusions, rats underwent a similar procedure as described above (Figure 13A), where 
they were trained to SA cocaine or saline, followed by either 0 or 120 CS re-exposures. 24 h 
after cue re-exposure sessions, ex vivo slices of the amygdala were prepared and light-evoked 
(473-nm) EPSCs were recorded from LA principal neurons (Figure 13B,C). Optogenetic 
stimulation of MGN terminals within the LA revealed increased EPSC amplitude in cocaine-
trained non-CS re-exposed animals relative to saline-trained controls, whereas 120 CS re-
exposure resulted in a reversal of this potentiation (Figure 13C). Again, the changes in synaptic 
strength appear to be primarily mediated by postsynaptic changes in AMPAR. Compared to 
cocaine-trained non-CS re-exposed animals, those that underwent extended cue re-exposure had 
significantly reduced AMPAR current, but there were no group differences for either NMDAR 
current or PPR (Figure 13D). These results suggest that drug-cue associations are mediated by 
dynamic changes in AMPAR at MGN-LA synapses. 
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Figure 13. MGN-LA synapses regulate cocaine-cue associations. 
(A) Diagram and schematic demonstrating the experimental timeline and injection of oChIEF-expressing AAV5 
targeting the MGN. Scale bars in traces: 50 ms, 100 pA. (B) Diagram and images demonstrating the position in the 
MGN at which AAV-oChIEF was stereotaxically injected (Top). Injection of virus resulted in labeling of MGN 
axon terminals that synapses at the LA (Bottom). (C) EPSCs were optically-evoked from LA principal neurons by 
stimulating AAV-infected MGN axon terminals with 0.1 ms pulses of blue light (473-nm). Cocaine-trained animals 
that were not re-exposed to cues had significantly higher EPSC amplitude relative to saline-trained controls and 
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cocaine-trained 120-CS re-exposed animals. One-way ANOVA, (F(2,25) = 6.87, P = .004); post hoc analysis: *p < 
.05, one-way ANOVA). Inset: Sample average EPSC traces evoked at -70 mV. (D) Plasticity at MGN-LA synapse is 
due to postsynaptic changes in AMPAR and NMDAR, but not due to presynaptic changes. Cocaine-cue memory 
manipulations significantly affect AMPAR current (Left: F(2,25) = 3.72, P = .039) but not NMDAR current (Middle: 
F(2,25) = 2.22, P > .05) or PPR (Right: F(2,30) = 0.03, P > .05); all one-way ANOVA; post hoc analysis: *p < .05. 
Inset: Sample average EPSC traces evoked at Erev -70 mV (AMPA, PPR) and Erev +40 mV (NMDA). Error bars 
equal mean ±SEM, n in italics, number of rats (number of neurons). Scale bars: 50 ms, 200 pA. 
 
2.3.3 In vivo optogenetic induction of LTD at MGN-LA synapses attenuates relapse-like 
behavior 
We next determined if we could mimic extinction of drug-cue memories via inducing circuit-
specific LTD at MGN-LA synapses. To do this, we first demonstrated the capacity to optically 
induce LTD at MGN-LA synapses. Rats were injected with AAV-oChiEF into the MGN and 
were trained to SA cocaine or saline, followed by either 0 or 120 CS re-exposure. 24 h later, ex 
vivo electrophysiological recordings were performed. In current-clamp configuration, LA-
projecting MGN afferents were stimulated with blue light to optically-evoke excitatory 
postsynaptic potentials (EPSPs). Following LTD induction (1 Hz, 15 min), a sustained 
suppression of EPSP slope and amplitude was reliably observed in cocaine-trained 0 CS re-
exposed animals (Figure 14A,B, and 15A). However, LTD was not observed in saline-trained 
animals (Figure 14A,B), nor cocaine-trained 120 CS re-exposed animals (Figure 14A,B), 
presumably because of an occlusion effect. These results suggest not only that you can induce  
72 
 
 
Figure 14. In vivo optical LTD of MGN-LA circuit inhibits cue-induced reinstatement. 
(A) Scatter plots demonstrating effect of ex vivo optical LTD induction on EPSP rise slope at MGN-LA terminals. 
15 min. of 1 Hz optical stimulation induced a sustained reduction in EPSP rise slope only in cocaine-trained non-CS 
re-exposed animals. (B) Quantification of A. Bar graph demonstrating effect of 1 Hz stimulation on EPSP rise slope 
as a percent change from baseline. LTD induction significantly decreased EPSP rise slope relative to baseline only 
in cocaine-trained non-CS re-exposed animals (Paired t-test, t(6) = 3.34, *P = .016, n in bars, number of neurons. 
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Inset: Sample average EPSP traces across groups during baseline (Pre, black) and 1 hour after LTD induction 
(Post, red). Scale bars: 100 ms, 10 mV. (C) Experimental timeline and schematic for testing the effect of in vivo 
LTD of MGN-LA synapses on cue-induced reinstatement. oChIEF-expressing AAV5 was injected into the MGN 
and optical fibers were implanted at the dorsal tip of the LA. (D) Diagram and images demonstrating the position of 
virus injection in the MGN (Top) and placement of optic fibers in the LA (Bottom). (E) In vivo dual hemisphere 
LTD of MGN-LA synapses attenuates EPSC amplitude relative to SHAM-controls (Unpaired t-test, t(4) = 6.60, **P 
= .003). Inset: Sample average EPSC traces across groups. Scale bars: 50 ms, 100 pA. (F) In vivo dual hemisphere 
LTD of MGN-LA synapses attenuates reinstatement. There were no differences in active lever pressing between 
groups during the last day of IE. All groups show pronounced reinstatement to drug-associated cues, but there is a 
significant reduction in active lever presses during reinstatement in rats that previously underwent optical LTD 
relative to SHAM controls. Two-way ANOVA, main effect of group (F(1,11) = 18.16, P = .001) and a day x group 
interaction (F(1,11) = 12.76, P = .004); post hoc analysis: **p < .01. 
 
 
LTD in cocaine-trained rats, but that an LTD-like process is induced at MGN-LA synapses by 
cue-memory extinction. 
Finally, we tested if in vivo optogenetic LTD induction was sufficient to block cue-
induced cocaine-seeking. Rats were again injected with the AAV-oChIEF targeting the MGN 
and optic fibers were implanted targeting the dorsal portion of the LA (Figure 14C,D). 
Following SA and IE, rather than undergoing cue re-exposure, rats received in vivo low 
frequency optical LTD (1 Hz, 15 min 473-nm light stim) of MGN-LA terminals. A second group 
of rats was treated similarly, but did not receive laser stimulation (SHAM-controls). 24 h later, 
either ex vivo optical recordings or cue-induced reinstatement was performed. Animals that were 
exposed to optical LTD had significantly reduced MGN-LA EPSC amplitude relative to SHAM- 
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controls (Figure 14E), confirming induction of LTD by our stimulation protocol. Furthermore, 
LTD-exposed rats also made significantly fewer lever responses during reinstatement compared 
to SHAM-controls (Figure 14F). Rats subsequently underwent an additional reinstatement test 7 
days later, and LTD-exposed rats maintained a low level of responding that was lower than 
SHAM-controls (Figure 15B). These data show that induction of LTD at MGN-LA synapses is 
sufficient to reduce drug-seeking behavior, in a manner similar to drug-cue extinction, and that 
this reduction can persist across multiple reinstatement tests. Together, these results indicate that 
drug-cue memories may be malleable to circuit-specific optogenetic manipulations, presenting 
the possibility for novel therapeutic approaches. 
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Figure 15. Further characterization and behavioral effects of MGN-LA optical LTD. 
(A) Scatter plots demonstrating effect of ex vivo optical LTD induction on EPSP peak amplitude at MGN-LA 
terminals. 15 min. of 1 Hz blue light stimulation induced a sustained reduction in EPSP amplitude only in cocaine-
trained non-CS re-exposed animals, with no effect on saline-trained or cocaine-trained 120-CS re-exposed animals; 
n in bars, number of neurons. (B) In vivo dual hemisphere LTD of MGN-LA synapses effects spontaneous recovery. 
7 days after initial cue-induced reinstatement, rats underwent a second reinstatement test, revealing a significant 
reduction in active lever pressing in animals that previously underwent MGN-LA LTD relative to SHAM controls. 
Two-way ANOVA, main effect of group (F(1,18) = 12.43, P = .002), significant interaction (F(1,18) = 7.03, P = .010); 
post hoc analysis, ***p < .001; n in bars, number of rats. 
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2.4 DISCUSSION 
We have previously shown that re-exposure to cocaine-associated discrete cues in the absence of 
cocaine reinforcement can attenuate cue-elicited drug-seeking (Rich et al., 2016). In this study, 
we extend our findings and demonstrate that sensory input from the thalamus, but not cortex, is 
critical for regulating cue-driven drug-seeking behaviors. Specifically, T-LA, but not C-LA 
synapses are potentiated by the repeated pairing of cocaine with a discrete audiovisual cue 
(Figures 9B and 12B). Importantly, this drug-cue association is long-lasting, as animals that 
underwent >7 days of instrumental extinction, still showed T-LA synaptic potentiation, which 
promotes reinstatement to the cue (Figures 7C and 9D). Conversely, re-exposure to the cue in 
the absence of drug reinforcement dose-dependently depotentiates T-LA synapses, thereby 
inhibiting relapse-like behavior (Figure 7C and 9B). Furthermore, in vivo optogenetic induction 
of LTD in the MGN-LA pathway of cocaine-trained animals was sufficient to prevent 
reinstatement (Figure 14F). While optical LTD of this pathway has previously been 
demonstrated to inhibit a fear-associated memory (Nabavi et al., 2014), our work provides the 
first direct evidence of circuit-specific neuroadaptations associated with drug-cue-specific 
memories that promote craving and relapse.  
In our study, rats that underwent brief cue re-exposure (3 CS) still exhibited the drug-cue 
conditioning-induced potentiation of T-LA synapses and remained vulnerable to cue-induced 
reinstatement (Figures 7C and 9B). Brief cue re-exposure has been proposed to reactivate the 
drug-cue memory, and initiate reconsolidation, during which time the memory is vulnerable to 
disruption via pharmacological manipulation (Arguello et al., 2014; Rich et al., 2016; Sanchez et 
al., 2010). Reconsolidation is thought to strengthen or at least maintain memory, and our study 
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reveals a slight, yet nonsignificant increase in T-LA EPSC amplitude relative to cocaine-trained 
non-CS re-exposed animals. The lack of a statistical significance does not rule out a memory-
strengthening effect of brief cue re-exposure. For example, the destabilization and restabilization 
of memory that occurs after reactivation is likely to involve postsynaptic signaling, which may 
explain the significant effect at NMDAR (Figure 9E). It is important to note, however, that our 
recordings occur 24 hours after reactivation, a timepoint at which the reactivated memory is 
thought to be restabilized. Other circuits within the brain are also impacted by reconsolidation 
(Hafenbreidel et al., 2017; Liang et al., 2017; Liu et al., 2017), and depending on the way 
memory is distributed throughout the brain, there may be a cumulative effect that leads to 
persistence of the drug-cue memory. Future experiments should examine a timepoint within the 
reconsolidation window (<6 hours after reactivation) to determine if there is evidence of 
destabilization, which would indicate that reconsolidation does indeed occur following brief cue 
reactivation. Furthermore, it would be useful for future experiments to examine the effect of cue 
re-exposure on saline self-administering rats. We would predict that because these animals do 
not form a strong association between saline and the conditioned stimuli, that there would be no 
differences between cue re-exposed and non-re-exposed animals. 
The importance of experience-driven synaptic plasticity within specific amygdala circuits 
has been well documented for the regulation of other types of associative learning. For example, 
auditory fear conditioning potentiates both the T-LA and C-LA pathway, resulting in increased 
freezing in the presence of the auditory cue. Cue extinction training reverses the synaptic 
changes and blocks the expression of fear (Hong et al., 2009; Kim et al., 2007a). The importance 
of the amygdala during reward-based learning has also been demonstrated (Fuchs et al., 2006; 
Robbins et al., 2008), but the specific afferent inputs involved have not been well examined, 
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especially in the context of drugs of abuse. Tye and colleagues showed that sucrose-reward 
learning rapidly strengthens T-LA synapses, but enhancement of C-LA synapses required 
elevated dopamine, which was achieved by blocking the dopamine transporter (DAT) (Tye et al., 
2008, 2010). In our study, despite the DAT-blocking effects of Coc, we did not see training-
induced C-LA potentiation; however, procedural differences including timing of ex vivo 
recordings and absence of sucrose reward may explain this seeming discrepancy. Here, we show 
that T-LA synapse are indeed strengthened by the formation of a drug-cue association, but that 
these alterations are reversible, depending on the amount of unreinforced cue re-exposure 
(Figure 9B). Moderate cue re-exposure (60 CS) slightly reduced, while extended cue re-
exposure (120 CS) fully reversed the cocaine-cue-associated potentiation. Recent evidence 
supports dose-dependent synaptic effects of cue re-exposure. The extinction of a fear-associated 
memory has been shown to consist of two separate phases, each with distinct mechanisms (An et 
al., 2017). Early fear extinction (following a single extinction session; 20 CS presentations) 
promotes the inhibition of the original fear memory through mechanisms including enhanced 
inhibitory tone in LA neurons, enhanced CS-evoked activity in the mPFC, and enhanced 
synaptic efficacy of amygdala intercalated neurons (Amano et al., 2010; Chhatwal, 2005; Lin et 
al., 2009; Milad and Quirk, 2002). Late fear extinction (following multiple extinction sessions; 
60 CS presentations) involves erasure of the fear memory, which consists of depotentation of T-
LA synapses. Thus, our results are consistent with the data from these multiple fear extinction 
session studies. However, we do find that this large number of CS presentations (120) is 
necessary to observe consistent reductions in the reinstatement of drug seeking, which is 
different from the fear conditioning literature.  
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The lack of group effects on C-LA synapses (Figure 12B) may speak to the importance 
of bottom-up signaling during reward-motivated behaviors that is less dependent on cognitive 
influence. Previous studies have demonstrated the influence of top-down circuits in extinction, 
however, these studies primarily involve extinction of the drug-taking action (Augur et al., 2016; 
Stefanik et al., 2016). Interestingly, we did observe synaptic depotentiation of C-LA synapses in 
response to instrumental extinction (Figure 12D), suggesting a role for this circuit in learning to 
inhibit the drug-taking action when the drug is unavailable. These findings do not rule out any 
cortical influence on drug-cue memory extinction, as the C-LA pathway mostly relays input from 
auditory, (Te2/Te3), visual, and perirhinal cortex (Mcdonald, 1998), while other cortical areas 
project via separate pathways. For example, mPFC afferents synapse on LA interneurons, which 
then locally inhibit LA principal neurons (An et al., 2017). However, in our study we only 
recorded from principal neurons, and the inclusion of picrotoxin in the bath solution blocks any 
contribution from this potentially important inhibitory circuit.  
Our study identifies postsynaptic glutamatergic signaling as a mechanism responsible for 
regulating drug-cue memory (Figures 9E and 13D). Future studies should continue to expand 
upon the mechanisms and circuits involved. Calcium signaling and intracellular kinases and 
phosphatases are important for cue-associated memories (Merlo et al., 2014; Rich et al., 2016), 
and these downstream signaling mechanisms are likely involved in synaptic modifications 
following drug-cue re-exposure; for example, the internalization of AMPAR, which is necessary 
for the extinction of acquired fear (Dalton et al., 2008). Additionally, mGluR1 and mGluR2 
receptors in the amygdala are critical for depotentiation and the extinction of fear-associated 
memories (Hong et al., 2009; Kim et al., 2007b). Although our study focuses on auditory 
thalamic inputs to the LA, the mediodorsal and paraventricular nuclei of the thalamus also 
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project to the mPFC, nucleus accumbens, and the amygdala (Do-Monte et al., 2017; Vertes et al., 
2015). These circuits have been implicated in fear conditioning (Penzo et al., 2015), incubation 
of drug seeking (Li et al., 2015; Lu et al., 2005), and the regulation of reward seeking when an 
anticipated reward is omitted (Do-Monte et al., 2017), and therefore could also influence drug-
cue memory. Finally, because drugs of abuse act on the brain’s reward system, the role of 
dopaminergic inputs from the VTA in modulating LA afferent input should also be examined. 
Activation of DA receptors was previously shown to enhance Te3-evoked responses in the LA 
(Rosenkranz and Grace, 2001). Similarly, elevated dopamine during cue-sucrose learning was 
sufficient to enhance cortico-amygdala plasticity when measured 30 minutes after training (Tye 
et al., 2010), so dopamine likely influences plasticity during reconsolidation and extinction of a 
drug-cue memory as well. 
The use of optogenetics in this study helps overcome the inherent limitations of ex vivo 
recordings that involve electrical stimulation. While our electrical stimulation experiments are 
informative, stimulation of the internal capsule in this manner, may cause unintentional 
activation of neurons that do not project via the internal capsule. Optical stimulation of LA-
projecting MGN neurons yields a higher degree of specificity. However, there remains several 
important controls that should be tested in future experiments. In order to show that MGN 
neurons are specifically involved in the regulation of drug-cue memory, other nuclei from the 
thalamus, such as the medial dorsal thalamus, which also projects to subregions of amygdala, 
should also be examined. It would also be beneficial to include a control group of animals that is 
optically stimulated at a frequency that would not be predicted to induce LTD. This is a stronger 
control than the SHAM group because these animals would still be exposed to light stimulation. 
Finally, another alternative control is a group of animals that is injected with a control virus 
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targeted to the MGN that is unresponsive to blue light stimulation. These animals could then 
receive the same 1 Hz LTD induction protocol, but since they do not express channelrhodopsin, 
there should be no effect of stimulation.   
One limitation of cue extinction as a therapy is that drug-seeking often spontaneously 
returns after a period of abstinence (Peters et al., 2008; Rescorla, 2004). Interestingly, in our 
study, extended cue extinction was sufficient to reduce relapse-like behavior, even in animals 
that had extensive drug-cue experience (Figure 9C), suggesting that long-term cue re-exposure 
in the absence of drug reinforcement may be effective at preventing relapse even in chronic drug 
abusers. Optical induction of LTD in the MGN-LA pathway, which is occluded by prior cue 
extinction, results in similar decreases in reinstatement (Figure 14), suggesting that cue 
extinction occurs via a persistent depotentiation of T-LA synapses. Furthermore, this reduction 
was maintained across multiple reinstatement tests, suggesting decreased spontaneous recovery 
(Figure 15B). Together, these results support the idea that circuit-specific neuroadaptations can 
support the long-term inhibition or erasure of a drug-cue memory and offer an important 
consideration for future treatments. 
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3.0  CALCINEURIN MODULATES NEUROPLASTIC CHANGES IN THE 
AMYGDALA TO SUPPORT THE INHIBITION OF DRUG-ASSOCIATED MEMORIES 
Interfering with memory reconsolidation or inducing memory extinction are two therapeutic 
approaches for weakening maladaptive memories in disorders such as PTSD and addiction. Both 
extinction and reconsolidation are regulated by various intracellular protein kinases and 
phosphatases, and interfering with these signaling molecules can alter memory strength. The 
calcium dependent protein phosphatase, calcineurin, is one such molecule that has been 
implicated in both the consolidation and extinction of fear memories. However, the role of 
calcineurin in regulating cocaine-cue associative memories has not been investigated. Previous 
studies have indicated that the lateral amygdala (LA) is a critical locus for cocaine-cue memory 
reconsolidation and extinction. Furthermore, in Chapter 2, we demonstrated that thalamo-
amygdala (T-LA), but not cortico-amygdala (C-LA) synapses are involved in the regulation of 
cocaine-cue memories. We therefore tested the effects of LA administration of an activator of 
calcineurin, chlorogenic acid (CGA), on both behavioral and electrophysiological indices of 
cocaine cue memory extinction and reconsolidation. Rats were trained to self-administer cocaine 
paired with an audiovisual cue. The cue memory was then either briefly reactivated, 
extinguished, or not manipulated followed immediately by LA infusion of CGA. Rats were 
tested 24 hrs later for cue-induced reinstatement, or LA slices were prepared for 
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electrophysiological recordings. We found that CGA infusions in the LA following cue 
extinction or reconsolidation caused a significant reduction in both EPSC amplitude at thalamic 
inputs to the LA and cue-induced reinstatement relative to vehicle-infused controls, suggesting 
that calcineurin can affect drug-cue memory reconsolidation and extinction by altering T-LA 
synaptic strength. Therefore, calcineurin may represent a novel target for disrupting cocaine-
associated memories to reduce relapse. 
3.1 INTRODUCTION 
Addiction is characterized by a progressive switch from occasional, casual drug use to a more 
frequent, habitual pattern of use (Everitt and Robbins, 2005). With repeated drug use, originally 
neutral environmental contexts and cues become conditioned by the drug and develop emotional 
significance based on the drug-using experience (Fuchs et al., 2009; Kalivas, 2009). Re-exposure 
to the cues, even in the absence of the drug itself, can activate memories of prior drug use that 
initiate feelings of craving and promote relapse (Parvaz et al., 2016). Reducing the strength of 
drug-associated memories may therefore help establish long-term abstinence. Memory 
weakening can be accomplished in one of two manners: either interfering with drug-cue memory 
reconsolidation or by promoting drug-cue memory extinction (Bossert et al., 2013; Torregrossa 
et al., 2011). Reconsolidation is the process of restabilization of a memory after retrieval. The 
reconsolidation process involves a cascade of intracellular signaling events and requires protein 
synthesis. Thus, during this period of lability, the administration of certain pharmacological 
agents can prevent memory re-stabilization, thereby weakening or even erasing the memory 
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(Tronson and Taylor, 2007). While reconsolidation is triggered by brief re-exposure to 
conditioned stimuli, the extinction process involves the repeated presentation of a conditioned 
stimulus in the absence of the expected outcome (e.g., foot shock or drug reinforcement), which 
leads to the formation of a new association that the cue is no longer predictive of the outcome. 
Thus, if drug-related cues are repeatedly presented in the absence of drug reinforcement, this 
extinction memory can inhibit craving and relapse upon subsequent cue re-exposure. (Holmes 
and Quirk, 2010; Nader et al., 2000; Nic Dhonnchadha et al., 2010).  
The lateral amygdala (LA) has been established as a locus for the encoding and storage of 
emotionally-salient memories. The LA receives afferent input from sensory thalamic and cortical 
sources, as well as inputs from the ventral tegmental area (VTA) and medial prefrontal cortex 
(mPFC), and therefore functions to integrate information during cue-associated learning (Janak 
and Tye, 2015; Maren, 2016). The LA is activated during both fear- and drug-associated 
conditioning and during subsequent re-exposure to fear- and drug-related cues (Ciccocioppo et 
al., 2001; Neisewander et al., 2000; Schafe et al., 2001). Recent work has begun to highlight 
specific synaptic changes within the LA during the reconsolidation and extinction of cue-
associated memories. Auditory thalamic and cortical synapses (T-LA and C-LA, respectively) 
are potentiated during fear conditioning, and depotentiated following cue extinction (Hong et al., 
2009; Kim et al., 2007a). However, during reward-associated learning a different pattern 
emerges where T-LA, but not C-LA synapses are preferentially involved (Tye et al., 2008; Rich 
et al., unpublished; See Chapter 2).  
Extinction and reconsolidation both involve similar neural mechanisms, and may be 
simultaneously activated during cue re-exposure, so timing and selection of the appropriate 
molecular target for pharmacological manipulation are important considerations. Previous 
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attempts to enhance cue extinction training have inadvertently promoted reconsolidation, leading 
to a strengthened drug-cue memory (Hofmann et al., 2012; Price et al., 2013). Due to these 
unintentional effects, it is necessary to identify agents that can bidirectionally regulate drug-cue 
memory. We recently found that inhibition of CaMKII in the amygdala can indeed 
bidirectionally interfere with a drug-associated memory (Rich et al., 2016). Intra-amygdala 
infusion of CaMKII inhibitors immediately after either drug-cue memory reactivation or 
extinction caused a reduction in cue-induced reinstatement relative to vehicle-infused controls. In 
this study, we investigate the involvement of calcineurin (CaN), a calcium-dependent 
phosphatase in drug-cue memory extinction and reconsolidation. CaN is considered a negative 
regulator of CaMKII, and so it is possible that upregulating CaN activity would have the same 
effects on drug-cue memory and relapse as inhibiting CaMKII activity. Inhibition of CaN in the 
hippocampus was previously shown to enhance reconsolidation of a contextual fear memory (de 
la Fuente et al., 2014). Additionally, the shift from maintenance to inhibition of an auditory fear 
memory by cue re-exposure is correlated with increased protein levels and enzymatic activity of 
CaN in the amygdala (Lin et al., 2003a, 2003b; Merlo et al., 2014), suggesting that increasing 
CaN activity at the time of memory retrieval may have amnestic effects. The goal of the present 
study was to determine if calcineurin activation would both interfere with the reconsolidation of, 
and enhance the extinction of, a memory associated with self-administered cocaine. Based on the 
prior physiological evidence that T-LA synapses are strengthened by cue-dependent learning and 
weakened by cue extinction (Kim et al., 2007a; Tye et al., 2008) we also investigated whether 
upregulation of CaN in the LA would alter T-LA synaptic plasticity. Our physiological and 
behavioral results demonstrate a causal role for CaN activity in the inhibition of drug-cue 
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memory reconsolidation and the activation of memory extinction. Therefore, CaN represents a 
potential therapeutic target for pharmaco-behavioral relapse prevention therapies. 
3.2 METHODS 
3.2.1 Subjects 
Naïve, adult male Sprague-Dawley rats (Envigo/Harlan), weighing 275-325 g on arrival, were 
used for all experiments. Rats were housed in a temperature- and humidity-controlled room, in 
auto-ventilated racks with an automated watering system. Animals were housed in pairs, given 
ad libitum access to food and water, and maintained on a 12/12 light-dark cycle. Prior to surgical 
procedures, rats were given at least 5 days to acclimate to the facility. Rats were food-deprived 
24 h prior to the start of behavioral experiments and maintained at ~90% of their free-feeding 
body weight (~20 g of chow per day) for the duration of testing. All behavioral experiments were 
run during the light-cycle. In addition, all procedures were conducted in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals and were 
approved by the University of Pittsburgh’s Institutional Animal Care and Use Committee. 
3.2.2 Self-administration test chambers 
Rats were trained to self-administer cocaine in standard operant conditioning chambers 
(MedAssociates), described previously (Rich et al., 2016). Experiments were counterbalanced 
across one of two chamber designs. The inclusion of two chambers allows the reconsolidation 
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group of rats to undergo reactivation in a novel context. The first type of chamber consisted of 
bar floors and the second type of chamber had grid floors. All chambers contained two 
retractable levers on one wall of the chamber, a tone-generator, stimulus-light above each lever, 
house light, and infusion pump. Operant boxes were kept in sound-attenuating chambers 
equipped with a fan for background noise. 
3.2.3 Drugs 
Cocaine hydrochloride (generously provided by the National Institute on Drug Abuse, Research 
Triangle Park, NC) was dissolved in sterile 0.9% saline (2 mg/ml) and filter-sterilized for self-
administration. Chlorogenic acid (CGA, Fisher Scientific) was dissolved in 1X PBS to a 
concentation of 200 ng/μl. CaN inhibitor, FK506 (Sigma) was dissolved in DMSO to a 
concentration of 10 μg/μl. 
3.2.4 Surgical procedures 
Surgeries were performed as previously described (Rich et al., 2016). Briefly, rats were 
anesthetized with ketamine hydrochloride (87.5 mg/kg; i.m.; Henry Schein) and xylazine 
hydrochloride (5 mg/kg; i.m.; Henry Schein) and then received an analgesic (Rimadyl, 5 mg/kg; 
s.c.; Henry Schein) and 5 ml of Lactated Ringer’s (s.c.). Betadine and 70% ethanol were applied 
to all incision sites. All rats were implanted with a chronic indwelling intravenous (i.v.) catheter 
(CamCaths) into the right jugular vein that was fed subcutaneously to the midscapular region, 
where they exited through a round incision. For experiments involving intracranial infusions, rats 
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were immediately placed into a stereotaxic instrument (Stoelting) and implanted with bilateral 
stainless-steel guide cannulae (22 gauge; Plastics One) targeting the LA (AP –3.0 mm, ML ±5.1 
mm, DV –7.9 mm, relative to bregma; Paxinos and Watson, 1998). For experiments involving 
intracranial infusions prior to electrophysiological recordings, guide cannulae were implanted 
more dorsal (DV: -7.2 mm) to prevent damage to axon fibers from the internal capsule which 
pass through the lateral amygdala. Guide cannulae were secured to the skull with 3 miniature 
screws and dental acrylic resin. Rats were then placed on a heating pad for recovery. After 
surgery, rats were individually housed, and given at least 7 days to recover before the start of 
behavioral training. Carprofen (5 mg/kg; s.c.) was administered for the first two days after 
surgery. Catheters were kept patent by daily infusions of sterile saline containing gentamicin (5 
mg/ml) and heparin (30 USP/ml). 
3.2.5 Self-administration procedures 
Rats administered saline or cocaine during daily sessions for 1 h, on a fixed ratio 1 (FR1) 
schedule of reinforcement with a 10 s timeout. The designated active lever (counterbalanced 
across left and right levers) produced a cocaine infusion paired with a 10 s tone-light compound 
cue. Pump durations were adjusted daily according to body weight in order to deliver the correct 
dose of drug (1.0 mg/kg/infusion). Responses on the inactive lever were recorded, but had no 
programmed consequences. Rats underwent training for at least 10 d and until they administered 
at least 8 infusions/day over 3 consecutive days. Rats that did not meet acquisition criteria by 20 
d were excluded from the study. The program was controlled by and data were collected using 
MedPC (MedAssociates). 
89 
 
3.2.6 Instrumental lever extinction 
For behavioral experiments only, after successful acquisition of self-administration, rats 
underwent instrumental lever extinction (IE) for at least 6 d. These sessions lasted for 1 h and 
continued until extinction criteria had been met (an average of < 25 lever presses on the last two 
days of extinction). Throughout IE, rats received no cocaine or cocaine-associated cue 
reinforcement. IE was conducted to reduce responding to a stable, low rate to later assess cue-
induced reinstatement. In addition, IE reduces the motivational value of other cues in the self-
administration context, such as the levers, so that subsequent testing specifically isolates the 
memory for the discrete cue associated with cocaine infusion.  
3.2.7 Pavlovian cue re-exposure procedures 
Cue re-exposure was conducted in the SA context. The session occurred 24 h after the final day 
of SA or, when included, IE, and lasted for 1 hr. During this session, rats received noncontingent 
presentations of the previously drug-paired cues: either 0 (no extinction), 3 
(reactivation/reconsolidation), or 60 (extinction) times. 
3.2.8 Intracranial infusions 
Immediately following cue re-exposure sessions, CGA or vehicle was administered in a volume 
of 0.5 µl/hemisphere. CGA was given at a dose of 100 ng/hemisphere. CGA has not been 
commonly used for infusion experiments, but this concentration is higher than the dose used in 
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vitro to achieve maximal CaN activity (Tong et al., 2007). For FK506 experiments, rats received 
one of four infusion cocktails: Veh + Veh, CGA + Veh, Veh + FK506, or CGA + FK506. FK506 
was given at a dose of 5 μg/side, which is a dose that has previously been administered via intra-
hippocampal microinfusions to inhibit CaN activity and enhance reconsolidation of a contextual 
fear memory (de la Fuente et al., 2014). Infusions were given by removing dummy cannuale and 
inserting injection cannulae (28 gauge; Plastics One) that extended 1 mm beyond the guide 
cannulae. The injectors were connected to Hamilton syringes controlled by a syringe pump via 
polyethylene tubing. Infusions were given over the course of 2 min and injectors were left in the 
cannulae for an additional 1 min to allow for drug diffusion. 
3.2.9 Cue-induced reinstatement 
24 h after cue memory manipulations, cue-induced reinstatement was assessed during a 1 h 
session that took place in the SA context. A lever press on the active lever produced a 10 sec 
presentation of the cocaine-associated cue on an FR1 schedule, but presses were not reinforced 
with cocaine. Lever presses on the inactive lever were recorded but had no programmed 
consequences. 
3.2.10 Prepartion of ex vivo amygdala slices 
Slices were prepared as described previously (Dong et al., 2006; Huang et al., 2008a), with slight 
modifications, with methods designed to improve neuronal health in adult rodents (Ting et al., 
2014). Briefly, 24 h after cue re-exposure sessions, rats were deeply anesthetized with isoflurane. 
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Rats were then briefly perfused with ice-cold cutting solution containing (in mM): 92 N-methyl-
d-glucamine (NMDG), 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 5 sodium 
ascorbate, 2 thiourea, 3 sodium pyruvate, 10 MgSO4, and 0.5 CaCl2, saturated with carbogen 
(95% O2/5% CO2), pH adjusted to 7.4 with HCl. Rats were then decapitated and brains 
removed. Acute coronal slices of the amygdala (250 μm thick) were obtained (normally 4–6 
slices were obtained from each rat) using a VT1200S vibratome (Leica, Germany) in 4 °C 
cutting solution. Slices were placed in a holding chamber filled with the same cutting solution 
and incubated at 37°C for 10-15 min before being transferred to a beaker of HEPES-based 
holding solution containing (in mM): 86 NaCl, 2.5 KCl, 1.2 NaH2PO4, 35 NaHCO3, 20 HEPES, 
25 glucose, 5 sodium ascorbate, 2 thiourea, 3 sodium pyruvate, 1 MgCl2, and 2 CaCl2, saturated 
with carbogen. Slices were allowed to recover for >30 min at room temperature before 
experimentation. 
3.2.11 Ex vivo electrophysiology 
Whole-cell recordings were obtained from individual principal neurons in the dorsal LA using 
glass pipettes (3–5 MΩ). Voltage-clamp experiments used pipettes filled with a cesium-based 
internal solution [in mM, cesium methanesulfonate 108, CsCl 15, CsEGTA 0.4, TEA-Cl 5, 
HEPES 20, Mg-ATP 2.5, Na-GTP 0.25, QX-314-Cl 1, sodium phosphocreatine 7.5, and L-
glutathione 1, at pH 7.3] and current-clamp experiments used pipettes filled with a potassium-
based internal solution [in mM, potassium methanesulfonate 108, KCl 20, K-EGTA 0.4, HEPES 
10, Mg-ATP 2.5, Na-GTP 0.25, sodium phosphocreatine 7.5, L-glutathione 1, MgCl2 2, at pH 
7.3]. During recordings, slices were superfused with aCSF that was heated to 31–33 °C by 
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passing the solution through a feedback-controlled in-line heater (Warner, CT) before entering 
the chamber. External perfusion consisted of a modified artificial cerebrospinal fluid (ACSF), 
containing, in mM NaCl 119, KCl 2.5, NaHCO3 26, NaH2PO4 1.2, glucose 12.5, HEPES 5, 
MgSO4 1, CaCl2 2, saturated with 95% O2/5% CO2. Neurons were voltage-clamped at -70 mV. 
To stimulate putative thalamic afferents, a concentric bipolar stimulating electrode (FHC, 
Bowdoin, ME) was placed over axon fibers emerging from the internal capsule. Evoked 
excitatory postsynaptic currents (EPSCs) were recorded by stimulating LA projections using 0.1 
ms pulses at a predetermined series of intensities (10-35 μA) from an isolated current stimulator 
(A-M instruments; Digitimer Ltd, Hertfordshire, England. For paired pulse recordings each pulse 
was separated by a 50 ms interpulse interval. AMPAR currents were elicited at ERev-70 mV 
holding potential and NMDAR currents were elicited at a ERev+40 mV holding potential. 
NMDAR amplitude was operationally defined as the amplitude of the current 35 ms after the 
peak of the AMPAR current; at this time point, AMPAR-mediated currents have subsided 
(Huang et al., 2008a). For all experiments, series resistance was 10–25 MΩ, uncompensated, and 
monitored continuously during recording. Cells with a change in series resistance beyond 20% 
were not accepted for data analysis. Synaptic currents were recorded with a MultiClamp 700B 
amplifier, filtered at 3 kHz, amplified 5 times, and then digitized at 20 kHz. Picrotoxin (100 μM) 
was included to inhibit GABAA receptor-mediated currents in all experiments. 
3.2.12 Histological analysis 
After the completion of behavioral experiments, rats with intracranial cannulae were sacrificed 
via decapitation. Brains were dissected and placed in 10% formalin for at least 3 d then 
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transferred to 30% sucrose for at least 3 d. Brains were then frozen and sectioned coronally 
through the BLA on a cryostat. Sections were taken at 50 µm and placed on slides for 
visualization of infusion placements (Figure 16). The investigator was blind to treatment group 
when analyzing histology, and animals with infusions outside of the BLA were removed from 
the main analysis. 
3.2.13 Statistical analyses 
All statistical analyses were performed using GraphPadPrism for Windows and results are 
expressed as mean ± SEM. Rats were distributed into groups based on a matching procedure that 
ensured that each group had no statistical differences in their cocaine infusions acquired over 
days, or differences in lever extinction behavior. For behavioral experiments, reinstatement tests 
were analyzed by two-way ANOVA with repeated measures, with the between-subjects factor 
being responding on the last day of lever extinction versus reinstatement responding and the 
within-subjects factor being CGA vs. Veh. For electrophysiological experiments, data were 
coded such that experimenters were not aware of treatment groups when performing data 
analysis, and then decoded for final results. Data were analyzed offline using ClampFit 10.3. For 
experiments in which the end points were from individual cells, such as EPSCs, we used the 
averaged value of a parameter from all cells recorded from an animal to represent the parameter 
of this animal. For electrical stimulation experiments EPSC amplitude was calculated at each 
stimulation intensity and compared between groups using two-way ANOVA with repeated 
measures. Paired pulse ratio (PPR) was calculated as the ratio of the peak current of the second 
EPSC to the peak current of the first EPSC. AMPA:NMDA ratio was calculated as the ratio of 
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peak current at -60mV to the current at +40 mV, 35 ms after stimulus. For, PPR, AMPA:NMDA 
ratio, AMPAR, and NMDAR current analyses, comparisons were made using unpaired t-tests. 
All data points are an average of 10 trials. Each experiment was replicated in at least 5-6 rats (1-
5 cells were recorded from each rat) for electrophysiological analysis and at least 7 rats for 
behavioral tests. For all analyses, significant effects were further analyzed by Tukey’s or 
Bonferroni’s post hoc tests, with significance set at P < 0.05. All data were determined to be 
normally distributed using the Shapiro-Wilk test, and Bartlett’s test was used to determine that 
there were no significant differences in the estimated variance between groups. 
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Figure 16. Histological verification of LA guide cannulae implants. 
Schematic showing guide cannulae placements throughout the anterior-posterior extent of the LA. The shaded area 
represents region of acceptable cannulae placement. Rats that received cannulae implants outside of these regions 
were excluded from analysis. Coordinates are in mm, posterior from bregma.  
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3.3 RESULTS 
To determine if CaN in the LA was involved in the regulation of cocaine-cue memory we used 
an approach that combined in vivo pharmacological activation of CaN with specific cue memory 
manipulations followed by behavioral and electrophysiological assessments. Rats were trained to 
self-administer (SA) cocaine on a fixed ratio (FR1) schedule of reinforcement, so that a single 
press on a predesignated active lever resulted in an intravenous cocaine infusion together with 
presentation of an audiovisual cue (conditioned stimulus, CS). Following SA, for reinstatement 
experiments, rats underwent instrumental lever extinction (IE) (Figure 17A,B). During IE, rats 
were allowed to perform operant responses, however, presses on the active lever were no longer 
reinforced by either cocaine or CS presentation. While this extinguishes the operant response, the 
cocaine-cue association remains, so that future presentations of the CS can promote 
reinstatement of the lever pressing response (Torregrossa and Taylor, 2013). For 
electrophysiology experiments, IE was omitted because our previous experiments show that 
thalamo-amgydala (T-LA) synaptic plasticity is not mediated by IE (Rich et al., unpublished; See 
Chapter 2). Rats were next assigned to one of three memory manipulation groups and exposed to 
passive presentations of CS: no reactivation (0 CS), cue reactivation (3 CS) or cue extinction (60 
CS) (Figure 17A,B). Immediately following these sessions, rats received intra-LA 
microinfusions of the CaN activator, chlorogenic acid (CGA; 100 ng/hemisphere) (Tong et al., 
2007), or vehicle (Veh) to determine what effect CaN activation has on cocaine-cue memory 
processes. Finally, 24 hours later, rats either received a cue-induced reinstatement test or ex vivo 
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Figure 17. Experimental design. 
Schematic demonstrating (A) timeline of each experimental phase and color-coded treatment groups (B) cartoon of 
operant chamber with visual depiction of each experimental stage, and (C) image of LA coronal section, with 
representative placement of stimulating electrode above IC fibers and position of patch pipette. EPSCs were evoked 
from LA principal neurons by stimulating the IC (putative T-LA synapses). SA, self-administration; IE, instrumental 
extinction; CS, conditioned stimuli; IC, internal capsule; EC, external capsule. 
98 
 
slices of the LA were prepared for electrophysiological recordings (Figure 17A,B). For 
reinstatement, rats returned to operant boxes and received response-contingent presentations of 
CS, but not cocaine. A high degree of lever pressing during reinstatement is suggestive of an 
intact drug-cue association, while low levels of lever pressing indicate that the drug-cue 
association has been disrupted. For electrophysiological recordings, whole-cell voltage clamp 
recordings were performed from LA principal neurons. EPSCs were evoked by stimulating 
internal capsule fibers to target T-LA synapses (Figure 17C). Using a predetermined series of 
stimulation intensities, we generated EPSC input-output relationships. We also compared 
measures of pre- and postsynaptic plasticity. This strategy enables a direct comparison between 
T-LA synaptic activity and cocaine-cue memory and allows for the assessment of the role of 
CaN-induced plasticity in mediating relapse-like behavior. 
3.3.1 Effect of Intra-LA CaN Activation in the Absence of Drug-Cue Memory Retrieval 
We first determined the effects of LA CaN activation in the absence of drug-cue memory 
retrieval (0 CS re-exposure). Previous studies have shown that amnestic agents are ineffective at 
inhibiting memories if they are not reactivated or retrieved; this prevents the memory from 
entering a destabilized, labile state, and so it cannot be interfered with pharmacologically (Rich 
et al., 2016; Tronson et al., 2006). Therefore, we predicted that CGA-induced activation of CaN 
would have no effect on reinstatement or T-LA synaptic plasticity in the absence of retrieval. For 
both experiments, rats were split into groups based on a random matching procedure that ensured 
no training differences between groups. There were no significant differences or interactions 
with day of training for active lever presses during SA or IE (Figure 18A,B; both two-way 
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ANOVA;  P > 0.05). We found that treatment with CGA following the no-reactivation control 
procedure had no significant effect on active lever responding during cue-induced reinstatement, 
indicating that pharmacological manipulation of CaN signaling has no effect on cocaine seeking 
in the absence of cue memory retrieval (Figure 18C; two-way ANOVA: P > 0.05).  
 
 
 
 
Figure 18. Calcineurin activation has no effect on cue-induced reinstatement in the absence of memory 
retrieval.  
(A,B) Mean number of active lever presses per day during self-administration (SA) and instrumental extinction (IE). 
There were no significant differences in active lever presses during (A) SA (Two-way ANOVA, F(1,20) = 0.343, P > 
0.05) or (B) IE (Two-way ANOVA, F(1,20) = 0.286, P > 0.05). Following IE, rats were placed back in training 
context and received a no-reactivation (0 CS) session followed immediately by infusion with either CGA or Veh. 
(C) Mean number of active lever presses during the last day of instrumental extinction compared to cue-induced 
reinstatement. CGA activation following 0 CS has no effect on reinstatement (two-way ANOVA, F(1,20) = 0.021, P > 
0.05). Data are expressed as mean ± SEM; n in bars, number of rats. 
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We next assessed if intra-LA infusion of CGA in the absence of memory retrieval would 
alter T-LA synaptic strength, and as expected, found no differences between CGA- and Veh-
treated animals for any measure of synaptic plasticity. EPSC input-output relationships did not 
vary between groups (Figure 19A). At the highest stimulation intensity (35 μA), CGA- and Veh-
groups had average EPSC amplitudes of 375 and 376 pA, respectively, which is consistent with 
our previous studies for animals in the no cue re-exposure condition (Rich et al., unpublished; 
See Chapter 2). Similarly, we saw no differences in PPR, AMPA:NMDA, AMPAR current, or 
NMDAR current  (Figure 19B-E; all unpaired t-test, P > 0.05). Together, these data suggest that 
in the absence of memory retrieval, attempted activation of CaN by CGA produces no alterations 
in T-LA pre- or postsynaptic plasticity, corresponding to the lack of difference in cue-elicited 
drug-seeking. 
3.3.2 Effect of Intra-LA CaN Activation during Drug-Cue Memory Reconsolidation 
We next investigated whether activating CaN in the LA immediately following drug-cue 
memory reactivation (3 CS) would alter subsequent cue-induced drug-seeking. CaN activity 
promotes LTD-like synaptic modifications (Baumgartel and Mansuy, 2012; Mulkey et al., 1994); 
because reconsolidation is regulated by opposing LTP-like mechanisms, we hypothesized that 
activating CaN following cue reactivation would interfere with reconsolidation. The resulting 
disruption of the cocaine-cue association would suppress the conditioned response (lever 
pressing) to subsequent cue presentations, thereby attenuating reinstatement. Again, rats were 
split into groups so that there were no significant differences or interactions with day of training 
for active lever presses during SA or IE (Figure 20A,B; both two-way ANOVA; P > 0.05). We 
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Figure 19. Calcineurin activation has no effect on T-LA plasticity in the absence of memory retrieval. 
Following self-administration, rats received a no-reactivation (0 CS) session followed immediately by infusion with 
either CGA or Veh. 24 h later, ex vivo recordings were performed in the LA. (A) Input-output curve demonstrating 
average evoked EPSC amplitude across various stimulation intensities. No significant differences in EPSC 
amplitude between groups were found at any of the stimulation intensities (Two-way ANOVA, F(1,9) = 0.356, P > 
0.05). (B) No significant differences in PPR between groups (Unpaired t-test, t(9) = 0.387, P > 0.05). (c-e) No 
significant differences between groups for (C) AMPA:NMDA (Unpaired t-test, t(9) = 0.188, P > 0.05), (D) AMPAR 
current (Unpaired t-test, t(9) = 0.363, P > 0.05), or (E) NMDAR current (Unpaired t-test, t(9) = 0.388, P > 0.05). Data 
are expressed as mean ± SEM; n in bars, number of rats (number of neurons). Insets: Sample average EPSC traces. 
Scale bars: 50 ms, 200 pA. 
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Figure 20. Calcineurin activation following cue reactivation inhibits reconsolidation and attenuates 
subsequent cue-induced reinstatement. 
(A,B) Mean number of active lever presses per day during self-administration (SA) and instrumental extinction (IE). 
There were no significant differences in active lever presses during (A) SA (Two-way ANOVA, F(1,20) = 0.542, P > 
0.05) or (B) IE (Two-way ANOVA, F(1,20) = 0.152, P > 0.05). Following IE, rats were placed back in training 
context and received a brief cue-reactivation (3 CS) session followed immediately by infusion with either CGA or 
Veh. (C) Mean number of active lever presses during the last day of instrumental extinction compared to cue-
induced reinstatement. CGA activation following 0 CS reduces active lever responding during reinstatement. Two-
way ANOVA, significant group x day interaction (F(1,20) = 4.79, P = 0.041); post hoc analysis: *p < 0.05. Data are 
expressed as mean ± SEM; n in bars, number of rats 
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found that treatment with CGA following cue reactivation did indeed reduce active lever 
responding during cue-induced reinstatement, indicating that pharmacological manipulation of 
CaN signaling disrupts reconsolidation (Figure 20C; two-way ANOVA; significant group x day 
interaction; F(1,20) = 4.79, P = 0.041). 
We next determined if the suppression in cue-induced reinstatement was caused by CaN-
dependent alterations at T-LA synapses. Unlike the non-reactivation condition, there were 
differences in measures of synaptic plasticity between CGA- and Veh-treated animals. First, we 
found that CGA-induced activation of CaN caused a reduction in the EPSC input-output 
relationship at T-LA synapses (Figure 21A; two-way ANOVA, significant group x stimulation 
intensity interaction, F(5,60) = 2.39, P = 0.048, P = 0.048). At the highest stimulation intensity (35 
μA), Veh-treated animals had an average EPSC amplitude of 497 pA, while CGA-treated 
animals had an average EPSC amplitude of 405 pA. These data suggest a synaptic basis for the 
disruption in reconsolidation produced by CGA that suppressed drug-seeking behavior. Next, we 
further examined measures of synaptic plasticity to determine if a pre- or postsynaptic 
mechanism could explain the reduced synaptic strength.  We again saw no group differences in 
PPR (Figure 21B; unpaired t-test, P > 0.05). However, AMPA:NMDA was reduced by CGA 
infusion at a trend level (Figure 21C; unpaired t-test, t(12) = 2.16, P = 0.052). Upon further 
examination, it became apparent that this reduction was driven by changes in AMPAR, as 
average AMPAR current was significantly reduced by CGA (Figure 21E; unpaired t-test, t(12) = 
3.02, P = 0.011) while there was no difference in NMDAR current (Figure 21E; unpaired t-test, 
P > 0.05).  Together, these data suggest that following drug-cue memory reactivation, CGA 
infusion leads to postsynaptic reductions in AMPAR that interfere with reconsolidation. 
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Figure 21. Calcineurin activation during reconsolidation alters synaptic plasticity through a postsynaptic 
reduction in AMPAR current. 
Following self-administration, rats received a brief cue reactivation (3 CS) session followed immediately by infusion 
with either CGA or Veh. 24 h later, ex vivo recordings were performed in the LA. (A) Input-output curve 
demonstrating average evoked EPSC amplitude across various stimulation intensities. Intra-LA CaN activation by 
CGA alters EPSC amplitude. Two-way ANOVA, significant group x stim intensity interaction (F(5,60) = 2.39, P = 
0.048). (B) No significant differences in PPR between groups (Unpaired t-test, t(12) = 0.111, P > 0.05). (C) CaN 
activation by CGA altered AMPA:NMDA at a trend level (Unpaired t-test, t(12) = 2.16, P = 0.052) (D) CaN 
activation by CGA significantly reduced AMPAR current (Unpaired t-test, t(12) = 3.02, P = 0.011), but had no effect 
on (E) NMDAR current (Unpaired t-test, t(12) = 0.623, P > 0.05). Data are expressed as mean ± SEM; n in bars, 
number of rats (number of neurons). *p < .05; #p < 0.10. Insets: Sample average EPSC traces. Scale bars: 50 ms, 
200 pA. 
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3.3.3 Effect of Intra-LA CaN Activation during Drug-Cue Memory Extinction 
Finally, we tested the effects of CGA-induced CaN activation following drug-cue memory 
extinction (60 CS). We hypothesized that we would observe CGA-induced enhancement of 
extinction. Specifically, we predicted that cue extinction is mediated by CaN activity, so an 
upregulation of CaN activity would further suppress the original drug-cue association, leading to 
an even more pronounced attenuation in active lever pressing during cue-induced reinstatement. 
Further, we predicted that these reductions would again be mediated by postsynaptic changes in 
AMPAR. As with the other experiments, rats were again split into groups so that there were no 
significant differences or interactions with day of training for active lever presses during SA or 
IE (Figure 22A,B; both two-way ANOVA; P > 0.05). As with reconsolidation, we found that 
CGA-induced CaN activation following cue extinction did indeed attenuate reinstatement 
relative to Veh-treated animals (Figure 22C; two-way ANOVA; F(1,17) = 6.89, P = 0.018), 
suggesting that upregulating CaN activity enhances cue extinction. To rule out any nonspecific 
effects of CGA, we next performed an experiment in which we combined intra-LA CGA 
infusions with a known inhibitor of CaN, FK-506 (de la Fuente et al., 2014). Rats again received 
cue extinction, but this time received one of four infusions (Veh-Veh, CGA-Veh, Veh-FK-506, 
CGA-FK-506) after the session, and were tested for reinstatement the following day. Results 
revealed that active lever responding during reinstatement depended on the compound that was 
infused (Figure 22D; two-way ANOVA, main effect of group; F(3,33) = 3.04, P = 0.043). CGA-
infusion alone resulted in a reduction in reinstatement, replicating our findings from the from 
Figure 22C. Additionally, we found that the CGA-induced reductions in reinstatement were  
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Figure 22. Calcineurin activation enhances cue extinction causing a reduction in subsequent cue-induced 
reinstatement. 
(A,B) Mean number of active lever presses per day during self-administration (SA) and instrumental extinction (IE). 
There were no significant differences in active lever presses during (A) SA (Two-way ANOVA, F(1,17) = 0.179, P > 
0.05) or (B) IE (Two-way ANOVA, F(1,17) = 1.35, P > 0.05). Following IE, rats were placed back in training context 
and received a cue-extinction (60 CS) session followed immediately by infusion with either CGA or Veh. (C) Mean 
number of active lever presses during the last day of instrumental extinction compared to cue-induced reinstatement. 
CGA activation following 0 CS reduces active lever responding during reinstatement. Two-way ANOVA, main 
effect of group (F(1,17) = 6.89, P = 0.018) (D) Effect of CGA on extinction is blocked by co-infusion of CaN 
inhibitor, FK-506. Two-way ANOVA, main effect of group (F(3,33) = 3.04, P = 0.043)  post hoc analysis: *p < 0.05, 
**p < .01. Data are expressed as mean ± SEM; n in bars, number of rats. 
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blocked by the addition of FK-506, suggesting that CGA does indeed exert its effects through 
activation of CaN, and that this upregulated activity is blocked by FK-506. 
We then determined if the CaN-dependent enhancements in drug-cue memory extinction 
were due to T-LA synaptic alterations. We found that CGA-induced activation of CaN during 
cue extinction caused a reduction in the EPSC input-output relationship at T-LA synapses 
(Figure 23A; two-way ANOVA, significant group x stimulation intensity interaction, F(5,65) = 
2.64, P = 0.031, P = 0.031). Interestingly, at the highest stimulation intensity (35 μA), both 
CGA- and Veh-infused animals had noticeably lower EPSC amplitudes than the 0 CS or 3 CS 
experiments. Veh-treated animals had an average EPSC amplitude of 311 pA; however, CGA-
treated animals were significantly lower than Veh-animals, with an average EPSC amplitude of 
just 239 pA. These data are consistent with previous results, in which 60 CS re-exposure reduces 
T-LA plasticity (Rich et al., unpublished, see Chapter 2). These data suggest a T-LA synaptic 
mechanism for both extincton learning and the enhancement in extinction by CGA that 
suppressed relapse-like behavior. Next, we further examined measures of synaptic plasticity to 
determine if a pre- or postsynaptic mechanisms could explain the reduced synaptic strength.  
Surprisingly, CGA-induced activation of CaN during cue extinction increased PPR (Figure 23B; 
unpaired t-test, t(13) = 2.75P = 0.031). Additionally, AMPA:NMDA was reduced by CGA 
infusion at a trend level (Figure 23C; unpaired t-test, t(12) = 1.99, P = 0.070), but further 
examination determined that this reduction was not driven by specific changes in AMPAR or 
NMDAR, as neither AMPAR current (Figure 23D; unpaired t-test, P > 0.05) nor NMDAR 
current (Figure 23E; unpaired t-test, P > 0.05) were significantly altered by CGA infusion. 
Together these data suggest that a presynaptic signaling mechanism (ie. change in glutamate 
release) is primarily responsible for CaN-induced reductions in synaptic strength that correlate 
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with enhanced drug-cue memory extinction. Additionally, there may be a combination of effects 
at AMPAR and NMDAR that together lead to slight changes at the postsynaptic membrane that 
contribute to reduced excitatory synaptic strength. 
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Figure 23. Calcineurin activation during cue extinction alters synaptic plasticity through a presynaptic 
mechanism. 
Following self-administration, rats received a cue-extinction (60 CS) session followed immediately by infusion with 
either CGA or Veh. 24 h later, ex vivo recordings were performed in the LA. (A) Input-output curve demonstrating 
average evoked EPSC amplitude across various stimulation intensities. Intra-LA CaN activation by CGA alters 
EPSC amplitude. Two-way ANOVA, significant group x stim intensity interaction (F(5,65) = 2.64, P = 0.031). (B) 
CGA infusion significantly increases PPR (Unpaired t-test, t(13) = 2.75, P = 0.12). CaN activation by CGA altered 
(C) AMPA:NMDA at a trend level (Unpaired t-test, t(12) = 1.99, p = 0.070), but had no effect on (D) AMPAR 
current (Unpaired t-test, t(12) = 0.972, P > 0.05) or (E) NMDAR current (Unpaired t-test, t(12) = 0.368, P > 0.05). Data 
are expressed as mean ± SEM; n in bars, number of rats (number of neurons). *p < .05; #p < 0.10. Insets: Sample 
average EPSC traces. Scale bars: 50 ms, 200 pA.  
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3.4 DISCUSSION 
The present study identifies a causal relationship between CaN-induced activity at T-LA 
synapses and the suppression of cue-elicited cocaine-seeking. Specifically, activation of CaN, 
during either reconsolidation or extinction of a memory associated with cocaine self-
adminsitration led to synaptic modifications that resulted in a reduction in cue-induced 
reinstatement (Figures 20C and 22C), effectively disrupting the drug-associated memory. These 
results are consistent with both a partial inhibition of reconsolidation of the original cocaine-cue 
memory and an enhancement in the new cocaine-cue extinction memory. Importantly, in the 
absence of memory retrieval, CaN activation had no memory-interfering effects, confirming that 
the memory trace must be reactivated in order to achieve pharmacologically-induced disruption 
(Figure 18C). We have previously found similar behavioral effects following intra-BLA 
infusion of CaMKII inhibitors (Rich et al., 2016; See Appendix A), suggesting that CaN and 
CaMKII within the BLA have opposing actions on drug-associated memory processes. We have 
also shown that T-LA synapses are an important locus for drug-cue memory, and that these 
synapses are differentially regulated by consolidation/reconsolidation and extinction (See 
Chapter 2). However, to our knowledge this study is the first report of pharmacologically-
induced changes in synaptic activity that are directly associated with changes in the conditioned 
response to drug-associated cues. Upregulation of CaN activity following cue retrieval induces 
postsynaptic changes, perhaps driven by activity at AMPAR that prevents the memory-
maintenance/strengthening effects of reconsolidation and results in less reinstatement (Figure 
21). Similarly, upregulation of CaN activity following cue extinction also induces synaptic 
changes, although this may be a combination of pre- and postsynaptic effects; for instance, a 
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decreased glutamate release probability along with AMPAR and NMDAR-mediated effects 
(Figure 23). Together, these synaptic changes appear to enhance the consolidation of drug-cue 
extinction, which further reduces the propensity of cues to trigger relapse-like behaviors. 
3.4.1 Targeting memory processes as a strategy for relapse prevention 
Interfering with memories that trigger drug-seeking in addicted individuals is hypothesized to 
assist in the maintenance of long-term abstinence, however, this strategy has had limited success 
in preventing relapse (Koob and Volkow, 2010). Clinical studies have attempted to use cue 
extinction as a means to interfere with drug-related memories. In these experiments, individuals 
were re-exposed to multimodal cues in an effort to decrease subsequent craving and relapse 
when the drug-associated cues were re-encountered (Price et al., 2013). This idea is taken from 
research on fear-associated memories, including PTSD, where cue exposure therapy has been 
quite successful at limiting the detrimental effects of maladaptive memories in both animals and 
humans (Hofmann et al., 2012; Monfils et al., 2009; Ressler et al., 2004). Unfortunately, unlike 
fear memories, extinction of drug-associated memories has not met with clinical success. 
However, it may be possible to combine behavioral therapies, like extinction, with 
pharmacological treatments. Indeed, this approach has been demonstrated to have the highest 
success rates (Carroll and Onken, 2005); however, it is becoming clear from preclinical studies 
that the best medications would be those that both block drug-cue memory reconsolidation and 
augment extinction learning (Cleva et al., 2010; Rich et al., 2016; Sorg, 2012; Torregrossa and 
Taylor, 2016).  Our current study investigating CaN activation further validates this theory. A 
bidirectional effect on memory overcomes previous limitations of pharmacological agents, such 
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as glutamatergic agonists like DCS (Lee et al., 2009; Price et al., 2013). The efficacy of DCS is 
dependent upon effective extinction training, and in the absence of memory extinction, DCS can 
cause unintentional, reconsolidation-associated memory-strengthening effects, limiting its 
usefulness as an adjunctive treatment (Lee et al., 2009).  As we have demonstrated with CaMKII 
inhibition (Rich et al., 2016), activating CaN signaling pathways in conjunction with exposure 
therapy may therefore be a viable treatment strategy, as memory weakening occurs under both 
memory reactivation and extinction conditions.  
In the current study, we demonstrate potential therapeutic effects of CaN activation 
following 3 (reconsolidation) or 60 (extinction) presentations of cocaine-associated cues. In our 
previous work we have shown that 120 presentations of cues during re-exposure results in an 
even more pronounced AMPAR-associated depotentiation at T-LA synapses that correlates with 
a further suppression of cue-induced reinstatement. That the number of unreinforced cue 
presentations is a critical determinant of extinction efficacy is not altogether a novel premise 
(Price et al., 2013; Unrod et al., 2014). However, we did not examine the effects of CaN 
activation following this extended extinction duration because we previously failed to observe 
pharmacological enhancement via CaMKII inhibtion, due to a potential floor effect (Rich et al., 
2016). Still, it would be interesting for future studies to examine what, if any, changes occur at 
T-LA synapses following the activation of CaN immediately after more extensive extinction. 
Furthermore, it would be interesting to see if the combination of extinction and CaN activation 
together prevents either context-dependent renewal or spontaneous recovery of drug-seeking, 
both of which have proven to limit the therapeutic potential of cue re-exposure. 
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3.4.2 Mechanisms of calcineurin action at the synapse 
CaN is a Ca2+/calmodulin-dependent phosphatase that has a high affinity for Ca2+ and can 
therefore be activated by a relatively low concentration of intracellular Ca2+.  When synaptic 
activity is sparse (ie. low frequency LTD induction), the primary means of Ca2+ entry is through 
L-type voltage-gated calcium channels (LTCC), which allow for a sustained, but low increase in 
Ca2+ that results in activation of CaN (Bi and Poo, 1998; Ghosh et al., 2017). CaN is a 
heterodimer composed of a catalytic A subunit and a regulatory B subunit (Mumby and Walter, 
1993). Sequential conformational changes following binding of Ca2+ and calmodulin to CaNB 
activates the phosphatase via displacement of the CaNA autoinhibitory domain (Shen et al., 
2008). CaN then directly dephosphorylates GluA1 at Ser845, which prevents kinase-induced 
membrane insertion of AMPAR (Beattie et al., 2000; Man et al., 2007; Roche et al., 1996). CaN 
also initiates a phosphatase cascade (via protein phosphatase 1 and protein phosphatase 2A) that 
ultimately leads to the inactivation of LTP-promoting kinases as well as downstream actions at 
AMPAR and other synaptic proteins (Baumgartel and Mansuy, 2012; Mulkey et al., 1994). CaN-
induced internalization of AMPAR causes changes in spine morphology, decreased spine density 
and decreased AMPA:NMDA (Beattie et al., 2000; Lu et al., 2000; Sanderson et al., 2016). 
These changes are consistent with our present results in which CaN activation following drug-
cue memory reactivation and extinction has effects on plasticity through a postsynaptic 
mechanism, including alterations in AMPAR (Figures 21 and 23).  
CaN has also been shown to have effects at the presynaptic membrane. For example, in 
the cortex, CaN is enriched at presynaptic terminals (Shields et al., 1985) and application of CaN 
inhibitors increases both the rate of spontaneous action potential firing and the frequency of 
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EPSCs (Victor et al., 1995). These data are suggestive of an inhibitory role of CaN in 
glutamatergic transmission and is consistent with the increase in PPR (decrease in release 
probability) that we observe following the activation of CaN during cue extinction (Figure 23B). 
Previous studies involving fear conditioning have found that activation of presynaptic group II 
metabotropic glutamate receptors (mGluRII) reduces T-LA synaptic transmission and reduces 
the expression of conditioned fear (Heinbockel and Pape, 2000; Lin et al., 2005). However, it 
should be noted that our previous experiments involving drug-cue memory extinction did not 
uncover any presynaptic-based changes in T-LA synaptic plasticity. Therefore, the implications 
of CaN-induced presynaptic plasticity, as well as the precise mechanisms by which this occurs, 
remain to be determined. 
3.4.3 Role for calcineurin in cue-dependent memory processes 
CaN has long been established as a negative regulator of emotionally-salient memories 
(Baumgärtel et al., 2008; Havekes et al., 2008; de la Fuente et al., 2014). CaN was first identified 
to play a role in the regulation of fear-associated memories, specifically the establishment of fear 
extinction. Fear extinction was shown to evoke increases in protein levels and enzymatic activity 
of CaN within the amygdala that were accompanied by the reversal of fear conditioning-induced 
protein phosphorylation (Lin et al., 2003a, 2003b). These effects were blocked by the 
administration of CaN inhibitors, suggesting that CaN either directly or indirectly 
dephosphorylates specific substrates whose phosphorylation is required for the consolidation of 
fear-associated memories. These investigators next attempted to model fear extinction via low-
frequency stimulation (LFS) of amygdala-projecting sensory cortical afferents, a manipulation 
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that elicited depotentiation in the LA following fear conditioning (Lin et al., 2003b). As with cue 
extinction, LFS-induced depotentiation was associated with an increase in CaN activity that was 
dependent on NMDAR and LTCC. Administration of CaN inhibitors blocked LFS-induced 
depotentiation in vitro and LFS-induced fear extinction in vivo. The fear extinction-associated 
effects of CaN appear to be dependent on the amount or duration of cue re-exposure. Everitt and 
colleagues demonstrated that protein levels of calcineurin increase after 10 (but not fewer) 
presentations of a fear-associated CS, suggesting that CaN is likely important for the switch 
between maintenance and loss of fear memory (Merlo et al., 2014).  
Finally, there is evidence that CaN is also involved in the regulation of drug-related 
memories, specifically the destabilization of a contextual memory associated with 
methamphetamine (METH) (Yu et al., 2016). In this study, authors performed conditioned place 
preference for METH and used a protein synthesis inhibitor (anisomycin) to disrupt the 
reconsolidation of the contextual memory. Destabilization was confirmed by observations of , 
reduced phosphorylation of GluA1 at Ser845, decreased spine density, and smaller 
AMPA:NMDA. When authors combined anisomycin treatment with inhibitors of either CaN or 
protein phosphatase 1, the destabilization-associated deficits were prevented, suggesting that 
destabilization of drug-related contextual memory occurs through a CaN-dependent 
dephosphorylation cascade that results in AMPAR internalization and LTD (Mulkey et al., 1994; 
Yu et al., 2016). Together with the results from the present study, there is strong evidence that 
upregulating CaN activity may be an effective strategy for reducing the strength of drug-related 
memories, either via the blockade of reconsolidation or by the enhancement of extinction. 
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4.0  GENERAL DISCUSSION 
The work presented in this dissertation focused on cellular and molecular mechanisms involved 
in the regulation of a memory associated with self-administered cocaine. We investigated 
whether specific afferent inputs to the LA were involved in the formation, maintenance, and 
modification of a cocaine-cue associative memory We also investigated whether modification of 
LA synapses (either through behavioral cue re-exposure, optogenetics, or site-specific infusion 
of a pharmacological agent), could suppress future drug-seeking behavior. Our primary 
conclusions are that cocaine-cue memories are encoded, at least in part, by the strengthening of 
thalamo-amygdala (specifically MGN), but not cortico-amygdala, synapses. Brief cue 
reactivation initiates a reconsolidation event that maintains the cocaine-cue association and 
promotes drug-seeking behavior. More extensive cue re-exposure, in the absence of cocaine 
reinforcement, extinguishes the cocaine-cue association by engaging cellular mechanisms that 
depotentiate T-LA synapses, thereby attenuating cue-elicited drug-seeking. Finally, we propose 
that cocaine-cue memories can be interfered with by promoting synaptic activity that mirrors cue 
extinction, either through optically-induced LTD of MGN-LA synapses (Chapter 2), or by 
administration of pharmacological agents that either activate the CaN signaling pathway 
(Chapter 3) or inhibit the CaMKIIα signaling pathway (See Appendix A). In this discussion, we 
will describe how our findings lead toward a better understanding of drug-related memories and 
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addiction in general, as well as potential therapeutic implications of a circuit- and pharmacology-
based approach for relapse prevention. 
4.1 UNDERSTANDING THE CELLULAR MECHANISMS OF 
RECONSOLIDATION AND EXTINCTION 
The results of this dissertation support the notion that drug-cue memory reconsolidation and 
extinction are separate and competing processes that likely co-occur following memory 
reactivation. We also demonstrate the involvement of competing neural mechanisms: cellular 
events that enhance synaptic strength promote reconsolidation and prevent extinction while 
cellular events that weaken synaptic strength support extinction and inhibit reconsolidation. 
Moreover, we have uncovered an opposing intracellular phosphatase/kinase pathway 
(CaN/CaMKII) that bidirectionally regulates the two processes. Activating CaN signaling and/or 
inhibiting CaMKII signaling simultaneously blocks reconsolidation and promotes extinction. 
Pharmacological manipulation of this molecular pathway overcomes limitations of previous 
pharmacotherapies that, in attempting to enhance extinction, inadvertently enhanced 
reconsolidation, thus unintentionally strengthening the memory.  
The amount of cue re-exposure appears to be a major determinant in the outcome of the 
memory, although this is not surprising when one considers the differences between LTP and 
LTD induction. Whereas LTP occurs following brief, phasic bouts of synaptic activity that lead 
to large increases in intracellular Ca2+, LTD occurs following synaptic activity that induces only 
moderate increases in Ca2+. Similarly, reconsolidation occurs following brief cue re-exposure (3 
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CS presentations), while extinction is induced after extensive cue re-exposure (60-120 CS 
presentations). Presumably, this is due to similar mechanistic differences, such that brief 
reactivation results in large Ca2+ increases, kinase activation, and AMPAR trafficking to the 
membrane, and longer exposure results in smaller, but sustained Ca2+ increases that 
preferentially activate phosphatases, leading to AMPAR internalization (Baumgartel and 
Mansuy, 2012; Mulkey et al., 1994). Future experiments could examine differences in Ca2+ 
transients during reconsolidation vs. extinction using in vivo Ca2+ imaging (Grienberger and 
Konnerth, 2012; Resendez et al., 2016). Injection of a GCaMP calcium indicator under control of 
the CaMKII promoter would enable viral expression in the LA that can then allow Ca2+ imaging 
in real time through an implanted microendoscope. These techniques can even be combined with 
traditional optogenetic approaches to add additional circuit-specific control over behavior. 
In our experiments, we often fail to demonstrate a “strengthening” of the cocaine-cue 
association following brief cue reactivation, as assessed by behavioral or physiological measures. 
However, this does not necessarily correspond to a lack of reconsolidation. In fact, several 
studies have consistently shown that cue reactivation fails to alter behavior or induce synaptic 
potentiation. For example, novel object recognition training induces a facilitation of CA3-CA1 
field potentials, but there was no further potentiation following reconsolidation (Clarke et al., 
2010). Interestingly, the field potentials were transiently depotentiated when measured 
immediately after reactivation. Similarly, the long-term facilitation of auditory-evoked field 
potentials in the LA was prevented when protein synthesis was inhibited (Doyère et al., 2007). 
Furthermore, reactivation of thalamic and cortical inputs to the LA does not cause further 
facilitation of field potentials (Li et al., 2013). While not indicative of a reconsolidation-
dependent synaptic enhancement, these studies demonstrate that brief reactivation triggers a 
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transient depotentiation (that corresponds with memory destabilization) that is followed by a 
protein synthesis-dependent restabilization (reconsolidation). Therefore, the lack of 
reconsolidation effects in our studies (increased reinstatement, enhanced synaptic potentiation) 
does not imply a fundamental absence of reconsolidation. Our studies involving pharmacological 
manipulation of CaN and CaMKII, suggest that reconsolidation does occur. For example, 
activation of CaN following brief cue reactivation (3 CS re-exposure) leads to a decrease in T-
LA synaptic strength and a decrease in cue-induced reinstatement that is not observed if the 
memory is not reactivated (0 CS re-exposure). Similar effects on reinstatement are observed 
following CaMKII inhibition, but again, only if the memory is reactivated. To fully rule out the 
possibility that brief reactivation fails to modify the drug-cue memory, future experiments should 
include a group of animals that is tested for reinstatement within the reconsolidation window (ie. 
1 hour after reactivation). Evidence for this possibility stems from previous studies that have 
identified GluA2 endocytosis as a mechanism for reactivation-induced depotentiation, with 
reconsolidation then dependent on the insertion of GluA2-lacking Ca2+-permeable AMPAR 
(Rao-Ruiz et al., 2011). Thus, we might predict that animals tested shortly after reactivation 
would exhibit a reduction in T-LA EPSC amplitude concurrent with a reduction in cue-induced 
reinstatement. It would also be useful for future studies to determine if drug-cue memory 
reconsolidation and extinction depend on AMPAR subunit specificity. During extinction of fear-
associated memories there is a specific internalization of Ca2+-permeable AMPAR (Clem and 
Huganir, 2010), but it is unclear if this extends to the extinction of drug-cue memories. 
Electrophysiological experiments could utilize subunit specific antagonists, such as Naspm, an 
antagonist for GluA2-lacking AMPAR (Ma et al., 2016). If EPSC amplitude was sensitive to 
Naspm, it would suggest that extinction does not internalize these specific receptors. 
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Recent experiments have taken advantage of the fact that memory reactivation initiates a 
transient depotentiation prior to reconsolidation in attempts to induce a persistent weakening of 
CS-US associations. Monfils and colleagues utilized a behavioral design in which they 
destabilized a fear memory via an isolated cue reactivation trial prior to a standard cue extinction 
session (Monfils et al., 2009). This retrieval-extinction paradigm creates a long-term disruption 
of fear memory that is resistant to reactivation, renewal, and spontaneous recovery. This and 
similar procedures have since been used to study the extinction of drug-associated memories. For 
example, CS-US retrieval-extinction in rats trained to self-administer heroin had long-lasting 
memory disruption effects (Xue et al., 2012). The same study also demonstrated clinical 
relevance, as this procedure also attenuated cue-induced craving of heroin for up to 180 days in 
abstinent heroin addicts. Retrieval-extinction has also been used to inhibit a cocaine-associated 
contextual memory (Sartor and Aston-Jones, 2014). Most recently, a slight modification to the 
procedure showed that brief US reactivation (drug re-exposure) prior to extinction of the CS can 
also inhibit drug-seeking (Luo et al., 2015). Overall, these procedures have promise as 
nonpharmacological methods to reduce drug-seeking behaviors; however, it should be noted that 
attempts by other labs to replicate the initial study by Monfils and colleagues have been 
unsuccessful (Goode et al., 2017; Ishii et al., 2015; Luyten and Beckers, 2017). Additionally, 
there is evidence that multiple reconsolidation events can make memories resistant to extinction 
(Dȩbiec et al., 2011), so the time course of reactivation and extinction is an important 
consideration if retrieval-extinction strategies are to be implemented as a therapeutic strategy.  
Finally, future optogenetics experiments could continue to build towards identifying the 
specific synaptic mechanisms underlying reconsolidation and extinction. We have not yet 
examined whether cue reactivation/reconsolidation results in an increase in the amplitude of 
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optically-evoked MGN-LA EPSCs. A related experiment could test whether in vivo high 
frequency optical stimulation of MGN-LA terminals is sufficient to induce an LTP-like state 
(increased EPSC amplitude, AMPAR current) that enhances cue-induced reinstatement. These 
experiments would help validate LTP as a mechanism for drug-cue memory reconsolidation, a 
result that has potential therapeutic implications. Additional experiments should also consider the 
role of NMDAR in optically-induced LTP/LTD. In Chapter 2 we demonstrate that ex vivo 
optical LTD is occluded in slices from animals that have already undergone cue extinction. 
MGN-LA synapses in these animals are already depotentiated, as indicated by decreased EPSC 
amplitude and AMPAR current relative to non-extinguished controls. If the extinction-induced 
depotentiation is dependent on NDMAR activation, then administration of an NMDAR 
antagonist such as APV or MK801 prior to cue extinction would block the extinction effects and 
allow for the generation of ex vivo LTD. Additionally, we show that brief cue reactivation 
induces significant increases in NMDAR current, suggesting enhanced expression and/or 
function at T-LA synapses. Future studies should continue to elucidate the potential role of 
NMDAR in drug-cue memory reconsolidation.  
4.2 ROLE OF NEURAL ENSEMBLES IN DRUG-CUE MEMORY 
In this dissertation we demonstrate that the formation of a cocaine-cue association results in 
potentiation of T-LA synapses and that extinction of the cocaine-cue association depotentiates T-
LA synapses. Larger EPSC amplitudes were observed in slices from cocaine-trained animals 
relative to saline-trained controls, and this increase was reversed by cue extinction. On average, 
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for cocaine-trained non-extinguished animals, EPSC amplitude was correlated to the number of 
CS-US pairings received during SA. While there is some degree of variability both between 
individual neurons and between animals, most neurons tested exhibited relatively large EPSC 
amplitudes compared to both the saline and extinction groups. This is interesting, and perhaps 
somewhat surprising, given the concepts of Hebbian learning that were described above. Based 
on this theory, it has been proposed that sparsely distributed patterns of neurons called neuronal 
ensembles, may be responsible for the encoding of learned associations, such as those that 
underlie cue-dependent drug-seeking (Buzsáki and Moser, 2013; Pennartz et al., 2004). Reports 
suggest that only 1-5% of neurons within a brain region make up an ensemble, but there may be 
several ensembles within a given region, and individual neurons can contribute to more than one 
ensemble (Bossert et al., 2011a; Chawla et al., 2005; Schwindel & McNaughton, 2011). It is 
generally believed that the subset of neurons that receive the strongest, most persistent afferent 
input will be the ones recruited into any given ensemble. In our studies we fail to fully 
demonstrate the existence of distinct neuronal subsets that do not participate in the given 
memory processes. This may be due to a few reasons, including inherent limitations of our 
experimental approach. Unfortunately, with the use of whole-cell slice electrophysiology our 
data set is limited by the number of neurons that can be recorded from during a small timeframe, 
while the slices remain healthy. It is difficult to gauge whether such a small sample size is a true 
representation of all neurons in a brain region. We are left with the possibility that there are 
indeed neurons or at least individual synapses that are not affected by the memory process. This 
limitation can be overcome by correlating electrophysiology with Fos imaging from activated 
neurons (Cruz et al., 2015). Strong, correlated activity generates Ca2+ influx, which influences 
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plasticity at dendritic spines, but also activates the ERK/MAPK pathway, which stimulates c-fos 
promoter activity in the nucleus (Brami-Cherrier et al., 2005; Lüscher et al., 2000).  
A novel approach known as the Daun02 inactivation procedure has been utilized to 
demonstrate the involvement of specific neuronal ensembles in mediating drug-seeking 
behaviors (Bossert et al., 2011; Cruz et al., 2014; Koya et al., 2009). In these experiments, c-fos-
lacZ transgenic rats are used, in which translation of β-galactosidase occurs in strongly activated, 
c-fos-expressing neurons. Daun02 is then injected and catalyzed to daunorubicin by β-
galactosidase, which is believed to then induce apoptotic cell death of only the previously 
activated neurons (Farquhar et al., 2002). Thus, the neural ensemble activated by a particular 
behavior would be eliminated. Unlike studies where entire brain regions are inactivated, this 
approach targets a small number of neurons and allows the investigation of how neuronal 
ensembles regulate drug-associated behaviors. For example, the elimination of a neuronal 
ensemble within the dorsolateral striatum can prevent context-induced seeking of 
methamphetamine, while inactivation of an ensemble within the dorsomedial striatum prevents 
incubation of methamphetamine craving (Caprioli et al., 2017; Rubio et al., 2015). This 
technique could be useful to confirm if ensembles of amygdala neurons are indeed involved in 
drug-cue memory formation, reconsolidation, and extinction. Future experiments could also 
utilize Fos-GFP transgenic rats so that electrophysiological recordings can be limited to Fos-
activated neurons, which would be useful in determining if reconsolidation and extinction 
triggered LTP/LTD in an ensemble-specific manner. It is entirely likely that different sets of 
neuronal ensembles are activated during reconsolidation versus extinction and therefore the same 
molecular events in the same brain region may occur during reconsolidation and extinction, but 
in different populations of neurons (Gore et al., 2015; Suto et al., 2016; Warren et al., 2016). The 
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possibility exists that activating or inhibiting the same molecular processes in distinct neuronal 
ensembles could lead to opposing outcomes. This is one potential explanation for how a common 
biochemical manipulation (i.e., activating CaN; inhibiting CaMKII) in the same brain region can 
simultaneously interfere with reconsolidation and promote extinction. 
4.3 CONTRIBUTION OF ADDITIONAL AMYGDALA AFFERENT PROJECTIONS 
In addition to sensory thalamic and cortical glutamatergic projections, the amygdala receives 
input from a diverse collection of brain regions. Those that are most important for controlling 
memory-related behaviors include glutamatergic input from the mPFC and hippocampus, 
dopaminergic input from the VTA, serotoninergic input from the dorsal raphe, and adrenergic 
input from the locus coeruleus, among others (Giustino and Maren, 2015; Loh and Roberts, 
1990; Pelloux et al., 2012; Quirk and Mueller, 2008; Wise, 2004). Local inhibitory projections 
from GABAergic interneurons and intercalated cells also have important effects (Asede et al., 
2015b; Lucas et al., 2016; Pinard et al., 2012). While most of these are outside the scope of this 
dissertation, it is worthwhile to contemplate the impact that this input may have, thus providing a 
deeper insight into the role of the amygdala in regulating drug-cue memories. 
As described, acute drug exposure increases dopaminergic transmission throughout the 
mesocorticolimbic system, including in the amygdala. When discrete cues are predictive of drug 
use, subsequent presentations of the cues alone cause DA neurons in the VTA to fire, increasing 
DA release (Phillips et al., 2003; Weiss et al., 2000). Although the precise impact of DA on 
reconsolidation and extinction of drug-cue memories has not been elucidated, one could 
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hypothesize that T-LA or C-LA synaptic activity would be modulated in a D1- or D2-specific 
manner. VTA DA has been shown to directly modulate the amygdala neuronal activity during 
Pavlovian conditioning. For instance, enhancements in activity that are observed by pairing a 
footshock with a particular odor can be blocked by administration of the nonspecific DA receptor 
antagonist, haloperidol (Rosenkranz and Grace, 2002). Furthermore, DA receptor activation 
increases kinase activity and downstream phosphorylation. For example, D1-receptor activation 
upregulates PKA, which can phosphorylate DARPP-32 (DA and cAMP-regulated 
phosphoprotein, 32kDa). DARPP-32 subsequently regulates excitatory transmission through 
effects at L-type voltage-gated calcium channels, AMPAR, and NMDAR (Bibb et al., 1999; 
Flores-Hernandez, 2002; Nishi et al., 1997). Conversely, D2-like receptor activation inhibits 
phosphorylation of DARPP-32, and a recent study showed that antagonism of D2 receptors in 
the amygdala impaired the extinction of a fear-associated memory (Nishi et al., 1997; Shi et al., 
2017). Interestingly, antagonism of D1 receptors was found to attenuate methylphenidate-
induced enhancements of cue-reward learning, while D2 antagonism increased task-irrelevant 
behavior, suggesting that D2 receptor activation suppresses this activity (Tye et al., 2010). 
Furthermore, the activation of presynaptically-located D2 receptors activates G-protein-coupled 
inwardly rectifying potassium (GIRK) channels, which can inhibit subsequent DA release, 
serving as an important feedback mechanism (Martel et al., 2011; Michaeli and Yaka, 2010). 
Future studies should investigate the role of D1- and D2-specificity during the reconsolidation 
and extinction of drug-associated memories. Finally, it is possible that DA could be modulating 
amygdala activity through indirect projections to the thalamus or mPFC. Studies have shown that 
the MGN has very low expression of DAT, suggesting that this subregion does not receive much 
dopaminergic input (García-Cabezas et al., 2009). However, other regions of the thalamus, 
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including mediodorsal and paraventricular nuclei (PVN), which also project to the amygdala, do 
express DAT, and could therefore play a role in drug-associated memory (Vertes et al., 2015). 
The PVN has already been associated with aspects of addiction; PVN projections to the NAc 
were shown to mediate the expression of physical symptoms and memory deficits during opiate 
withdrawal (Zhu et al., 2016). Midline thalamic subregions are spatially distinct from the MGN, 
removing the possibility that we accidentally targeted medial thalamus with our optogenetics 
experiments. Still, midline thalamic subregions may be important sites to investigate in future 
studies of drug-related memory.  
Another circuit of interest involves reciprocal connections between the mPFC and the 
amygdala. Hypofunction of the mPFC can result in the loss of inhibitory control over drug 
seeking (Goldstein and Volkow, 2011; Jentsch and Taylor, 1999). Initially, evidence suggested 
that amygdala projections from the IL and PL had opposing roles in the control of fear-related 
memories, likely through differential recruitment of amygdala subregions (Arruda-Carvalho and 
Clem, 2015; Courtin et al., 2013). IL activity promotes fear extinction, possibly through 
projections to intercalated cell masses (Pinard et al., 2012; Quirk et al., 2000) while PL 
activation is associated with cue-elicted freezing, perhaps through direct projections to the basal 
nucleus or indirect projections to the PVN (Arruda-Carvalho and Clem, 2014; Do-Monte et al., 
2015; Milad et al., 2004). The development of optogenetics techniques have allowed the further 
characterization of this circuitry and should be considered in future studies of drug-associated 
learning and memory. Notably, in this dissertation, the presence of a GABAA antagonist during 
electrophysiological recordings removes a likely important contribution from GABAergic 
projections. Because of evidence suggesting that PFC projects heavily to GABAergic neurons, 
future studies should assess the impact of inhibitory signaling. 
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4.4 IMPLICATIONS FOR ADDICTION THERAPY 
In Chapter 2 and Appendix A of this dissertation, we present two targets (CaN and CaMKII) 
for a pharmacology-based treatment that can simultaneously interfere with drug-cue memory 
reconsolidation and promote drug-cue memory extinction. Manipulation of these signaling 
pathways presents the possibility for eventual development of a medication that can consistently 
reduce craving and drug-seeking behaviors by targeting molecules that are important for T-LA 
synaptic regulation. This is supported by our electrophysiological experiments from Chapters 1 
and 2, in which we demonstrate specific synaptic mechanisms that are at least partly responsible 
for the encoding of drug-related memories and show that evoking depotentiation of specific 
synapses can lead to a suppression of the conditioned drug-seeking response. Importantly, we 
also uncovered different synaptic modifications that were associated with one of two specific 
types of drug-related memories. Depotentiation of thalamo-amygdala synapses was driven by 
extinction of drug-cue specific memories while depotentiation at cortico-amygdala synapses was 
associated with extinction of the drug-seeking action. This is importantly clinically, as cue 
exposure therapy involves extinction of memories that are evoked by drug-associated stimuli, so 
pharmacological agents that induce depotentiation of thalamo-amygdala synapses may indeed 
prolong the therapeutic efficacy of cue exposure therapy. If a treatment were also to have 
nonspecific effects (e.g., at cortico-amygdala synapses) then other drug-related memories 
associated with drug taking may also be disrupted, which could have added benefit.  
It should be noted that all of our experiments were performed on adult rats. However, 
there is evidence in both humans and rodents that adolescence represents a period of 
vulnerability to drugs of abuse. Epidemiological studies show that experimentation with drugs of 
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abuse is highest during adolescence or young adulthood, while reward-related brain circuits are 
still developing (Chambers et al., 2003; Dayan et al., 2010; Stanis and Andersen, 2014). In 
general, risk-taking behavior is elevated during this period, which can contribute to a relatively 
early onset of substance use disorders. Indeed, preclinical models have shown that greater risk 
taking during adolescence is predictive of greater cocaine use during adulthood as well as 
changes in dopaminergic signaling in the striatum (Mitchell et al., 2014). Furthermore, studies 
from our lab show that adolescent rodents will willingly self-administer a synthetic cannabinoid 
agonist (Kirschmann et al., 2017). However, specific components of drug-related memories have 
not been well elucidated in adolescent rats. It is possible that key differences in the neural 
circuitry might exist, so it would be beneficial for future studies to examine drug-cue memory 
processes (extinction and reconsolidation) during adolescence. 
Although pharmacotherapy is one potential method to induce relapse-blocking synaptic 
changes, an alternative approach, which is supported by our optogenetics experiment from 
Chapter 1, involves stimulating affected brain regions to modulate or normalize neuronal firing. 
Clinically, two separate methods of brain stimulation have been utilized: deep brain stimulation 
(DBS) and repetitive transcranial magnetic stimulation (rTMS). DBS involves the surgical 
implantation of bipolar electrodes within specific subcortical brain regions in which a pulse 
generator delivers high-frequency stimulation that depolarizes or hyperpolarizes local neurons 
(McIntyre, et al., 2004). The mechanism of action remains unclear, but studies indicate that 
normal brain function can be reestablished by a synchronization or desynchronization of brain-
wide circuits (Murrow, 2014). While DBS has been successful at improving outcomes for 
several neurological and psychiatric disorders, including Parkinson’s disease and depression 
(Riva-Posse et al., 2014; Wagenbreth et al., 2015), relatively few studies have directly assessed 
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the effects of DBS on addictive behaviors. In animal studies, DBS has transiently suppressed 
cocaine-induced locomotor sensitization, reduced ethanol consumption, and attenuated cocaine-
primed reinstatement (Creed et al., 2015; Knapp et al., 2009; Vassoler et al., 2013). Most 
addiction-related DBS findings in humans come from case reports or poorly controlled studies, 
but the results have yielded optimism. Studies have shown the effectiveness of DBS for alcohol, 
nicotine, and heroin. In a small clinical study of 5 alcohol-dependent individuals, bilateral DBS 
in the NAc resulted in the remission of craving in all individuals, and long-term abstinence in 2 
of the 5 (Müller et al., 2016b). Similar results were achieved in a study of smokers, where rates 
of smoking cessation 30 months post-DBS were higher than rates of unaided smoking cessation 
in the general population (30% vs 8.7%) (Kuhn et al., 2009). Finally, two case reports of heroin-
abusing individuals also yielded complete remission of drug use following DBS in the NAc 
(Valencia-Alfonso et al., 2012; Zhou, Xu, & Jiang, 2011). Together, these studies demonstrate 
the potential relapse-preventing potential of DBS and evidence from this dissertation suggests 
the amygdala as a novel target for stimulation-based therapy. 
rTMS is a noninvasive form of brain stimulation in which magnetic pulses are delivered 
on top of the skull to indirectly generate electrical currents (Gorelick et al., 2014; Rossini et al., 
2015). The frequency of stimulation can be varied, whereby low frequency stimulation (< 1 Hz) 
reduces neuronal activity and high frequency stimulation (between 5 and 20 Hz) enhances 
activity (Salling and Martinez, 2016; Speer et al., 2000). As with DBS, the mechanisms of action 
are not completely understood, but evidence suggests that TMS acts to locally alter blood flow, 
neuronal excitability and firing frequency, and neurotransmitter release (Grall-Bronnec and 
Sauvaget, 2014). Glutamatergic signaling appears to be involved, as NMDAR antagonists block 
the long-term effects of high frequency TMS (Huang et al., 2008a). Most clinical rTMS studies 
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of addiction have utilized high-frequency stimulation in the dorsolateral PFC (dlPFC), which is 
involved in cognitive processing, working memory, and impulse control (Barbey et al., 2013; 
Steinbeis et al., 2012). Although the effects of rTMS are generally limited to cortical tissue, there 
are reports of possible downstream effects in deeper brain structures (Fox et al., 1997). Studies of 
rTMS have produced mixed results in drug-dependent individuals; some have demonstrated 
acute reductions in craving and drug use (Eichhammer et al., 2003; Johann et al., 2003; Mishra et 
al., 2010; Politi et al., 2008), whereas others have shown no effect on craving (Herremans et al., 
2012). Recently, Bonci and colleagues have suggested that rTMS rescues drug-induced 
hypoactivity of the PFC (Chen et al., 2013; Terraneo et al., 2016). In a rodent model, long-term 
cocaine self-administration decreased excitability of PL pyramidal neurons, while in vivo 
optogenetic PL stimulation prevented compulsive drug seeking (Chen et al., 2013). In a clinical 
study of cocaine abusers, rTMS-driven stimulation of the DLPFC resulted in a significantly 
higher number of cocaine-negative drug tests as well as significantly lower levels of craving 
compared to a control group (Terraneo et al., 2016).  
Despite the mixed results of brain stimulation for the treatment of addiction, these 
techniques do offer promise for targeting neuroplasticity in the long-term prevention of craving 
and relapse. It is important to continue to study the mechanisms responsible for the 
normalization of drug-induced brain deficits. Circuit-specific approaches, like the ones presented 
in this dissertation may prove helpful at determining appropriate stimulation parameters and 
specific brain regions to target. 
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4.5 SUMMARY AND CONCLUSIONS 
In summary, this dissertation describes a previously unstudied thalamo-amygdala circuit in the 
regulation of a memory associated with self-administered cocaine. Collectively, we have shown 
that MGN specific thalamic projections to the amygdala are recruited during cocaine self-
administration leading to the formation of a cocaine-cue association. Subsequent re-exposure to 
the cocaine-associated cues can either initiate reconsolidation or extinction, depending on the 
amount of unreinforced cue re-exposure. Reconsolidation maintains, while extinction, which is 
associated with a reversal in thalamo-amygdala synaptic potentiation, inhibits the original 
cocaine-cue association. Furthermore, optically-induced depotentiation of the MGN-LA 
projection mimics cue extinction and suppresses cue-evoked reinstatement of drug-seeking. 
Finally, pharmacological agents that promote depotentiation of this circuit (CaMKII inhibitors, 
CaN activators) present with high therapeutic potential. We propose a model for the bidirectional 
regulation of cocaine-cue memories (Figure 24). Brief cue re-exposure initiates a relatively large 
increase in Ca2+ that activate kinases such as CaMKII, leading to AMPAR phosphorylation and 
expression at the synapse that strengthens or maintains the cocaine-cue association 
(reconsolidation). Longer cue re-exposure is accompanied by lower Ca2+ influx, preferential 
activation of phosphatases such as CaN, AMPAR dephosphorylation and internalization, and a 
weakening of the cocaine-cue association. Manipulation of these events, either by pharmacology 
or circuit-specific stimulation can affect memory outcome and have potentially beneficial effects 
that prevent relapse. 
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Figure 24. Model summarizing major conclusions. 
Simplified schematic showing the cellular mechanisms involved in the formation, reconsolidation, and extinction of 
a cocaine-cue memory within the LA. Initial formation of a cocaine-cue association involves enhanced thalamo-
amygdala synaptic activity, including MGN-specific activity, likely through increased postsynaptic AMPAR. Brief 
re-exposure to drug-related cues triggers increased CaMKII activity/decreased CaN activity, likely because of a 
large increase in Ca2+. CaMKII phosphorylates synaptic targets that further increases/stabilizes AMPAR at the 
postsynaptic membrane and strengthens/maintains the original drug-cue association and leads to increased drug 
seeking, possibly by enhanced NAc/CeA activity. Extended cue re-exposure results in a smaller influx of Ca2+ that 
activates CaN and inhibits CaMKII. CaN dephosphorylates synaptic targets, resulting in internalization of AMPAR. 
This weakens the original drug-cue association and decreases subsequent cue-evoked drug-seeking, possibly by 
decreased downstream activity at the NAc/CeA.  
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APPENDIX A 
PHOSPHOPROTEOMIC ANALYSIS REVEALS A NOVEL MECHANISM OF CAMKII 
ALPHA REGULATION INVERSELY INDUCED BY COCAINE MEMORY 
EXTINCTION VERSUS RECONSOLIDATION 
Matthew T. Rich, Thomas B. Abbott, Lisa Chung, Erol E. Gulcicek, Kathryn L. Stone, 
Christopher M. Colangelo, TuKiet T. Lam, Angus C. Nairn, Jane R. Taylor, Mary M Torregrossa 
(Adapted from J Neurosci. 36(29):7589-7600, (2016)) 
 
Successful addiction treatment depends on maintaining long-term abstinence, making relapse 
prevention an essential therapeutic goal. However, exposure to environmental cues associated 
with drug use often thwarts abstinence efforts by triggering drug using memories that drive 
craving and relapse. We sought to develop a dual approach for weakening cocaine memories 
through phosphoproteomic identification of targets regulated in opposite directions by memory 
extinction compared with reconsolidation in male Sprague-Dawley rats that had been trained to 
self-administer cocaine paired with an audiovisual cue. We discovered a novel, inversely-
regulated, memory-dependent phosphorylation event on calcium-calmodulin dependent kinase II 
alpha (CaMKIIα) at serine (S)331. Correspondingly, extinction-associated S331 phosphorylation 
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inhibited CaMKIIα activity. Intra-BLA inhibition of CaMKII promoted memory extinction and 
disrupted reconsolidation, leading to a reduction in subsequent cue-induced reinstatement. 
CaMKII inhibition had no effect if the memory was neither retrieved nor extinguished. 
Therefore, inhibition of CaMKII represents a novel mechanism for memory-based addiction 
treatment that leverages both extinction enhancement and reconsolidation disruption to reduce 
relapse-like behavior. 
A.1 INTRODUCTION 
The successful treatment of addictive disorders requires maintaining long-term abstinence from 
drug use (Kalivas and Volkow, 2005; Milton and Everitt, 2010). However, individuals frequently 
encounter environmental cues previously associated with drug use that can increase craving and 
the likelihood of relapse (Fuchs et al., 2009; Kalivas, 2009). The ability of drug-associated 
memories to induce relapse is perhaps the greatest obstacle to overcome for the successful 
treatment of addictive disorders (Bossert et al., 2013; Torregrossa et al., 2011). Thus, reducing 
the strength of drug-associated memories has therapeutic potential for individuals struggling with 
addiction. 
Behavioral and pharmacological interventions can disrupt or weaken drug-associated 
memories through two primary mechanisms. The first is to pharmacologically prevent 
reconsolidation of the memory into long-term storage after the memory is retrieved or 
reactivated (Taylor et al., 2009; Torregrossa and Taylor, 2013). It is possible to disrupt 
reconsolidation because when a memory is retrieved it can enter a labile state that requires 
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protein synthesis-dependent restabilization (reconsolidation) for the memory to be maintained in 
long-term storage. During the period of lability, memories are susceptible to interference, and 
can be weakened or strengthened with specific pharmacological manipulations (Tronson and 
Taylor, 2007). The second mechanism for weakening drug-associated memories is through the 
process of extinction. Extinction involves repeatedly presenting drug-associated cues in the 
absence of the drug. In this situation, the individual learns that the cues are no longer predictive 
of drug availability, and thus, subsequent encounters with the cue produce less craving and 
relapse. Extinction memories undergo their own consolidation and reconsolidation processes that 
can also be enhanced or inhibited with pharmacological manipulations (Holmes and Quirk, 2010; 
Nic Dhonnchadha et al., 2010; Vurbic and Bouton, 2011). Disrupting reconsolidation and 
enhancing extinction have long been proposed as potential strategies to disrupt aversive 
memories that form the basis of anxiety disorders (Agren et al., 2012; Gamache et al., 2012; 
Monfils et al., 2009), and these strategies have been extended to the addiction field (Arguello et 
al., 2014; Torregrossa et al., 2010; Tronson et al., 2012b). However, clinical application of 
extinction- or reconsolidation-based treatments has met with limited success, likely because both 
processes involve overlapping molecular mechanisms, making selective targeting of one or the 
other challenging. Indeed, previous attempts to disrupt drug-associated memories using 
pharmacological agents combined with extinction training may have been unsuccessful due to 
unintentional memory strengthening (Hofmann et al., 2012; Price et al., 2013). 
Therefore, the goal of the present study was to identify cellular signaling events that are 
regulated in opposition by extinction relative to reconsolidation of a memory associated with 
self-administered cocaine. Such molecules, once identified, could represent targets for the 
development of a single medication that can enhance extinction while inhibiting reconsolidation 
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to ensure memory weakening and a reduction in relapse. We used a discovery-based 
phosphoproteomics strategy to identify proteins that exhibit a divergent pattern of 
phosphorylation following reconsolidation relative to extinction, as initial memory consolidation 
events involve the activation of kinase and phosphatase cascades (Merlo et al., 2014; Sanchez et 
al., 2010). The basolateral amygdala (BLA) was analyzed as it is the locus for associative 
learning and mediates the encoding of drug-associated memories (Fuchs et al., 2006; Nic 
Dhonnchadha et al., 2013; Sanchez et al., 2010). The proteomics analysis found a small number 
of opposing signaling events, including identification of a novel phosphorylation event on 
calcium-calmodulin dependent kinase II alpha (CaMKIIα) on serine (S) 331. Although CaMKIIα 
phosphorylation events on the highly characterized autophosphorylation site at threonine (T) 286 
have been previously linked to drug-related learning (Easton et al., 2013, 2014; Salling et al., 
2016), the role of S331 phosphorylation has not been investigated. Here, we report a functional 
role for S331 phosphorylation in vitro and describe the behavioral effects of CaMKII inhibition 
on both the reconsolidation and extinction of a cocaine-associated memory in vivo. Our findings 
suggest that molecular mechanisms exist that could allow for the combined enhancement of 
extinction and disruption of reconsolidation. 
137 
 
A.2 MATERIALS AND METHODS 
A.2.1 Subjects 
Naïve, adult male Sprague-Dawley rats, weighing 275-325 g on arrival, were used in all studies. 
All rats were housed in a temperature- and humidity-controlled room. Animals were housed in 
pairs, given ad libitum access to food and water, and maintained on a 12 h light-dark cycle. Rats 
were given at least 5 days to acclimate to the facility before undergoing surgical procedures. 
Following surgery, rats were individually housed and given at least 1 week to recover before the 
start of behavioral training. Rats were food-deprived 24 h prior to the start of behavioral 
experiments and maintained at ~90% of their free-feeding body weight (~20 g of chow per day) 
for the duration of testing. All behavioral experiments were run during the light-cycle. The 
experiments used to generate samples for proteomic analysis were conducted at Yale University 
in the Connecticut Mental Health Center, while all subsequent experiments were conducted at 
the University of Pittsburgh. Sprague-Dawley rats were obtained from Charles River (Kingston, 
NY) at Yale and from Harlan (Frederick, MD) at the University of Pittsburgh. We used different 
vendors to minimize animal shipping time to both facilities. At Yale rats were housed in shoebox 
cages with water bottles on standard racks, while at the University of Pittsburgh, rats were 
housed in auto-ventilated racks with an automated watering system. All other housing and 
procedural parameters were the same between the two universities, unless otherwise noted. In 
addition, all procedures were conducted in accordance with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals and were approved by each institution’s 
Institutional Animal Care and Use Committee. 
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A.2.2 Self-administration test chambers 
Rats were trained to self-administer cocaine in standard operant conditioning chambers 
(MedAssociates, St. Albans, VT). Experiments were counterbalanced across one of two chamber 
designs, providing two distinct contexts. The first type of chamber consisted of bar floors and 2 
nosepoke apertures. The second type of chamber consisted of grid floors and 5 nosepoke 
apertures. All chambers contained two retractable levers on one wall of the chamber, a tone-
generator, stimulus-light above each lever, house light, and infusion pump. Operant boxes were 
kept in sound-attenuating chambers equipped with a fan for background noise. 
A.2.3 Drugs 
Cocaine hydrochloride (generously provided by the National Institute on Drug Abuse, Research 
Triangle Park, NC) was dissolved in sterile 0.9% saline (2 mg/ml) and filter-sterilized for self-
administration. KN-62 (Tocris, Bristol, UK) was dissolved in 0.9% saline + 62% DMSO. KN-93 
(Tocris) was dissolved in 1X PBS + 10% DMSO. 
A.2.4 Surgical procedures 
Rats were fully anesthetized with ketamine hydrochloride (87.5 mg/kg; i.m.) and xylazine 
hydrochloride (5 mg/kg; i.m.) and then received an analgesic (Rimadyl, 5 mg/kg; s.c.) and 5 ml 
of Lactated Ringer’s (s.c.) prior to surgery. Betadine and 70% ethanol were applied to all 
incision sites. All rats were implanted with a chronic indwelling intravenous (i.v.) catheter 
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(CamCaths, Cambridge, UK) into the right jugular vein, as described previously (Torregrossa 
and Kalivas, 2008; Torregrossa et al., 2010). Catheters were fed subcutaneously to the 
midscapular region, where they exited through a round incision. For experiments involving 
intracranial infusions, rats were immediately placed into a stereotaxic instrument (Stoelting, Kiel, 
WI), and implanted with bilateral stainless steel guide cannulae (22 gauge; Plastics One) 
targeting the area just dorsal to the BLA (AP –3.0 mm, ML ±5.3 mm, DV –7.9 mm, relative to 
bregma; Paxinos and Watson, 1998). Guide cannulae were secured to the skull with 3 miniature 
screws and dental acrylic resin. Dummy cannulae were inserted the length of the guide cannulae 
to maintain patency. Rimadyl (5 mg/kg; s.c.) was administered for the first two days after 
surgery. Catheters were kept patent by daily infusions of 0.1 ml of an antibiotic solution of 
cefazolin (10.0 mg/ml) dissolved in heparinized saline (30 USP heparin/ml). 
A.2.5 Cocaine self-administration procedures 
Rats administered cocaine during daily sessions for 1 h, on a fixed ratio 1 (FR1) schedule of 
reinforcement with a 10 s timeout. The designated active lever (counterbalanced across left and 
right levers) produced a cocaine infusion paired with a 10 s tone-light conditioned stimulus (CS). 
Pump durations were adjusted daily according to body weight in order to deliver the correct dose 
of drug (1.0 mg/kg of body weight per infusion). Responses on the other, inactive, lever were 
recorded, but had no programmed consequences. Rats underwent training for at least 10 d and 
until they administered at least 8 infusions per day over 3 consecutive days. Rats that did not 
meet acquisition criteria by 14 d were excluded from the study. The program was controlled by 
and data were collected using MedPC (MedAssociates). 
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A.2.6 Instrumental lever extinction 
After successful acquisition of self-administration, rats underwent instrumental lever extinction 
for at least 7 d. During these daily 1 h sessions, responses on both the active and inactive levers 
were recorded, but had no programmed consequences. Lever extinction continued until 
extinction criteria had been met (an average of < 25 lever presses on the last two days of 
extinction). Throughout lever extinction, rats received no cocaine or cocaine-associated cue 
reinforcement. Lever extinction was conducted to reduce responding to a stable, low rate to later 
assess cue-induced reinstatement. In addition, lever extinction reduces the motivational value of 
other cues in the self-administration context, such as the levers, so that subsequent testing 
specifically isolates the memory for the discrete cue associated with cocaine infusion. 
A.2.7 Identification of cellular signaling events regulated by cocaine-associated memory 
extinction and reconsolidation 
Memory manipulations. Following cocaine self-administration and instrumental lever extinction, 
rats were assigned to a memory manipulation group (extinction, memory reactivation, or no 
manipulation controls) based on a matching procedure that ensured that each group had no 
statistical differences in their cocaine infusions acquired over days, or differences in lever 
extinction behavior. All groups were placed in the opposite context from which they received 
self-administration training (different in flooring texture, shape, and smell), for a 30 min session 
on 2 consecutive days. During these sessions, rats had no opportunity for instrumental 
responding, i.e., the levers were retracted.  
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Extinction: For cue extinction, the cocaine-associated CS was presented for 10 s, 60 times, with 
each presentation separated by 30 s, on each of the two days. Thus, the rats were exposed to a 
total of 120 CS presentations, which we have previously shown to significantly reduce cue-
induced reinstatement on a subsequent test day (Torregrossa et al., 2010). 
Memory Reactivation:  For cue reactivation, the CS was presented 3 times at the end of the last 
session on the second day, with each CS presentation separated by 1 min. Previous work from 
our lab has shown that 3 CS presentations is sufficient to induce memory reactivation and 
reconsolidation, but is not sufficient to produce extinction (Sanchez et al., 2010; Wan et al., 
2014).   
No Memory Manipulation Control: The control group was placed in the operant chambers for the 
same amount of time as rats in the cue extinction and reactivation groups, but with no CS 
presentations. Thus, the time spent in the operant boxes and the type of operant box was 
equivalent between groups prior to sacrifice. Fifteen minutes following memory manipulations, 
rats were lightly anesthetized with isofluorane to minimize stress prior to euthanasia by focused 
microwave irradiation. Focused microwave irradiation was used to preserve the phosphorylation 
state of proteins. Importantly, because no group had the opportunity to make instrumental 
responses prior to sacrifice, differences in behavioral activity should not substantially affect 
levels of protein phosphorylation. The brains were immediately dissected and individual brain 
regions, including the basolateral amygdala complex were obtained and stored at -80 C until 
processing. 
Label-free quantitative proteomics: sample preparation. Brain regions of interest, including the 
amygdala reported here, were homogenized by sonication in a buffer containing urea (8 M), 
ammonium bicarbonate (0.4 M), and phosphatase inhibitor cocktails (Sigma). Samples from 2 
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rats in each experimental group were randomly pooled to create a total of 4-5 sample pools per 
group. The extinction group included one sample “pool” that consisted of just one rat due to an 
odd number of rats meeting acquisition criteria. Pooled samples were then analyzed by the 
Yale/NIDA Neuroproteomics Center at Yale. 20 µL of 45 mM DTT was added to each sample 
and incubated at 37 ºC for 20 min to reduce Cys residues. Samples were cooled and 20 µL of 100 
mM iodoacetamide (IAM) was added to each sample and incubated at RT in the dark for 20 min 
for alkylation of the reactive free sulfhydro of the reduced Cys. Dual enzymatic digestion was 
carried out by adding 600 µL of dH2O and 30 µL of 1 mg/mL Lys C followed by incubation at 
37 ºC for 4 hrs, with subsequent digestion by incubation with 30 µL of 1 mg/mL trypsin 
overnight at 37 ºC. Samples were macrospin desalted and dried by speedvac. Pellets were 
dissolved in 50 µL of a solution containing 0.5% TFA and 50% acetonitrile. Samples were then 
subjected to titanium dioxide (TiO2) phosphopeptide enrichment using TopTips (Glygen, 
Columiba, MD). The TopTip was washed 3 times at 2000 rpm for 1 min with 40 µL 100% 
acetonitrile, then 0.2 M sodium phosphate (pH 7.0), 0.5% TFA, and 50% acetonitrile.  The 
acidified digest supernatants were loaded into the TopTip, spun at 1,000 rpm for 1 min, and then 
at 3,000 rpm for 2 min. The flow through from these washes (less phosphorylated fraction) was 
saved for analysis by LC-MS/MS as described below. Phosphopeptides were eluted from each 
TopTip by 3 washes with 30 µL of 28% ammonium hydroxide. Both the flow through and eluted 
fractions were dried by speedvac. Enriched fractions were dissolved in 10 µL of 70% formic acid 
and 30 µL of 50 mM sodium phosphate. Peptide concentrations were determined by Nanodrop to 
load 0.3 µg/5µL of each sample. 
LC/MS-MS. 5 µL of each sample was injected onto a LTQ Orbitrap LC-MS/MS system. Peptide 
separation was performed on the nanoACQUITY™ ultra-high pressure liquid chromatography 
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(UPLC™) system (Waters, Milford, MA), using a Waters Symmetry® C18 180 µm x 20 mm 
trap column and a 1.7 µm, 75 µm x 250 mm nanoACQUITY™ UPLC™ column (35 ºC). 
Trapping was done at 15 µL/min, with 99% Buffer A (0.1% formic acid in water) for 1 min. 
Peptide separation was performed over 120 min at a flow rate of 300 nL/min beginning with 
95% Buffer A and 5% Buffer B (0.075% formic acid in acetonitrile) to 40% B from 1–9 min, to 
85% B from 9-91 min, held at 85% B from 91-95 min, then returned to 5% B from 95-96 min. 
Two washes were made between each sample run to ensure no carry over (1. 100% acetonitrile, 
2. Buffer A). The LC was in-line with an LTQ-Orbitrap mass spectrometer. MS was acquired in 
the Orbitrap using 1 microscan, and a maximum inject time of 900 ms followed by 3-6 data 
dependent MS/MS acquisitions in the ion trap (with precursor ion threshold of >3000). The total 
cycle time for both MS and MS/MS fragmentation by collision induced dissociation (CID) were 
first isolated with a 2 Da window followed by normalized collision energy of 35%. Dynamic 
exclusion was activated where former target ions were excluded for 30 sec. Three technical 
replicates were injected for each sample and all samples and replicates were randomized across 
an entire run time.  
Data analyses.  Feature extraction, chromatographic/spectral alignment, data filtering, and 
statistical analysis used Nonlinear Dynamics Progenesis LC-MS software (www.nonlinear.com). 
Raw data files were imported into the program and detected mass spectral features were aligned 
based on retention time of the detected m/z peaks based on a randomly selected reference run. 
All other runs were automatically aligned to the reference run to minimize retention time (RT) 
variability between runs. No adjustments were necessary in the m/z dimension due to high mass 
accuracy of the spectrometer (typically < 3 ppm). All runs were selected for detection with an 
automatic detection limit. Features within retention time ranges of 0-5 min were filtered out, as 
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were features with charge state greater than +6 or singly charged peptides (as no MS/MS 
fragmentations were taken for these charge states during data collection) for reduction of false 
positive peptide assignments.  A normalization factor was then calculated for each run to account 
for differences in sample load between injections. The experimental design grouped multiple 
injections from each condition. The algorithm then calculated and tabulated raw and normalized 
abundances, max fold change, and Anova p values for each feature in the data set. Stringent 
conditions were set in MASCOT to filter out low scoring identified peptides by imposing a 
confidence probability score (p) of < 0.05.  Additionally a positively identified protein that was 
quantified contained at least two unique identified tryptic peptides. The filtered MS/MS spectral 
features along with their precursor spectra were exported in the form of an .mgf file (Mascot 
generic file) for database searching using the Mascot algorithm (Hirosawa et al., 1993). The data 
was searched against the Uniprot (Rattus norvegicus) database. The confidence level was set to 
95% within the MASCOT search engine for peptides assigned hits based on randomness. 
MS/MS analysis was based on the use of trypsin and the following variable modifications: 
carboamidomethyl (Cys), Oxidation (Met), Phospho (Ser, Thr, Tyr). Other search parameters 
included peptide mass tolerance of ± 15 ppm, fragment mass tolerance of ± 0.5 Da, and 
maximum missed cleavages of 3. A decoy search (based on the reverse sequence search) was 
performed to estimate False Discovery Rate (FDR), with setting of acceptable protein ID having 
FDR of 2%. Using the Mascot database search algorithm, a protein is considered identified when 
Mascot lists it as significant (bold red) and more than 2 unique peptides match the same protein. 
The Mascot significance score match is based on a MOWSE score and relies on multiple 
matches to more than one peptide from the same protein. The Mascot search results were 
exported to an .xml file using a significance cutoff of < 0.05, and ion score cutoff of 28, and a 
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requirement of at least one bold (first time any match to the spectrum has appeared in the report) 
and red (top scoring peptide match for this spectrum) peptide. The .xml file was then imported 
into the Progenesis LCMS software, where search hits were assigned to corresponding detected 
features, identified as described above. 
SRM proteomics. Identified peptides and their modifications were mined to a list of 
approximately 80 unique peptides for quantitative analysis between groups by selective reaction 
monitoring (SRM). The list was created based on ionization signal quality and to reduce the 
number of high abundance, highly modified phosphoproteins (e.g., neurofilament proteins) and 
proteins with unclear function. Analyses were carried out on a 5500 Q-TRAP instrument coupled 
online to a Waters nanoACQUITY™ UPLC™ system. Four µL of each sample was loaded onto 
a 5 µm, 180 µm x 20 mm Symmetry C18 nanoAcquity trapping column with 100% water/0.1% 
formic acid at a flow rate of 15 µL/min for 1 min. Peptides were then separated on a 1.7 µm, 75 
µm x 100 mm BEH130 C18 nanoAcquity column with a 30 min, 2-40% acetonitrile/0.1% formic 
acid linear gradient at a flow rate of 0.75 µL/min. SRM scanning was conducted using 211 
transitions and a cycle time of 2.4 s with a 5 ms dwell time per transition (5 transitions/peptide) 
in positive polarity. Data were processed using MRMPilot 2.0, Analyst 1.5 with MIDAS, and 
Multiquant 2.0 software. Peptide identification was further confirmed using MASCOT. Data 
were analyzed using nested linear models with transition nested within peptide. Interaction 
effects were included in the model and significant group x transition effects within a peptide 
were used to identify outlying transitions for exclusion from further analysis. Statistics were 
calculated using SRMstats with restricted scope (freely available in R (Chang et al., 2012). We 
report phosphopeptides with significantly different abundances in either the extinction or 
reactivation group relative to control with P < 0.05 considered significant after correcting for 
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multiple comparisons. The statistical methods used here, as described by Chang et al., are robust 
in detecting statistical differences from SRM experiments, particularly when there is little 
underlying biological variability in the protein abundance. This statistical method was chosen for 
hypothesis generation, as the primary aim of the present study was to identify phosphorylation 
events that are bi-directionally regulated by the extinction vs. reconsolidation of cocaine-
associated memories. The analysis was therefore biased towards potentially identifying false 
positives rather than creating false negatives. We also include analytical results using a more 
conservative linear mixed effects model for comparison in Table 1. Within the table, the first 
column lists the Uniprot defined protein abbreviations (not gene names), the second column 
shows the peptide sequence identified with lower case “p”s indicating sites of phosphorylation 
and “ox” indicating oxidation of Methionine. The next set of 6 columns (orange) gives data for 
the extinction group relative to control, and the next 6 columns (purple) represent data from the 
reactivation group relative to controls. Within in each group, the green columns are the results 
from the SRM stats analysis, while the blue columns are the linear mixed effects model analysis. 
Each analysis includes the unadjusted p-value, the estimated fold change from controls, and the 
p-value after correcting for multiple comparisons. 
A.2.8 Assessment of effect of CaMKIIα phosphorylation at S331 on catalytic activity 
Site-directed mutagenesis. CaMKIIα phospho-deficient (serine 331 to alanine; S331A) and 
phospho-mimetic (serine 331 to glutamate; S331E) mutants were created using the QuikChange 
II XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA). The PCR mixture 
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contained 50 ng template plasmid DNA (pCMV6-CaMKIIα-Myc-DDK plasmid; Origene, 
RR201121), 125 ng of each oligonucleotide 
(For: GGCGTGAAGGAATCCGCTGAGAGCACCAACACC) 
(Rev: GGTGTTGGTGCTCTCAGCGGATTCCTTCACGCC),  
1 μL dNTP mix, 2.5 U PfuUltra DNA polymerase, 5 μL 10X Reaction buffer, and 3 μL 
Quiksolution reagent in a final volume of 50 μL. PCR was performed under the following 
conditions; denaturation at 95°C for 50 sec, annealing at 60°C for 50 sec and extension at 68°C 
for 1 min/kb. The PCR product was digested with 10 U of DpnI for 1 h at 37°C and then 
transformed into 45 μL of XL10-Gold Ultracompetent E. coli cells. Presence of the mutation was 
confirmed by DNA sequencing of the construct.  
Cell culture and plasmid transfection. HEK293T cells were maintained in culture in a humidified 
5% CO2 atmosphere at 37°C in medium consisting of DMEM/F12 supplemented with 10% fetal 
bovine serum, and penicillin-streptomycin. Transfections were carried out using the 
Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA). HEK293T cells were seeded in 6-well 
plates at 3 X 105 cells per well, grown for 24h and then incubated overnight with 2 mL of serum-
free medium containing 5 μg wildtype (WT) or mutant pCMV6-CaMKIIα expression vectors, 
and 7.5 μg Lipofectamine. Control cells were incubated with a plasmid-free mixture of medium 
and Lipofectamine. After overnight incubation, the medium was replaced by fresh medium 
supplemented with 500 μg/μL geneticin (Invitrogen) to select for transfected-cells. To determine 
basal levels of CaMKIIα expression in HEK293T cultures, a subset of the control cells did not 
receive geneticin treatment. 
Immunoblot and kinase activity assay. HEK293T whole-cell lysates were prepared by washing 
cultures with ice-cold 1X PBS followed by treatment with ice-cold lysis buffer containing 
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protease inhibitors (1:100). Cells were collected and incubated on ice for 30 min, then 
centrifuged at 16,000 g for 20 min at 4°C. Supernatants from two 6-well plates were collected 
and pooled together, and protein content was quantified using the Pierce BCA assay kit. 
Supernatants with equal amounts of protein (10 μg) were resolved via sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. 
Membranes were blocked with 5% nonfat dairy milk in PBST (phosphate-buffered saline + 0.1% 
Tween 20). Membranes were then probed with the following primary antibodies: Rabbit Anti-
CaMKII (Millipore07-1496, 1:500; Millipore, Billerica, MA) and Mouse Anti-GAPDH 
(Millipore MAB374, 1:1000). Goat Anti-Rabbit IgG (Li-Cor 926-32211, 1:5000; Li-Cor, Licoln, 
NE) and Goat Anti-Mouse IgG (Li-Cor 926-68070, 1:5000) secondary antibodies were used. 
Odyssey Infrared Imager (Li-Cor) was used for the detection of protein bands. Kinase activity 
was quantified following the instructions of the ADP-GloTM Kinase Assay (Promega, Madison, 
WI) in the presence of CaCl2, MgCl2, calmodulin, and the CaMKII selective substrate, 
Autocamtide-2. For each reaction, relative amounts of protein supernatant (~2.5 μg) were loaded 
based on total protein levels in the lysate, corrected for loading of GAPDH. Reactions were 
initiated by the addition of 250 μM ATP then incubated for 15 min at 30°C. Reactions were 
terminated and the unconsumed ATP depleted by the addition of ADP-Glo Reagent, then 
incubated for 40 min at RT. Kinase Detection Reagent was then added to each reaction to 
convert ADP back to ATP while also introducing luciferase and luciferin to detect ATP. This 
was followed by another 40 min incubation at RT. Luminescence was measured using the 
FLx800 Multi-Detection Microplate Reader (BioTek, Winooski, VT) Using a linear standard 
curve, the amount of depleted ADP was determined, and these values were converted to specific 
kinase activity. 
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A.2.9 CaMKII inhibition and reinstatement of cocaine seeking 
Memory manipulations. Memory manipulations took place as described in the proteomics 
experiment above with the following differences. Pavlovian cue extinction was conducted in the 
same context in which rats received self-administration training, and took place for either a 
single 30 min session (moderate extinction) or a 30 min session on 2 consecutive days (extended 
extinction). For cue reactivation, rats were placed in operant chambers, in the opposite context 
from which they were trained, for a single memory reactivation session. During this session, the 
cocaine-associated cue was presented for 10 sec, 3 times, with each presentation separated by 1 
min. Control rats were again placed in the opposite context form which they were trained, but 
were never presented with the cocaine-associated cues.  
Intracranial infusions. Drugs were administered in a volume of 0.5 µl/hemisphere. KN-62 was 
given at one of two doses: 340 or 680 ng/side. KN-93 was given at either 5 or 10 µg/side. These 
doses were based on effective doses in prior publications using intracranial infusions (Rodrigues, 
2004; Sakurai et al., 2007). Infusions were given immediately following the memory 
manipulations, by removing dummy cannuale and inserting injection cannulae (28 gauge; 
Plastics One; Roanoke, VA) that extended 1 mm beyond the guide cannulae. The injectors were 
connected to Hamilton syringes (Hamilton Robotics, Reno, NV) controlled by a syringe pump 
via polyethylene tubing. Infusions were given over the course of 2 min and injectors were left in 
the cannulae for an additional 1 min to allow for drug diffusion.  
Cue-induced reinstatement. 24 h after the final Pavlovian cue extinction session or memory 
reactivation session, cue-induced reinstatement was assessed during a 1 h session that took place 
in the original self-administration context. A lever press on the active lever produced a 10 sec 
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presentation of the cocaine-associated cue on an FR1 schedule, but no drug reinforcement. Lever 
presses on the inactive lever were recorded but had no programmed consequences. 
Histological analysis. After the completion of experiments, rats with intracranial cannulae were 
sacrificed via decapitation. Brains were dissected and placed in 10% formalin for at least 3 d 
then transferred to 30% sucrose for at least 3 d. Brains were then frozen and sectioned coronally 
through the BLA on a cryostat. Sections were taken at 50 µm and placed on slides for 
visualization of infusion placements. The investigator was blind to treatment group when 
analyzing histology, and animals with infusions outside of the BLA were removed from the main 
analysis. Schematic of acceptable infusion locations is seen in Figure 25. 
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Figure 25. Histological representation of infusion locations in the BLA. 
The black squares represent the outermost range in the medial-lateral and dorsal-ventral planes that were considered 
a hit in the BLA, all other placements were located within these bounds. Numbers by each section represent 
millimeters from bregma. 
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A.2.10 Code availability 
All behavioral training and testing was conducted using custom MedPC programs. The computer 
code used is available to researchers upon request. 
A.2.11 Statistical analyses 
Behavioral and kinase activity data were analyzed using GraphPadPrism for Windows. For 
proteomic data, the normalized average intensity across transitions for each phosphopeptide was 
computed for each sample and these values were averaged within groups. Group averages were 
compared statistically using a SRMstats restricted analysis and p-values corrected for multiple 
comparisons. For immunoblot data, intensities of protein bands were quantified using Odyssey 
Imaging Software ver 3.0. Total CaMKII amount was normalized based on the signal intensity of 
GAPDH and expressed as %WT. For kinase activity data, samples were run in duplicate. 
Luminescence was normalized to a ‘no-substrate control’ and converted to kinase specific 
activity based on a standard conversion curve. Data was analyzed using a one-way ANOVA. 
Reinstatement tests were analyzed by two-way ANOVA with repeated measures, with the 
between-subjects factor being responding on the last day of lever extinction versus reinstatement 
responding and the within-subjects factor being the dose of drug. For the no reactivation control 
group, vehicle groups were statistically similar, and therefore collapsed across treatment groups. 
For the anatomical control experiment, data were analyzed using an independent samples t-test. 
For all analyses, significant effects were further analyzed by Bonferroni’s post hoc tests, with 
significance set at P < 0.05. All data were determined to be normally distributed using the 
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Shapiro-Wilk test, and Bartlett’s test was used to determine that there were no significant 
differences in the estimated variance between groups. 
A.3 RESULTS 
A.3.1 Identification of novel signaling events that are regulated by cocaine-cue memory 
extinction and reconsolidation 
To identify candidate signaling events that are regulated in opposition by extinction vs. 
reconsolidation of a memory associated with self-administered cocaine, we employed a high 
resolution tandem mass spectrometry-based phosphoproteomics approach, where we examined 
differential protein phosphorylation events after memory manipulations as an index of increased 
or decreased protein activity. Rats were trained to self-administer cocaine paired with an 
audiovisual cue (conditioned stimulus (CS)) for 10 days, followed by 5-7 days of extinction of 
instrumental lever responding (Figure 26A). Each rat was assigned to a memory manipulation 
group in a random manner that ensured no training differences between groups. There were no 
significant differences or interactions with day of training for infusions earned (Figure 26B) or 
active lever presses during extinction (Figure 26C; two way repeated-measures ANOVA: P > 
0.05, n = 7-10 rats per group). No statistical differences were observed for active lever presses 
during acquisition or inactive lever presses at any stage (data not shown). Following lever 
extinction, rats were exposed to one of three memory conditions: reactivation, extinction, or  
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Figure 26. Self-administration and extinction training data from rats used for phosphoproteomic analysis. 
(A) Timeline for proteomics experiments. (B) Mean number of cocaine infusions per day during acquisition and (C) 
mean number of active lever presses per day during instrumental extinction in rats prior to memory manipulations. 
There were no differences in acquisition or instrumental extinction between manipulation groups (both p > 0.05, n = 
7, 9, and 10 rats, respectively, for control, extinction, and reconsolidation). Data are expressed as mean + s.e.m. 
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control context exposure. Fifteen min following the memory manipulation, rats were euthanized 
by focused microwave irradiation to maintain protein post-translational modifications, and the 
brains were dissected for proteomics analysis. Fifteen min was chosen as it is thought to 
represent the time when many of the intracellular signaling cascades regulating the extinction or 
reconsolidation of a memory would be active. Here we describe results from the analysis of the 
BLA, as it is the locus for associative learning and mediates the encoding of drug-associated 
memories (Schafe and LeDoux, 2000; See, 2005). 
Total homogenates were enriched for phosphopeptides, and discovery-based, label free 
quantitative analysis was used to identify putative memory-regulated proteins. A large number of 
phosphopeptides were detected corresponding to 355 unique proteins. From this list of 
phosphopeptides, we pseudorandomly chose ~80 phosphopeptides for quantitative validation by 
selective reaction monitoring (SRM) mass spectrometry. We prioritized the phosphopeptides to 
be chosen by selecting those with robust ionization intensity that were likely to provide clear MS 
signals and to exclude highly abundant, heavily phosphorylated proteins, such as neurofilaments 
and microtubule associated proteins. Phosphorylation of these proteins are potentially relevant to 
memory processes, but because of their abundance and high degree of phosphorylation, they may 
be over-represented in the analysis. A total of 72 unique phosphopeptides had sufficient data 
quality from the SRM experiment for data analysis. Table 1 contains the statistical analysis, as 
described in the methods, and estimated fold change in the level of phosphopeptides in the 
extinction and reactivation groups relative to the control. Figure 27 summarizes the data from all 
phosphopeptides that showed a significant change from control when analyzed using SRMstats 
with a significance cut-off of p < 0.05 after correction for multiple comparisons. Each panel is 
organized to illustrate the phosphopeptides significantly regulated by both extinction and 
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Figure 27. Identification of signaling pathways regulated by cocaine-associated memory extinction and 
reconsolidation. 
(A-D) Phosphoproteomic analysis from tissue collected 15 min following memory manipulations reveals several 
phosphopeptides that were significantly regulated (A) in the opposite direction by extinction vs. reconsolidation, (B) 
in the same direction by both memory conditions, (C) by memory extinction only (only red bars significantly 
different from control), or (D) by memory reconsolidation only (only blue bars significantly different from control). 
The y-axes list the Uniprot database protein abbreviation. The number in parenthesis following an abbreviation is 
the ID we assigned when multiple unique phosphopeptides were identified from the same protein. Bars represent the 
estimated fold change in phosphopeptide abundance relative to non-memory manipulated controls. Positive values 
indicate significant increases in the abundance of the phosphopeptide, and negative values decreased abundance. All 
p < 0.05 relative to control after correction for multiple comparisons using SRMstats for statistical analysis of SRM 
data (Chang et al., 2012). 
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reconsolidation in the opposite direction (Figure 27A); those significantly regulated in the same 
direction by both conditions (Figure 27B); those only significantly regulated in the extinction 
condition (Figure 27C); and those only significantly regulated in the reactivation condition 
(Figure 27D).  Of greatest interest for our study were the 5 phosphopeptides regulated in the 
opposite direction by extinction vs. reconsolidation, as these could represent targets that can both 
enhance extinction while inhibiting reconsolidation to ensure sufficient weakening of a drug-
associated memory. These phosphopeptides included CaMKIIα (KCC2A, pS331), c-Jun N-
terminal kinase 3 (JNK3 or MK10, pT221+Y223), the gap junction protein connexin 43 (CXA1, 
pS328+pS330), the GABAB receptor subunit 2 (GABR2, pS883), and phospholipase C beta 1 
(PLCB1, pS988). Interestingly, CaMKIIα, phospholipase C, and GABAB receptors are 
important regulators of Ca2+ signaling (Chalifoux and Carter, 2011; Lyon and Tesmer, 2013), 
and JNK3 activation can be regulated by PLC (Buckley et al., 2004), indicating a convergence of 
opposing calcium-related cellular events dependent on whether a cocaine memory is 
reconsolidated or extinguished. 
A.3.2 Phosphorylation of CaMKII at S331 decreases catalytic activity 
CaMKIIα is known to be an important regulator of learning and memory (Coultrap and Bayer, 
2012; Sanhueza and Lisman, 2013), and is an abundant protein, thus it is not surprising that 
CaMKIIα was identified in our analysis.  Yet, somewhat surprisingly, the differentially regulated 
phosphorylation event on CaMKIIα was on residue S331. S331 phosphorylation was 
significantly increased after memory extinction, but was significantly decreased after memory 
reactivation (Figure 28A). To our knowledge, S331 phosphorylation has never been previously 
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Figure 28. Phosphorylation of CaMKIIα at S331 inhibits enzyme activity. 
(A) Schematic representation of site-directed mutagenesis of CaMKIIα at S331 to generate phospho-deficient 
(S331A) or phospho-mimetic (S331E) mutants. (B) Wild-type (WT), S331A, and S331E plasmids were expressed in 
HEK293T cells. Supernatants were collected and CaMKIIα expression was quantified via immunoblot, normalized 
to GAPDH, and expressed as %WT. Results indicate a lack of CaMKIIα in the non-transfected control (No Tfx) 
condition, but similar expression of all recombinant forms of CaMKIIα (n = 8 samples per group). Representative 
immunoblots are shown in the upper panel. (C) Quantification of CaMKII activity from whole cell lysates. Kinase 
activity was regulated by the phospho-mimetic mutation of S331 (n = 8 samples per group). Catalytic activity of the 
CaMKIIα S331E mutant was significantly lower than that of the S331A mutant . Data are expressed as mean + 
s.e.m. *p < 0.05.   
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reported in relation to learning and memory or any other biological process. However, one recent 
study has found that S331 is a potential autophosphorylation site (Baucum et al., 2015). 
Therefore, we proceeded to determine if phosphorylation of S331 regulates the enzymatic 
activity of CaMKIIα. Phospho-deficient (S331A) and phospho-mimetic (S331E) forms of 
CaMKIIα DNA were generated (Figure 28A) and, along with a wild-type (WT) form, expressed 
in HEK293T cells. The absence of endogenous CaMKIIα in HEK293T cells, as previously 
reported (Jenkins et al., 2010; Tsui et al., 2005), was confirmed by immunoblot analysis, while 
expression of all recombinant forms of CaMKIIα was comparable (Figure 28B; one-way 
ANOVA: F(3,28) = 25.84, P < 0.001, n = 8 samples per group). CaMKIIα activity in whole-cell 
lysates was measured in the presence of Ca2+, calmodulin, ATP, and the CaMKIIα selective 
substrate, autocamtide-2. Kinase activity differed across plasmid types (Figure 28C; one-way 
ANOVA: F(3,28) = 8.714, P < 0.001, n = 8 samples per group). The catalytic activity of phospho-
mimetic CaMKIIα (S331E) was significantly lower than that of the S331A mutant enzymes (P < 
0.05). The kinase activity of WT CaMKIIα was between the levels observed for S331A- and 
S331E-mutated lysates. Although the phosphorylation state of the WT CaMKIIα at S331 is 
unknown, it is likely that the total protein contains a mixture of phosphorylated and non-
phosphorylated S331, and as an autophosphorylation site, had the potential to be phosphorylated 
in the presence of Ca2+, calmodulin, and ATP. However, our results suggest that in HEK293 
cells, WT CaMKIIα is predominantly not phosphorylated, as kinase activity more closely 
mimicked that of the phospho-deficient mutant. 
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A.3.3 Inhibition of CaMKII in the BLA enhances drug-cue memory extinction 
Based on the apparent increase in an inhibitory phosphorylation event at S331 on CaMKIIα after 
extinction, and a decrease in phosphorylation after reactivation, we hypothesized that memory 
reconsolidation must require active CaMKIIα in the BLA, while extinction requires a 
deactivation of CaMKIIα. Therefore, we investigated if CaMKII inhibition could both inhibit 
drug-cue memory reconsolidation and enhance extinction to reduce relapse-like cue-induced 
reinstatement. For this set of experiments, rats again underwent standard cocaine self-
administration and lever extinction training before placement into memory manipulation groups. 
Following memory manipulations rats received immediate infusion of one of two doses of two 
related CaMKII inhibitors (KN-93 or KN-62) or the vehicle directly into the BLA, and the 
propensity to reinstate cocaine-seeking in response to the cue was assessed 24 h later (Figure 
29A). For all experiments involving CaMKII inhibition, there were no pre-existing differences 
between drug-treatment groups in number of reinforcers earned, active lever responding, or 
inactive lever responding during acquisition or lever extinction (KN-93: Figure 29B; KN-62: 
Figure 29C; all P > 0.05, n = 5-11 rats/group). This ensures that any memory manipulation or 
drug effect on cue-induced reinstatement was not due to pre-existing differences in propensity to 
self-administer drug or extinguish drug seeking.  
 Pavlovian cue extinction has previously been demonstrated as an effective method for 
reducing drug-cue motivated behavior (Torregrossa et al., 2010, 2013)). To determine if the 
effects of cue extinction on reinstatement could be amplified by inhibiting CaMKII, rats were 
given intra-BLA infusions of a CaMKII inhibitor immediately following two types of extinction 
training: 60 vs. 120 CS presentations. In this manner, we could determine if CaMKII inhibition 
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Figure 29. No differences in training data between groups prior to memory manipulations/BLA infusions. 
(A) Experimental timeline. Rats received bilateral infusions of one of two CaMKII inhibitors (KN-93 or KN-62) or 
vehicle into the BLA immediately following memory manipulation sessions. 24 h later, rats were tested for cue-
induced reinstatement under drug free conditions.  Data are displayed separately for groups treated with the CaMKII 
inhibitor KN-93 (B) or KN-62 (C). Left panels: Mean number of cocaine infusions per day during acquisition. 
Center panels: Mean number of active (solid shapes) and inactive (open shapes) lever presses per day during 
acquisition. Right panels: Mean number of active and inactive lever presses per day during instrumental extinction. 
For simplicity, data is grouped via dose of CaMKII inhibitor, collapsed across memory manipulation. There are no 
differences, in any measures, during acquisition or instrumental extinction between treatment groups for any of the 
memory manipulations (all p > 0.05). Data are expressed as mean + s.e.m. 
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could facilitate sub-optimal (moderate), as well as extended, extinction training. All cue 
extinction and reinstatement testing occurred in the same context to specifically understand 
extinction consolidation processes, rather than contextual encoding or renewal. CaMKII 
inhibition with either KN-93 or KN-62 following moderate cue extinction reduced subsequent 
cue-induced reinstatement (Figure 30A; KN-93: F(2,15) = 6.671, P = 0.009, n = 5-7 rats per 
group; KN-62: F(2,17) = 5.036, P = 0.019, n = 6-7 rats per group; both two-way ANOVAs). These 
data suggest that CaMKII inhibition after extinction training can enhance the effects of moderate 
cue extinction training to reduce reinstatement. On the other hand, an extended cue extinction-
duration protocol (120 cues) immediately followed by infusion of the CaMKII inhibitor KN-62, 
failed to reduce reinstatement relative to vehicle-treated controls. As a whole, all rats that 
experienced extended cue extinction in the self-administration context exhibited the expected 
extinction-induced reduction in reinstatement that could not be further potentiated by CaMKII 
inhibition (Figure 30A; two way ANOVA: P > 0.05, n = 6-8 rats per group), indicating that 120 
CS presentations likely produces a floor effect. These results are similar to previously published 
work demonstrating that extended cue extinction in the self-administration context could not be 
potentiated by treatment with D-cycloserine (DCS), even though DCS can promote extinction 
learning under other conditions (Torregrossa et al., 2010). 
A.3.4 Inhibition of CaMKII in the BLA interferes with drug-cue memory reconsolidation 
We then tested if CaMKII inhibition in the BLA following reactivation of the cocaine cue 
memory (3 CS presentations) could disrupt reconsolidation. After cocaine self-administration 
and lever extinction training, the cocaine-associated cue memory was reactivated in a novel  
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Figure 30. CaMKII inhibition enhances drug-cue memory extinction and disrupts memory reconsolidation to 
reduce cue-induced reinstatement. 
(A) Mean number of active lever presses during cue-induced reinstatement, 24 h after extinction manipulations. 
CaMKII inhibition by KN-93 (left panel) and KN-62 (middle panel) enhanced the effects of a single (moderate) cue 
extinction session. Both doses of KN-93 and the 680 ng/side dose of KN-62 significantly decreased reinstatement in 
the moderate extinction condition. CaMKII inhibition by KN-62 (right panel) had no effect after extended extinction 
training (p > 0.05). (B) Mean number of active lever presses during cue-induced reinstatement, 24 h after memory 
reactivation manipulations. CaMKII inhibition by KN-93 (left panel) and KN-62 (right panel) disrupted drug-cue 
memory reconsolidation. Both doses of KN-93, but only the 340 ng/side dose of KN-62 reduced reinstatement. Data 
are expressed as mean + s.e.m.; number of rats per group indicated by number inside bars. *P < 0.05 versus vehicle. 
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context, followed by immediate infusion of CaMKII inhibitors into the BLA. Rats were then 
tested for cue-induced reinstatement of cocaine seeking 24 h later.  KN-93 at both doses 
decreased active lever responding during reinstatement relative to VEH-treated controls, while 
only the low dose of KN-62 significantly reduced reinstatement (Figure 30B; KN-93: main 
effect: F(2,20) = 3.587, P = 0.047, n = 7-9 rats per group; KN-62: significant interaction between 
treatments: F(2,23) = 4.413, P = 0.024, n = 6-11 rats per group; both two-way ANOVA). Due to 
the consistency of effects with both doses of KN-93 and the low dose of KN-62, we suspect that 
the high dose of KN-62 produced non-specific effects that occluded any influence of CaMKII 
inhibition; however, we cannot rule out the possibility that there is a U-shaped dose effect 
function in the ability of CaMKII inhibition to interfere with memory reconsolidation. 
Nevertheless, together these data suggest that CaMKII may be important for the reconsolidation 
(restabilization) of the drug-cue memory following reactivation, and inhibition of CaMKII has 
the potential to interfere with this reconsolidation. 
A.3.5 Intra-BLA CaMKII Inhibition does not affect reinstatement in the absence of 
memory manipulations  
Finally, we wanted to confirm that the effects of CaMKII inhibition were selective to memory 
manipulations rather than non-specific effects on locomotion or motivation, and that inhibitor 
actions were mediated within the BLA.  First, we determined whether the highest dose of either 
CaMKII inhibitor could affect cue induced reinstatement if it was given following placement of 
rats in a novel operant context without cue presentation or the opportunity to make an 
instrumental response (i.e., a no reactivation control experiment). Post-session treatment with the 
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high dose of either KN-93 or KN-62 had no significant effect on active responding during cue-
induced reinstatement, indicating no effect on cocaine seeking in the absence of a memory 
manipulation (Figure 31A; Two-way ANOVA: P > 0.05, n = 5-9 rats per group). Therefore, 
effects of CaMKII inhibition on cue-induced reinstatement are likely due to specific actions on 
extinction and reconsolidation processes. Next, we determined if infusions of CaMKII inhibitors 
outside of the BLA had any effect on subsequent cue-induced reinstatement. We analyzed the 
data from animals whose vehicle or inhibitor infusion locations were found to lie outside of the 
BLA after histological analysis.  We included rats whose infusion locations were dorsal, lateral, 
and medial to the BLA. We found no significant effect of CaMKII inhibitors infused after 
extinction or reactivation of the cocaine memory on cue-induced reinstatement if the infusions 
were outside of the BLA, suggesting that drug spread into other regions does not explain our 
behavioral results (Figure 31B,C; both unpaired t-test: P > 0.05, n = 5-8 rats per group). 
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Figure 31. CaMKII inhibition has no effect on cue-induced reinstatement if the memory was not reactivated 
or infusions occurred outside of the BLA. 
(A) Cue-induced reinstatement in animals that did not receive drug-cue memory extinction or reactivation. For this 
control, rats were placed back in self-administration chambers, but received 0 CS presentations. There were no 
effects of CaMKII inhibition on active lever presses during the cue-induced reinstatement test. (left bar: vehicle, 
middle bar: KN-93, right bar: KN-62). (B-C) Cue-induced reinstatement in animals with infusions outside of the 
BLA. There were no effects of CaMKII inhibition on active lever presses during the cue-induced reinstatement test 
in rats that received infusions outside of the boundaries of the BLA after (B) a single (moderate) cue extinction 
session or (C) reactivation. Reinstatement data is from rats infused with either the effective dose of KN-93 or KN-62 
(5 μg/side and 680 ng/side, respectively). Rats were pooled due to the low numbers of animals in each individual 
inhibitor condition, and because there was no difference in reinstatement behavior between the compounds. Data are 
expressed as mean + s.e.m.; number of rats per group indicated by number inside bars. 
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A.4 DISCUSSION 
The present study identified brain-region specific protein phosphorylation events that occur in 
response to the reactivation or extinction of cocaine-cue-specific memories. Our proteomic 
analysis indicated that several cellular signaling cascades were activated in the same manner by 
both extinction and reconsolidation, including increased phosphorylation of extracellular 
regulated kinase 2 (ERK2) and 60S ribosomal subunits, which regulate protein synthesis. These 
results are consistent with prior findings in the literature indicating that ERK activity and protein 
synthesis are required for both the reconsolidation and extinction of memory (Cestari et al., 
2006; Duvarci et al., 2005; Tronson and Taylor, 2007). The proteomic analysis also revealed 
several phosphorylation events that were selective to one memory condition or the other, and 
importantly, identified 5 proteins that exhibited opposing directions of phosphorylation under 
extinction vs. reactivation conditions. Thus, we report the identification of several signaling 
pathways that may be viable targets for developing medications to be used in conjunction with 
memory-based behavioral interventions. In particular, phospholipase C and c-jun N-terminal 
kinase 3 are two proteins that have been associated with memory regulation in other paradigms, 
and deserve further study. It should be noted that it is possible that some of the protein 
phosphorylation changes observed are not related to memory, but rather could be associated with 
a change in motivational state. Nonetheless, use of this discovery-based approach represents a 
novel method for determining signaling events involved in specific memory processes.  
Specifically, we found a novel residue on CaMKIIα, S331, where phosphorylation was 
increased after extinction and decreased after reactivation.  Mutagenesis experiments indicated 
that phosphorylation of S331 reduced enzymatic activity of CaMKIIα. Additionally, we found 
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that pharmacological inhibition of CaMKII within the BLA can lead to a reduction in drug-cue 
motivated behavior if the inhibition occurs immediately following either memory reactivation or 
memory extinction. This is consistent with both a partial impairment in the reconsolidation of the 
original drug-cue memory and an enhancement in the learning/consolidation of the new cue-
extinction memory, effectively weakening the drug-associated memory trace. 
A.4.1 Targeting memory processes as a therapeutic strategy 
Manipulations that inhibit drug-cue memory reconsolidation and promote extinction have high 
therapeutic potential for relapse prevention in addiction (Sorg, 2012; Torregrossa et al., 2011). 
Despite a remarkable effort to develop pharmacotherapies for drug addiction, there has been little 
success in helping addicted individuals maintain long-term abstinence (Koob and Volkow, 
2010). Currently, clinical efforts that combine treatment medications with behavioral therapies 
have demonstrated the highest success rates (Carroll and Onken, 2005). A common behavioral 
approach involves exposing individuals to multimodal cues in an extinction-based therapy to 
decrease subsequent craving and relapse when drug-associated cues are re-encountered (Price et 
al., 2013). Previous research has demonstrated some effectiveness of this approach to inhibit 
fear-associated memories in rodent models and in humans (Hofmann et al., 2012; Monfils et al., 
2009; Ressler et al., 2004). In the present study, we show that a single cue extinction session is 
mildly effective in reducing responding for cocaine during a cue-induced reinstatement session, 
but that this reduction is amplified by the addition of a second cue extinction session, consistent 
with the fact that the number of unreinforced cue presentations is a critical determinant of 
extinction efficacy (Price et al., 2013; Unrod et al., 2014).  
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Although cue extinction therapy can have moderate success (Kantak and Nic 
Dhonnchadha, 2011; Price et al., 2010), developing medications that can be given in conjunction 
with exposure therapy to augment extinction learning will likely improve treatment outcomes. In 
particular, intra-BLA CaMKII inhibition immediately following a single cue-extinction session 
(moderate extinction) potentiated the reduction in cue-induced reinstatement observed 24 h later. 
CaMKII inhibition also disrupted reconsolidation, indicating that insufficient extinction training 
would not prevent efficacy, as may be the case for glutamatergic agonists like DCS (Lee et al., 
2009; Price et al., 2013). Therefore, inhibiting CaMKII signaling pathways in conjunction with 
exposure therapy may be a viable treatment strategy. However, CaMKII inhibition had no 
additional benefit after extended cue-extinction indicating a potential floor effect. Extended 
extinction alone was sufficient to drastically reduce levels of responding during reinstatement, 
even in VEH-treated animals, suggesting that sufficient exposure therapy could be beneficial, 
though the addition of CaMKII inhibition may have been able to inhibit renewal of cocaine 
seeking after a change of context or reduce spontaneous recovery, which could be tested in future 
experiments. 
A.4.2 Mechanisms of CaMKII action in memory processes 
Identifying CaMKIIα as an important component in the maintenance of drug-associated 
memories is not altogether surprising. It is well established that CaMKII activity is necessary for 
NMDAR-dependent forms of long-term potentiation (LTP) and synaptic modifications (Coultrap 
and Bayer, 2012; Lisman et al., 2012; Sanhueza et al., 2011). However, the identification of a 
phosphorylation event that is bidirectionally regulated by reconsolidation relative to extinction of 
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a memory is novel. CaMKII is activated by Ca2+ influx through NMDAR or voltage-gated Ca2+ 
channels, resulting in its autophosphorylation at T286. CaMKII then translocates to synapses, 
initiating a biochemical cascade, including phosphorylation of glutamatergic receptors that 
potentiates synaptic transmission (Barria, 1997; Bayer, 2006; Coultrap et al., 2014; El Gaamouch 
et al., 2012; Lemieux et al., 2012; Lu et al., 2010; Raveendran et al., 2009; Sanhueza and 
Lisman, 2013). Moreover, CaMKIIα knockout mice have deficits in LTP(Silva et al., 1992a), 
and in learning a hippocampus-dependent spatial task (Silva et al., 1992b), further demonstrating 
that CaMKIIα is necessary for memory formation. On the other hand, CaMKII activity, 
including phosphorylation of T286, is also needed for some forms of long-term depression 
(LTD) (Pi et al., 2010). Whereas CaMKII mediates LTP via phosphorylation of GluA1 at S831, 
LTD is likely evoked by CaMKII-mediated phosphorylation of GluA1 at S567 (Coultrap et al., 
2014). Thus, in our study, the effect of CaMKII inhibitors on reconsolidation and extinction 
might be explained by differential effects on LTP vs. LTD, respectively. 
Consistent with this possibility, it has been shown that increased activation of CaMKIIα 
can impair an NMDAR-dependent form of synaptic depotentiation in mice lacking cytoplasmic 
polyadenylation element binding protein 3 (CPEB3) (Huang et al., 2014). Coupled with the 
finding that CPEB3 KO mice exhibit deficits in the extinction of contextual fear memory (Chao 
et al., 2013), this further supports the notion that CaMKII inhibition could enhance extinction 
learning, and highlights a potential involvement of an LTD-like synaptic mechanism in this 
process. Additionally, there are a few reports that CaMKII also regulates memory 
reconsolidation. For example, reconsolidation of an amphetamine-conditioned place preference 
was disrupted by infusion of KN-93 into the hippocampus prior to re-exposure to the conditioned 
context (Sakurai et al., 2007). Likewise, CaMKII activity in the hippocampus is important for the 
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maintenance of a spatial memory after retrieval (Da Silva et al., 2013). On the other hand, the 
reconsolidation of a cocaine-associated contextual memory was not affected by intra-BLA 
CaMKII inhibition (Arguello et al., 2014). Although inconsistent with our results, the procedural 
differences between the two studies, including manipulating contextual rather than discrete cue 
memories, likely explains the differential findings. 
A.4.3 Role of CaMKII signaling in regulating drug-associated behaviors 
CaMKIIα phosphorylation events have recently been linked to drug-related learning (Easton et 
al., 2013, 2014; Salling et al., 2016). For example, mice without the capacity for CaMKIIα 
autophosphorylation (T286A mice) exhibited a delay in the establishment of a preference for 
cocaine, (Easton et al., 2014), and increased phosphorylation of CaMKIIα at T286 was observed 
in the amygdala after rats lever press for alcohol (Salling et al., 2016). In addition, reduction of 
CaMKIIα function in the NAc shell prevented amphetamine-associated plasticity and reduced 
self-administration (Loweth et al., 2013). Together these studies are consistent with our 
conclusions that CaMKIIα activity is a critical component of drug-related memory processes. 
Our proteomics results further suggest a very precise and novel, memory-specific regulation of 
CaMKIIα at S331. Phosphorylation of S331 has not been previously reported to change in a 
biological context, but a recent study has found S331 to be a putative autophosphorylation site 
that exists in vivo (Baucum et al., 2015). Interestingly, S331 is located within the linker region of 
CaMKIIα, and the linker region has the potential to regulate the function of CaMKII via multiple 
mechanisms in addition to kinase activity (Chao et al., 2011; Stratton et al., 2013). The present 
study is the first to report that S331 phosphorylation may inhibit kinase activity, suggesting that 
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CaMKIIα may have the ability to autoinhibit, potentially providing a negative feedback 
mechanism and/or a mechanism for mediating LTD. Future studies will further explore how and 
when this novel phosphorylation site on CaMKIIα is regulated, if memory manipulation-specific 
phosphorylation events occur in distinct sub-populations of BLA neurons, and how CaMKIIα 
S331 phosphorylation affects synaptic plasticity. 
A.4.4 Summary 
Taken together, the present study identified several signaling cascades regulated by the 
extinction and reconsolidation of a memory associated with self-administered cocaine. In 
particular, we identified a novel mechanism by which CaMKIIα can regulate both memory 
processes. Furthermore, our results suggest that inhibiting CaMKII or related signaling cascades 
could be a novel approach for combined behavioral and pharmacological therapy in the treatment 
of addictive disorders. 
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Table 1. Results from SRM Proteomics Analysis 
  Extinction vs. Control 
  SRM Stats Restricted Scope 
Linear Mixed Effects 
Model 
Protein Peptide Sequence + Modification(s) 
non 
adjusted 
pval 
Fold 
Change-
estimate 
adjusted 
pval 
non 
adjusted 
pval 
Fold 
Change-
estimate 
adjuste
d pval 
ADCY9  GQGTASpPGSpVSDLAQTVK  0.2413  0.3017  0.3475  0.5004  0.3017  0.7506 
AKA12 ALGSpLGGSpPSLPDQDK 0.0172 -0.5640 0.0403 0.3275 -0.5640 0.7284 
ARHG7 MSpGFIYQGK 0.4373 0.0582 0.5524 0.6516 0.0582 0.8530 
BAIP2 SSSpMAAGLER 0.7626 0.0362 0.8133 0.8628 0.0362 0.9557 
BSN SPQVLYSpPVSpPLSPHR 0.0118 0.2460 0.0340 0.1478 0.2460 0.7284 
CKD18 RASpLSDIGFGK 0.0000 -0.2172 0.0000 0.4012 -0.2172 0.7284 
CSKI1 KVPLPGPGSpPEVK 0.0173 -0.2256 0.0403 0.1374 -0.2256 0.7284 
CTNA1 SRTpSpVQTpEDDQLIAGQSAR 0.0144 -0.2016 0.0370 0.1565 -0.2016 0.7284 
CTNA1 SRTSpVQTpEDDQLIAGQSAR 0.0345 0.1416 0.0653 0.3944 0.1416 0.7284 
CTNB1 RTSMGGTpQQQFVEGVR 0.2586 -0.0518 0.3581 0.8423 -0.0518 0.9557 
CTND2 ALQSpPEHHIDPIYEDR 0.9798 -0.0032 0.9798 0.9794 -0.0032 0.9925 
CXA1 M(ox)GQAGSTISpNSpHAQPFDFPDDNQNAK 0.3219 -0.0462 0.4292 0.8552 -0.0462 0.9557 
CXA1 MGQAGSTISpNSpHAQPFDFPDDNQNAK 0.0152 -0.3070 0.0377 0.3096 -0.3070 0.7284 
CXA1 VAAGHELQPLAIVDQRPSSpRASpSpR 0.0000 -0.5198 0.0000 0.0540 -0.5198 0.7284 
DGKB GAITpPPRSSpPANTCSPEVIHLK 0.0032 -0.1344 0.0117 0.5449 -0.1344 0.7846 
EF1D ATAPQTQHVSpPMR 0.7508 -0.1949 0.8133 0.7508 -0.1949 0.8862 
FAK2 RNSpLPQIPTLNLESR 0.0000 0.2027 0.0000 0.2270 0.2027 0.7284 
FGF12 EPSpLHEIGEK 0.2060 -0.1028 0.3027 0.4973 -0.1028 0.7506 
GABR1 HPPTpPPDPSGGLPR 0.0002 0.1330 0.0011 0.4323 0.1330 0.7284 
GABR1 RHPPTpPPDPSGGLPR 0.0556 0.1371 0.1002 0.3379 0.1371 0.7284 
GABR2 DPIEDINSpPEHIQR 0.0035 0.2341 0.0119 0.2114 0.2341 0.7284 
GIT1 HGSpGAESDYENTQSGEPLLGLEGK 0.0000 -0.2619 0.0002 0.0726 -0.2619 0.7284 
GIT1 NQSDLDDQHDYDSpVASpDEDTDQEPLPSAGATR 0.1288 0.0910 0.2065 0.3636 0.0910 0.7284 
IF3M LLYLTpSpAK 0.5401 0.2342 0.6418 0.5401 0.2342 0.7846 
IPP2 EQESpSpGEEDNDLSPEER 0.9515 0.0051 0.9787 0.9830 0.0051 0.9925 
KCC2A ESSESTpNTpTpIEDEDTK 0.5437 0.0698 0.6418 0.8973 0.0698 0.9762 
KCC2A ESSpESTNTTIEDEDTK 0.0000 0.3596 0.0004 0.0737 0.3596 0.7284 
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KCNQ2 HGTSpPVGDHGSLVR 0.1291 -0.2891 0.2065 0.1291 -0.2891 0.7284 
KPCB HPPVLTpPPDQEVIR 0.0000 -0.1477 0.0002 0.5564 -0.1477 0.7855 
KPCG AAPALTpPPDR 0.5667 -0.2324 0.6535 0.5902 -0.2324 0.8058 
KPCG TpFCGTPDYIAPEIIAYQPYGK 0.0008 -0.1151 0.0034 0.4350 -0.1151 0.7284 
        
MARCS EAAEAEPAEPGSpPSAETEGASASSTSSPK 0.0000 0.2408 0.0000 0.1891 0.2408 0.7284 
MARCS GEAAAERPGEAAVASpSPSK 0.3813 0.2147 0.4992 0.3813 0.2147 0.7284 
MARK2 DQQNLPFGVTPASpPSGHSQGR 0.0020 0.1821 0.0075 0.0738 0.1821 0.7284 
MINK1 SDSVLPASHGHLPQAGSpLER 0.0001 0.1289 0.0005 0.2101 0.1289 0.7284 
MK01 VADPDHDHTGFLTpEYpVATR 0.0002 0.1278 0.0014 0.3636 0.1278 0.7284 
MK10 TAGTSFMMTpPYpVVTR 0.0236 -0.4020 0.0499 0.4244 -0.4020 0.7284 
NBEA EIEDLSQSQSpPESpETDYPVSTDTR 0.2533 0.0973 0.3576 0.4144 0.0973 0.7284 
NBEA TPLENVPGNLSpPIKDPDR 0.0180 -0.1595 0.0406 0.3981 -0.1595 0.7284 
NCAM1 DESpKEPIVEVR 0.9721 0.0015 0.9798 0.9925 0.0015 0.9925 
NCAM2 ITNHEDGSpPVNEPNETTPLTEPEK 0.0423 0.1622 0.0781 0.2935 0.1622 0.7284 
NCAM2 ITNHEDGSpPVNEPNETTpPLTEPEK 0.3886 0.4858 0.4996 0.3886 0.4858 0.7284 
NMDE2 HSQLSDLYpGK 0.9273 0.0241 0.9676 0.9608 0.0241 0.9925 
PAK1 TVSETPAVPPVSpEDEDDDDDATPPPVIAPRPEHTK 0.7681 0.0103 0.8133 0.9220 0.0103 0.9762 
PEA15 QPSpEEEIIK 0.7666 -0.0792 0.8133 0.8489 -0.0792 0.9557 
PLCB1 SEPSSPDHGSSpAIEQDLAALDAEMTQK 0.0129 -0.1209 0.0344 0.4324 -0.1209 0.7284 
PLCB1 VNLKSpPSpSEEVQGENAGR 0.1122 0.1155 0.1878 0.3816 0.1155 0.7284 
PP1R7 HGGGIVADLSpQQSpLK 0.0211 0.1865 0.0460 0.3519 0.1865 0.7284 
PPR1B IAESHLQTISNLSENQASpEEEDELGELR 0.0000 -0.3538 0.0001 0.5932 -0.3538 0.8058 
PTPRN LPEEGGSSpRAEDSSpEGHEEEVLGGHGEK 0.0263 0.2670 0.0513 0.4188 0.2670 0.7284 
RLA1 KEESpEESpEDDM(ox)GFGLFD 0.0002 0.2178 0.0013 0.1795 0.2178 0.7284 
RLA2 KEESpEESpDDDM(ox)GFGLFD 0.0003 0.3184 0.0016 0.1069 0.3184 0.7284 
RP3A WHQLQNENHVSSpD 0.4637 -0.2760 0.5757 0.4625 -0.2760 0.7506 
SCN2A RFSSpPHQSpLLSIR 0.0005 0.1191 0.0021 0.6348 0.1191 0.8464 
SHAN2 RAPSpPVVSpPTELSK 0.0002 0.2541 0.0014 0.3608 0.2541 0.7284 
SHAN3 SRSpPSpPSpPLPSPSPGSGPSAGPR 0.0263 0.2147 0.0513 0.3748 0.2147 0.7284 
SRBS2 SESpMGSpLLCDEGSK 0.0068 0.4027 0.0204 0.1111 0.4027 0.7284 
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SRCN1 DSGSSSVFAESpPGGK 0.0051 0.1440 0.0161 0.2492 0.1440 0.7284 
SRCN1 KAESpEELEIQKPQVK 0.6499 0.0178 0.7312 0.9149 0.0178 0.9762 
SRCN1 RFSpNVGLVHTSER 0.0005 -0.2261 0.0021 0.0394 -0.2261 0.7284 
SRCN1 RGSpDELTVPR 0.1518 -0.0512 0.2377 0.6823 -0.0512 0.8773 
SRCN1 SSpGATpPVSGPPPPAVSSTPAGQPTAVSR 0.3208 0.1193 0.4292 0.4850 0.1193 0.7506 
STMN1 DLSpLEEIQK 0.2030 0.0679 0.3027 0.7102 0.0679 0.8862 
STMN1 ESVPEFPLSpPPK 0.0251 -0.0784 0.0513 0.7438 -0.0784 0.8862 
STMN1 RASpGQAFELILSpPR 0.0123 0.2622 0.0340 0.3793 0.2622 0.7284 
STX1A HSAILASpPNPDEK 0.0676 -0.1172 0.1187 0.3204 -0.1172 0.7284 
STX1A TAKDSpDDDDDVTVTVDR 0.0004 0.1918 0.0020 0.1052 0.1918 0.7284 
SYPH LHQVYpFDAPSCVK 0.0847 0.0850 0.1452 0.7301 0.0850 0.8862 
SYT1 DQALKDDDAETGLTpDGEEK 0.4814 0.1493 0.5875 0.4814 0.1493 0.7506 
TNIK SEGSpPVLPHEPSK 0.1999 -0.0503 0.3027 0.3956 -0.0503 0.7284 
VIAAT GGAPLPPSGSpK 0.5718 -0.0553 0.6535 0.7363 -0.0553 0.8862 
 
  Reactivation vs. Control 
  SRM Stats Restricted Scope 
Linear Mixed Effects 
Model 
Protein Peptide Sequence + Modification(s) 
non 
adjusted 
pval 
Fold 
Change-
estimate 
adjusted 
pval 
non 
adjusted 
pval 
Fold 
Change-
estimate 
adjuste
d pval 
ADCY9 GQGTASpPGSpVSDLAQTVK 0.0041 0.5934 0.0084 0.1647 0.5934 0.4146 
AKA12 ALGSpLGGSpPSLPDQDK 0.7666 -0.0604 0.8119 0.9193 -0.0604 0.9734 
ARHG7 MSpGFIYQGK 0.0030 0.3177 0.0065 0.1157 0.3177 0.3783 
BAIP2 SSSpMAAGLER 0.7281 0.0759 0.8119 0.8649 0.0759 0.9730 
BSN SPQVLYSpPVSpPLSPHR 0.0063 0.2866 0.0120 0.0908 0.2866 0.3783 
CKD18 RASpLSDIGFGK 0.1156 -0.0447 0.1734 0.8288 -0.0447 0.9730 
CSKI1 KVPLPGPGSpPEVK 0.0305 -0.3568 0.0500 0.0260 -0.3568 0.2341 
CTNA1 SRTpSpVQTpEDDQLIAGQSAR 0.0604 -0.1133 0.0945 0.5393 -0.1133 0.7949 
CTNA1 SRTSpVQTpEDDQLIAGQSAR 0.0000 0.2878 0.0000 0.0124 0.2878 0.1491 
CTNB1 RTSMGGTpQQQFVEGVR 0.6712 0.0640 0.7922 0.8436 0.0640 0.9730 
CTND2 ALQSpPEHHIDPIYEDR 0.7668 0.0369 0.8119 0.7588 0.0369 0.9419 
CXA1 M(ox)GQAGSTISpNSpHAQPFDFPDDNQNAK 0.0000 0.3038 0.0000 0.1234 0.3038 0.3783 
CXA1 MGQAGSTISpNSpHAQPFDFPDDNQNAK 0.0000 0.3992 0.0001 0.1918 0.3992 0.4359 
CXA1 VAAGHELQPLAIVDQRPSSpRASpSpR 0.0000 -0.3599 0.0000 0.0198 -0.3599 0.2037 
DGKB GAITpPPRSSpPANTCSPEV 0.9499 -0.0044 0.9738 0.9901 -0.0044 0.9901 
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IHLK 
EF1D ATAPQTQHVSpPMR 0.7183 -0.2315 0.8119 0.7183 -0.2315 0.9403 
FAK2 RNSpLPQIPTLNLESR 0.0000 0.2167 0.0001 0.1670 0.2167 0.4146 
FGF12 EPSpLHEIGEK 0.0000 -0.8485 0.0000 0.2585 -0.8485 0.5444 
GABR1 HPPTpPPDPSGGLPR 0.5901 -0.0188 0.7201 0.9144 -0.0188 0.9734 
GABR1 RHPPTpPPDPSGGLPR 0.4862 -0.0397 0.6251 0.8359 -0.0397 0.9730 
GABR2 DPIEDINSpPEHIQR 0.0054 -0.2011 0.0105 0.3330 -0.2011 0.5994 
GIT1 HGSpGAESDYENTQSGEPLLGLEGK 0.3029 -0.0707 0.4194 0.5410 -0.0707 0.7949 
GIT1 NQSDLDDQHDYDSpVASpDEDTDQEPLPSAGATR 0.0002 0.2143 0.0005 0.0370 0.2143 0.2661 
IF3M LLYLTpSpAK 0.7412 0.1111 0.8119 0.7412 0.1111 0.9419 
IPP2 EQESpSpGEEDNDLSPEER 0.0052 0.3180 0.0104 0.2948 0.3180 0.5736 
KCC2A ESSESTpNTpTpIEDEDTK 0.0003 0.4759 0.0008 0.0322 0.4759 0.2578 
KCC2A ESSpESTNTTIEDEDTK 0.0000 -0.6186 0.0001 0.4973 -0.6186 0.7949 
KCNQ2 HGTSpPVGDHGSLVR 0.1937 -1.4748 0.2847 0.1937 -1.4748 0.4359 
KPCB HPPVLTpPPDQEVIR 0.0000 -0.1782 0.0000 0.6023 -0.1782 0.8339 
KPCG AAPALTpPPDR 0.3605 -0.3204 0.4806 0.3961 -0.3204 0.6633 
KPCG TpFCGTPDYIAPEIIAYQPYGK 0.0000 -0.2607 0.0000 0.1253 -0.2607 0.3783 
MARCS EAAEAEPAEPGSpPSAETEGASASSTSSPK 0.0000 0.3923 0.0000 0.0730 0.3923 0.3726 
MARCS GEAAAERPGEAAVASpSPSK 0.2646 -1.9668 0.3736 0.2646 -1.9668 0.5444 
MARK2 DQQNLPFGVTPASpPSGHSQGR 0.0000 0.2598 0.0001 0.0023 0.2598 0.0559 
MINK1 SDSVLPASHGHLPQAGSpLER 0.0085 0.1011 0.0153 0.3707 0.1011 0.6509 
MK01 VADPDHDHTGFLTpEYpVATR 0.0004 0.1374 0.0008 0.3844 0.1374 0.6590 
MK10 TAGTSFMMTpPYpVVTR 0.0002 0.7296 0.0004 0.1492 0.7296 0.4132 
NBEA EIEDLSQSQSpPESpETDYPVSTDTR 0.0088 0.2889 0.0155 0.0659 0.2889 0.3648 
NBEA TPLENVPGNLSpPIKDPDR 0.0003 -0.2541 0.0006 0.1069 -0.2541 0.3783 
NCAM1 DESpKEPIVEVR 0.4820 -0.0317 0.6251 0.8555 -0.0317 0.9730 
NCAM2 ITNHEDGSpPVNEPNETTPLTEPEK 0.9769 -0.0021 0.9769 0.9894 -0.0021 0.9901 
NCAM2 ITNHEDGSpPVNEPNETTpPLTEPEK 0.5354 -0.3821 0.6763 0.5354 -0.3821 0.7949 
NMDE2 HSQLSDLYpGK 0.9603 0.0113 0.9738 0.9690 0.0113 0.9901 
PAK1 TVSETPAVPPVSpEDEDDDDDATPPPVIAPRPEHTK 0.2036 -0.0521 0.2932 0.6999 -0.0521 0.9383 
PEA15 QPSpEEEIIK 0.7288 0.0539 0.8119 0.8991 0.0539 0.9734 
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PLCB1 SEPSSPDHGSSpAIEQDLAALDAEMTQK 0.0348 0.1013 0.0558 0.7037 0.1013 0.9383 
PLCB1 VNLKSpPSpSEEVQGENAGR 0.5520 -0.1562 0.6853 0.5302 -0.1562 0.7949 
PP1R7 HGGGIVADLSpQQSpLK 0.0001 0.4104 0.0002 0.0546 0.4104 0.3275 
PPR1B IAESHLQTISNLSENQASpEEEDELGELR 0.0000 -0.4040 0.0000 0.5816 -0.4040 0.8211 
PTPRN LPEEGGSSpRAEDSSpEGHEEEVLGGHGEK 0.0001 0.4983 0.0003 0.1004 0.4983 0.3783 
RLA1 KEESpEESpEDDM(ox)GFGLFD 0.0000 0.3790 0.0000 0.0048 0.3790 0.0868 
RLA2 KEESpEESpDDDM(ox)GFGLFD 0.0001 0.4373 0.0003 0.0009 0.4373 0.0559 
RP3A WHQLQNENHVSSpD 0.0067 -0.4470 0.0124 0.5687 -0.4470 0.8189 
SCN2A RFSSpPHQSpLLSIR 0.0000 0.4239 0.0000 0.0446 0.4239 0.2922 
SHAN2 RAPSpPVVSpPTELSK 0.0000 0.3424 0.0000 0.2148 0.3424 0.4686 
SHAN3 SRSpPSpPSpPLPSPSPGSGPSAGPR 0.0009 0.5152 0.0019 0.1261 0.5152 0.3783 
SRBS2 SESpMGSpLLCDEGSK 0.0002 0.6422 0.0005 0.0801 0.6422 0.3726 
SRCN1 DSGSSSVFAESpPGGK 0.0000 0.2076 0.0001 0.1560 0.2076 0.4146 
SRCN1 KAESpEELEIQKPQVK 0.0146 -0.1133 0.0250 0.4970 -0.1133 0.7949 
SRCN1 RFSpNVGLVHTSER 0.0000 -0.3600 0.0001 0.0083 -0.3600 0.1191 
SRCN1 RGSpDELTVPR 0.0001 -0.2053 0.0004 0.1774 -0.2053 0.4259 
SRCN1 SSpGATpPVSGPPPPAVSSTPAGQPTAVSR 0.9596 0.0141 0.9738 0.9630 0.0141 0.9901 
STMN1 DLSpLEEIQK 0.6268 0.0313 0.7522 0.8983 0.0313 0.9734 
STMN1 ESVPEFPLSpPPK 0.3329 -0.0552 0.4523 0.7488 -0.0552 0.9419 
STMN1 RASpGQAFELILSpPR 0.0000 0.5433 0.0001 0.1049 0.5433 0.3783 
STX1A HSAILASpPNPDEK 0.0193 -0.1344 0.0323 0.3284 -0.1344 0.5994 
STX1A TAKDSpDDDDDVTVTVDR 0.7533 -0.0147 0.8119 0.8233 -0.0147 0.9730 
SYPH LHQVYpFDAPSCVK 0.0037 -0.4914 0.0079 0.2792 -0.4914 0.5583 
SYT1 DQALKDDDAETGLTpDGEEK 0.0828 -0.2498 0.1269 0.0828 -0.2498 0.3726 
TNIK SEGSpPVLPHEPSK 0.0000 -0.3677 0.0001 0.0019 -0.3677 0.0559 
VIAAT GGAPLPPSGSpK 0.0002 -0.4927 0.0005 0.3042 -0.4927 0.5763 
 
 
 
Table 1. Results from SRM Proteomics Analysis 
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